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Abstract 
 
 
 Since centuries microorganisms have been used to produce fermented 
products. Nowadays, the consciousness about the importance of these bags to set 
up eco-friendly industrial workflows is pronounced more than ever. Nevertheless, bio-
based processes are much more ‘delicate’ than chemistry-based counterparts. For 
instance, microbes are susceptible to infections by viruses that are naturally present 
in raw matrices, such as the milk for diary industries. Moreover, viruses are the most 
abundant biological entities on Earth, thus the probability that a give microorganism 
could encounter such ‘predators’ is very high. In this regard, huge losses of 
fermenting biomasses have been already documented, thus leading to open the way 
to search for new solutions to meet this issue. One of the antiviral mechanisms that 
could be exploited to obtain resistant strains is the CRISPR-Cas system. This latter 
relies on the incorporation, upon infection, of sequences from the foreign nucleic acid 
into the host chromosome at specific CRISPR loci. A locus is an array repeats 
(similar in length and sequence) interspaced by spacers (dissimilar in sequence) that 
derive from foreign genetic elements, such as viruses and plasmids. Transcription of 
these loci generates long precursor pre-crRNAs that are subsequent processed to 
short crRNAs. Thereafter, these mature RNAs provide specificity to a 
ribonucleoprotein complex that degrades the invading nucleic acid. 
 To test the possibility of exploiting the CRISPR-Cas system to produce Virus 
Insensitive Thermophilic Strains (VITSs), it was resolved to analyse host-virus 
relationships between the thermophilic archaeon Sulfolobus solfataricus and two 
related member of the Fuselloviridae viral family, i.e. SSV1 and SSV2. Intriguingly, 
although these two viruses show strong similarities, such as virion morphology, 
genome sequence, gene synteny and expression patterns, it was shown that they 
are capable of inducing distinct hot reactions. Indeed, whereas SSV1 did not 
significantly affect the host gene expression, a strong host response was reported 
upon infection by SSV2. In particular, more than a hundred genes were differentially 
expressed during the growth of the SSV2-infected strain and, even more interesting, 
was the up-regulation of both CRISPR loci and cas genes. Data reported herein 
strongly suggest that the host response is influenced by the ability of the virus to 
control its own gene expression and genome replication during lysogenic growth. In 
this regard, it was found that SSV1 is a temperate virus that regulates the expression 
of its genes towards the activity of the transcription repressor F55. As a result, the 
SSV1 copy number is kept quite low and constant in the lysogenic cells. On the other 
hand, SSV2 lacks such a regulator and it is incapable of self-regulating its replication; 
therefore, the infection by SSV2 represents a mush more stressing load for the host. 
Moreover, this study highlighted an interesting feature of the host-viral interaction in 
the frame of the CRISPR-response, i.e. host cells containing an integrated copy of 
the viral genome (provirus) are forced to develop a surviving strategy in order to 
avoid self-attack by the CRISPR-system. This finding has cast doubt on the feasibility 
of using this system to challenge viral infections, at least as regards integrative 
viruses. Further implication and possible solutions to this potential drawback will be 
herein discussed. 
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Riassunto 
 
 I microrganismi, soprattutto quelli fermentanti, sono utilizzati da secoli per i 
processi produttivi più svariati. Classici esempi sono quelli della produzione di vino, 
birra, formaggi e pane. Infatti, si è ben presto compreso il loro impareggiabile valore 
nel trasformare le materie prime in prodotti con nuove ed attraenti caratteristiche 
organolettiche. Inoltre, a rendere sempre più richiesto l’impiego di batteri e lieviti nei 
processi industriali, vi è la capacità di questi ultimi di alterare le proprietà chimiche 
del prodotto (come il pH) e di produrre molecole con attività antibiotica che facilitano 
la conservazione dei prodotti fermentati. Il ruolo dei microrganismi nei processi 
industriali è divenuto ancora più importante grazie a numerose scoperte scientifiche 
che, nel corso degli ultimi decenni, hanno permesso di modificarli geneticamente 
rendendoli sempre più indispensabili come ‘bio-factories’, non solo per la produzione 
di prodotti alimentari. Infatti, da tempo si sono consolidate metodiche di produzione di 
molecole bioattive, quali vaccini, ormoni e anticorpi, nonché di biomasse microbiche 
da utilizzare come probiotici per complementare la dieta sia dell’uomo che del 
bestiame. Altrettanto importante è la possibilità di sostituire la sintesi chimica di 
molecole d’interesse commerciale con quella catalizzata da enzimi prodotti per via 
ricombinante in ceppi microbici, in modo da rendere sempre più ecosostenibili i 
processi di produzione industriale del futuro. Ciononostante, l’utilizzo di 
microrganismi pone numerose problematiche che riguardano, ad esempio, 
l’insorgenza di ceppi patogeni per l’uomo oppure dei possibili cali della resa 
produttiva dovuti a un depauperamento della biomassa microbica. 
 A tal proposito, non è raro che siano riportati casi d’ingenti perdite produttive 
dovute a infezione a carico della biomassa fermentante da parte di virus o 
batteriofagi (o fagi), che possono essere presenti naturalmente all’interno delle 
materie prime utilizzate. Infatti, come la maggior parte degli organismi viventi, i 
microrganismi sono spesso ‘prede’ di virus. Poiché è stato dimostrato che questi 
ultimi sono le entità biologiche più abbondanti sul nostro pianeta, è molto probabile 
che nel corso della propria esistenza ogni organismo sia infettato almeno una volta. 
Inoltre, la loro propensione ad accumulare facilmente mutazioni li rende 
particolarmente adatti a fronteggiare le variazioni ambientali, come ad esempio lo 
sviluppo d’immunità da parte dell’ospite. Questo è ancora più vero se il sistema virus-
ospite è costituito da un fago ed un batterio. Infatti, questi ultimi sono altresì capaci di 
adattarsi velocemente in risposta agli stimoli ambientali e hanno sviluppato 
numerose strategie per difendersi dalle infezioni virali. A tal proposito, è stato 
ipotizzato che il ‘conflitto’ tra microrganismi e virus  abbia rappresentato, e 
rappresenti ancora, la forza evolutiva più importante all’interno delle comunità 
microbiche. Questa continua ‘corsa agli armamenti’ è stata descritta molto 
efficacemente da Leigh Van Valen nel 1973 utilizzando un celebre romanzo di Lewis 
Carroll “Through the Looking-Glass, and What Alice Found There”. La famosa 
ipotesi, prende il nome di evolutionary arms race hypothesis o Red Queen 
hypothesis, e postula che l’adattamento del predatore (il virus) genera una pressione 
selettiva sulla preda (l’ospite) che a sua volta si ripercuote sul predatore stesso che 
deve contro-adattarsi per sopravvivere. Come risultato si ottiene che entrambi i 
protagonisti della ‘lotta’ vivano in un equilibrio instabile in qui devono continuamente 
adattarsi per aumentare le loro probabilità di sopravvivenza. Questa ipotesi giustifica 
largamente le innumerevoli strategie evolute dai microorganismi per difendersi dai 
virus e di conseguenza le contro-strategie impiegate da questi ultimi per evitare di 
estinguersi. 
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 L’involucro cellulare (membrana plasmatica e parete) rappresenta la prima 
barriera alle infezioni virali, infatti, il virus deve essere in grado di adsorbirsi alla 
superfice cellulare al fine di invadere la cellula ospite. Nella maggior parte dei casi, 
quest’evento richiede l’interazione tra una proteina di superficie della particella virale 
e uno specifico recettore esposto dall’ospite. È facile pensare che l’ospite possa 
sfavorire quest’interazione, ad esempio: i) mutando il recettore, ii) impedendo 
stericamente l’interazione, producendo una matrice extracellulare oppure iii) 
secernendo molecole simili al recettore che possano competere, interagendo con la 
proteina di superfice del virus. Di conseguenza, per infettare l’ospite, i virus possono 
evolvere: i) nuove varianti delle proteine di superficie in grado di interagire con il 
recettore mutato dell’ospite, ii) acquisire, attraverso trasferimento genico orizzontale, 
geni codificanti per enzimi che degradano le componenti della matrice extracellulare 
oppure iii) evolvere proteine di superficie che interagiscono con altri recettori. Se 
questa prima linea difensiva fallisce, il virus può iniettare il proprio genoma (DNA o 
RNA) all’interno della cellula ospite. Ciononostante, l’invasore si trova a dover 
fronteggiare altre barriere intracellulari che possono riconoscere l’acido nucleico 
virale come estraneo e degradarlo. Tra i più caratterizzati figurano i sistemi di 
modifica e restrizione, che si basano sull’espressione da parte dell’ospite di due 
enzimi: i) uno con attività transferasica (più comunemente una metil-transferasi) che 
modifica il DNA endogeno e ii) un enzima di restrizione, ovvero, una endonucleasi 
sequenza-specifica che taglia il DNA esogeno non modificato. L’efficacia difensiva di 
questi sistemi dipende dalla processività dell’enzima di restrizione, infatti, se il DNA 
estraneo viene modificato, non sarà più possibile riconoscerlo come ‘non-self’ e 
degradarlo. Alcuni virus sfruttano proprio questa ‘falla’ nel sistema per sfuggire alla 
restrizione enzimatica, ad esempio, esprimendo a loro volta enzimi di modifica 
oppure proteine che accelerano la processiva della metil-transferasi endogena. 
Sebbene questi sistemi abbiano permesso l’evolversi di metodiche d’ingegneria 
genetica tutt’oggi utilizzate, hanno trovato scarso utilizzo a livello industriale per 
rafforzare le difese delle biomasse microbiche. 
 Mentre i meccanismi descritti sinora possono essere paragonati all’immunità 
innata degli eucarioti, il sistema di difesa antivirale noto con il nome di CRISPR-Cas 
è sicuramente il progenitore dell’immunità adattativa. Infatti, si tratta di un sistema 
adattativo ed ereditabile che si basa sulla costruzione di una ‘memoria’ delle 
precedenti infezioni, attraverso l’incorporazione, all’interno del genoma dell’ospite, di 
brevi sequenze di DNA derivanti da virus o plasmidi. In particolare, le sequenze 
riconosciute sul genoma estraneo ‘protospacers’ sono inserite come nuovi ‘spacers’ 
all’interno dei loci CRISPR tra due sequenze identiche chiamate ‘repeats’, in modo 
da mantenere una classica struttura ‘repeat-spacer-repeat’. All’interno di un singolo 
locus possono essere presenti da uno fino a un centinaio di unità ‘repear-speacer’, 
dove le ‘repeats’ sono identiche in lunghezza e in sequenza all’interno di uno stesso 
locus, mentre gli ‘spacers’ differiscono nella loro sequenza e mostrano spesso 
identità con DNA virali o plasmidici. Affinché il sistema sia funzionale, un locus 
CRISPR deve essere trascritto in un lungo precursore noto con il nome di pre-crRNA 
(precursor CRISPR RNA), che sarà in seguito processato in corti crRNAs maturi che 
potranno essere utilizzati come guida nel riconoscimento dell’acido nucleico 
estraneo. Il tutto dipende dall’attività di numerose proteine Cas che intervengono 
nelle tre fasi fondamentali del processo, ovvero, l’adattamento, la trascrizione-
maturazione ed l’interferenza. Sulla base delle differenze nel funzionamento delle 
proteine Cas coinvolte è stato possibile distinguere tre tipi principali di sistemi 
CRISPR-Cas, che differiscono: i) nella modalità di selezione della sequenza 
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‘protospacer’, ii) nel tipo di proteine coinvolte e nel tipo di maturazione del precursore 
pre-crRNA, iii) nella composizione del complesso ribonucleoproteico che effettua 
l’interferenza, nonché iv) nel target finale, che può essere per alcuni sistemi il DNA 
(tipi I e II) mentre per altri sia il DNA che l’RNA (tipo III). La scoperta di un’immunità 
adattativa nel regno procariotico, che include Bacteria e Archaea, ha 
immediatamente aperto la strada a ricerche volte a comprendere come costruire 
ceppi microbici selettivamente resistenti contro un determinato tipo di virus. 
D’altronde, per sfruttare al meglio le potenzialità di tali sistemi, è necessario studiare 
e caratterizzare numerosi sistemi ospite-virus al fine di comprendere i meccanismi 
regolativi e le funzioni delle proteine coinvolte nel processo. 
 Nel presente progetto è stato utilizzato come organismo modello, per lo studio 
dell’interazione ospite-virus, il crenarchaeon termofilo Sulfolobus solfataricus. Tale 
scelta è stata basata su recenti analisi di genomica comparativa che hanno 
evidenziato la presenza massiva, proprio nei genomi di organismi termofili, di geni 
deputati a funzioni di difesa contro elementi genetici estranei. Infatti, sono state 
identificate delle vere e proprie ‘isole di difesa’ all’interno delle quali, si pensa, 
possano crearsi numerose opportunità di ricombinazione che potrebbero portare 
all’evolversi di nuovi sistemi di difesa. Inoltre, l’analisi del genoma di S. solfataricus 
ha mostrato la presenza di ben sei loci CRISPR e numerosi geni cas. Diversamente 
da altri Archaea e Bacteria, S. solfataricus codifica per differenti tipologie di 
complessi effettori (complessi ribonucleoproteici), ovvero: i) sottotipo IA, anche noto 
come complesso CASCADE, ii) sottotipo IIIA (complesso CSM) e iii) sottotipo IIIB 
(complesso CMR). Questi complessi gli permettono di degradare sia il DNA 
(CASCADE e CSM) che l’RNA (CMR), dunque, rendendolo un organismo 
d’eccezione per studiare anche l’interazione tra più sistemi CRISPR all’interno dello 
stesso ospite. Ad aggiungere un ulteriore livello di complessità, vi è la scelta dei virus 
utilizzati per infettare S. solfataricus. I due virus impiegati negli esperimenti descritti 
di seguito sono membri della famiglia virale Fuselloviridae, ovvero, SSV1 e SSV2. 
Sulfolobus spindle-shaped virus 1 (SSV1) è il membro fondatore della famiglia, 
poiché è stato il primo a essere isolato e caratterizzato. Sebbene il suo ospite 
naturale sia Sulfolobus shibatae B12 isolato da una pozza sulfurea in Beppu 
(Giappone), SSV1 è in grado d’infettare anche l’ospite permissivo S. solfataricus P2 
isolato in località Pisciarelli (Pozzuoli). SSV1 è l’unico virus UV-inducibile della 
famiglia Fuselloviridae e pertanto ha offerto un’opportunità unica di studio.  
Numerose analisi condotte negli ultimi trent’anni hanno permesso di caratterizzare a 
fondo l’interazione ospite-virus tra SSV1 e i suoi ospiti. In particolare, l’analisi 
dell’espressione genica di SSV1 ha portato non solo alla definizione della mappa 
trascrizionale virale, ma ha anche permesso di gettare le basi per comprendere 
come la trascrizione è regolata negli Archaea. Quando SSV1 infetta una cellula 
ospite, il virus integra una copia del proprio genoma all’interno del cromosoma ospite 
a livello di un gene codificante per un arginil-tRNA, formando quello che è noto come 
provirus. D’altra parte, diversamente da altri virus batterici UV-inducibili (come ad 
esempio il fago lambda), SSV1 è presente nella cellula ospite anche con un numero 
di 4-5 copie episomali (plasmidiche, non integrate). Questo dato è in accordo con 
l’identificazione di un ristretto numero di geni espressi dal virus durante la lisogenia 
che gli assicurano sia una replicazione basale che la produzione di progenie anche 
in assenza dello stimolo induttivo. Questo è possibile grazie alla natura non litica di 
SSV1. Appena le cellule lisogeniche sono esposte a luce ultravioletta, si                
può osservare un ‘pattern’ d’espressione virale cronologicamente regolato che 
comprende l’espressione di: i) un corto trascritto UV-inducibile chiamato Tind,            
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ii) i trascritti precoci (T5, T6 e T9), iii) i trascritti tardivi (T1/2, T3, Tx, and T4/7) e iv) quelli 
estesi tardivamente (T4/7/8). Questa cascata di eventi porta, in seguito, all’induzione 
della replicazione virale e ad un conseguente aumento del numero di copie di 
genomi virali. Ciononostante, finora è stato possibile solo ipotizzare le funzioni dei 
geni virali in base ai tempi d’espressione. Infatti, la mancanza di dati strutturali e 
funzionali, ha impedito qualsiasi ipotesi sul coinvolgimento dei singoli geni di SSV1 
nei processi d’ingresso/rilascio delle particelle virali, della replicazione e della 
trascrizione. Inoltre, i meccanismi regolativi che permettono a SSV1 di mantenere 
uno stato lisogenico stabile all’interno della cellula ospite non erano ancora noti. Per 
quanto riguarda invece il Sulfolobus spindle-shaped virus 2 (SSV2), erano evidenti 
alcune similitudini con SSV1, quali l’identità della sequenza genomica (65%), 
l’organizzazione del genoma stesso e la sintenia genica. Tuttavia, SSV2 è un virus la 
cui replicazione è indotta dallo stato metabolico/fisiologico dell’ospite, piuttosto che 
da uno stimolo esterno come la luce ultravioletta. Infatti, almeno nell’ospite naturale 
Sulfolobus islandicus REY 15/4, l’induzione della replicazione di SSV2 è regolata 
dall’ingresso nella fase stazionaria della crescita dell’ospite. Fenomeno, quest’ultimo, 
che non avviene nell’ospite permissivo S. solfataricus, nel quale SSV2 mostra un 
tasso di replicazione paragonabile a quello che si raggiunge nell’ospite naturale solo 
in fase stazionaria. Questo ha fatto ipotizzare che un regolatore prodotto da S. 
islandicus (e non da S. solfataricus) potesse essere responsabile delle differenze 
osservate. Le discrepanze nella modalità d’induzione della replicazione sono ancora 
più sorprendenti alla luce di un recente studio in cui è stato riportato che la mappa 
trascrizionale di SSV2 è praticamente sovrapponibile a quella di SSV1. Partendo 
dalle differenze e dalle similitudini appena descritte, in questo progetto si è proposto 
di studiare: i) le basi molecolari responsabili della regolazione dell’espressione 
genica e dell’induzione della replicazione di SSV1 ii) la risposta dell’ospite S. 
solfataricus in seguito all’infezione dei due virus e iii) l’interazione ternaria virus-
ospite-virus in un ceppo infettato contemporaneamente da SSV1 e SSV2. 
 Sebbene SSV1 abbia rappresentato negli ultimi trent’anni un modello per 
studiare l’interazione ospite-virus nel dominio Archaea, i meccanismi alla base dello 
‘switch’ dalla fase lisogenica all’induzione della replicazione virale erano ancora poco 
chiari. Un iniziale passo avanti nella comprensione di questo processo è stato fatto 
grazie ad esperimenti pilota condotti durante la tesi magistrale, nell’ambito di un 
progetto Erasmus (2009/2010), sotto la supervisione del professor Qunxin She 
presso il Danish Archaea Centre dell’Università di Copenaghen (Danimarca). Infatti, 
analisi preliminari di microarray su cellule di S. solfataricus infettate da SSV1, hanno 
permesso l’individuazione di un nuovo gene virale (f55) espresso da SSV1 in cellule 
lisogeniche. In particolare, la localizzazione di f55 lasciava pensare che la proteina 
da esso codificata (F55) potesse svolgere un ruolo chiave nel mantenimento della 
lisogenia. Infatti, f55 è localizzato all’interno di una regione del genoma virale che 
ricorda quella che codifica per il repressore CI nel genoma del fago UV-inducibile 
lambda. Inoltre, predizioni di struttura secondaria e terziaria indicavano che la 
proteina F55 potesse assumere una strutturazione di tipo Ribbon-Helix-Helix (RHH), 
tipica di repressori della trascrizione. Ancora più interessante e stata l’individuazione 
dei classici segnali di legame al DNA riconosciuti da questi regolatori, cioè, sequenze 
ripetutene in tandem all’interno dei promotori dei geni espressi in risposta 
all’irradiazione con luce ultravioletta. Tutte queste evidenze lasciavano ipotizzare un 
ruolo di F55 nel regolare l’espressione di questi geni importanti per l’induzione. Per 
questi motivi, il putativo repressore trascrizionale F55 è stato oggetto di 
caratterizzazioni in vitro e in vivo nell’ambito di questo progetto di dottorato, al fine di 
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comprendere il suo ruolo nella regolazione del ciclo vitale di SSV1 e come questo 
potesse ripercuotersi sulla risposta dell’ospite. Gli esperimenti riportati confermano la 
capacità di F55 di interagire in vitro con numerose sequenze operatrici ricavate dai 
promotori dei principali geni espressi durante la transizione dallo stato lisogenico      
a quello indotto. Inoltre, la messa a punto di un protocollo d’irradiazione 
standardizzato, ha consentito di studiare l’attività regolatrice di F55 in vivo, 
confermando il suo ruolo di repressore trascrizionale. I dati prodotti, non solo 
forniscono il primo esempio di fattore trascrizionale codificato da un fusellovirus la cui 
funzione regolatrice è stata sperimentalmente dimostrata, ma confermano, inoltre, 
che SSV1 è un virus temperato in grado di autoregolare la propria espressione 
genica e di conseguenza d’instaurare una pacifica co-esistenza con la cellula ospite, 
che non ha portato all’attivazione del sistema CRISPR-Cas da parte dell’ospite. 
 Tutt’altro scenario è fornito da SSV2, infatti, i dati discussi di seguito 
dimostrano che l’interazione da parte di questo fusellovirus comporta l’attivazione 
trascrizionale non solo dei loci CRISPR di S. solfataricus, ma anche di geni cas 
codificanti per proteine che costituiscono il noto complesso d’interferenza CASCADE. 
Questa evidenza è in totale contrasto con il pattern d’espressione di SSV2 in cellule 
lisogeniche, infatti, solo minime differenze sono state riscontrate quando paragonato 
con quello di SSV1. Esempi sono: i) l’espressione esclusiva di f55 da parte di SSV1, 
che non presenta un omologo nel genoma di SSV2 e ii) l’espressione di d79 e b223 
di SSV2, i cui omologhi non sono espressi da SSV1. Mentre la presenza del 
regolatore F55 conferma che il virus SSV1 sta controllando autonomamente la fase 
lisogenica, mantenendo anche un basso numero di copie, l’espressione della DnaA-
like B223 da parte di SSV2 lascia immaginare un tentativo da parte di ques’ultimo di 
far convergere il macchinario replicativo dell’ospite verso il proprio genoma, dunque, 
mantenendo un tasso di replicazione più elevato nella fase lisogenica. Ancora più 
interessante sono i dati ottenuto a seguito di una selezione di cloni singoli               
dal ceppo di S. solfataricus infettato con SSV2. In particolare, è stato dimostrato che 
l’attivazione del sistema CRISPR-Cas ha determinato un’effettiva diminuzione del 
numero di copie del genoma di SSV2 all’interno dell’ospite, ma purtroppo seppure 
alcuni cloni con una quantità minima di DNA virale siano stati isolati, non è stato però 
possibile identificare ceppi definitivamente ‘curati’ dall’infezione. Quando poi il sito 
d’integrazione virale all’interno dell’ospite è stato analizzato mediante esperimenti di 
PCR, è stato subito chiaro che l’impossibilità nell’isolare cloni curati dipendesse da 
fenomeni d’intrappolamento del genoma virale all’interno del cromosoma dell’ospite. 
Infatti, i cloni che mostravano una quantità minima di DNA virale, erano gli stessi che 
mostravano un grado di occupazione del sito di integrazione pari quasi al 100%. 
L’intrappolamento del provirus all’interno del genoma ospite può essere spiegato 
prendendo in considerazione che gli unici genomi virali ad esprimere una copia 
funzionale del gene codificante l’integrasi virale, deputata ad integrare ed escindere il 
DNA virale, sono quelle episomali, poiché la ricombinazione del DNA virale con 
quello dell’ospite porta alla ‘rottura’ di questo gene sulla copia provirale. Se               
si considera che l’attivazione del sistema CRISPR-Cas dell’ospite porta alla 
degradazione della maggior parte delle copie virali episomali, è semplice immaginare 
che questo evento abbia portato ai fenomeni di intrappolamento osservati. Ancora 
più interessante è la ripercussione sull’ospite di tale circostanza, infatti, analizzando i 
loci CRISPR delle cellule che mostravano il provirus intrappolato nel loro genoma, si 
è sorprendentemente osservato che uno dei loci (il locus F) avesse subito delezione 
di alcuni ‘spacers’. L’analisi della sequenza degli ‘spacers’ deleti ha evidenziato che 
almeno due di questi fungono da guida nell’interferenza contro il virus SSV2. Questo 
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dato pone una domanda molto interessante, ovvero: perché un ospite che sta 
reagendo contro  l’infezione virale tende a perdere ‘spacers’ contro il virus invasore? 
Questa domanda ha ricevuto una risposta alla luce di alcuni recenti studi che hanno 
dimostrato che la presenza nei loci CRISPR di ‘spacers’ diretti contro sequenze 
endogene non fosse da considerarsi come un’ulteriore evoluzione del sistema verso 
la regolazione dell’espressione genica endogena (tipo interferenze eucariotico), ma 
che l’incorporazione di sequenze ‘self’ fosse in realtà un errore seguito spesso dalla 
perdita della funzionalità dell’intero sistema. Come correlare queste informazioni con 
i risultati ottenuti? La risposta è fornita proprio dall’abilità dei fusellovirus d’integrarsi 
all’interno del genoma ospite, dunque, diventano vere e proprie sequenze ‘self’. 
Infatti, poiché le sequenze delle copie episomali e quella del provirus sono identiche, 
se il sistema di difesa è in grado di riconoscere e degradare le copie episomali, 
questo deve poter verificarsi anche con il provirus. Il taglio endonucleolitico a livello 
del provirus espone inevitabilmente estremità del DNA degradabili da esonucleasi, 
evento che con molta probabilità coinvolgerebbe anche il cromosoma dell’ospite. A 
tal proposito, è stato proposto che la pressione selettiva generata da questi eventi 
d’autoimmunità, abbia favorito l’insorgenza nella popolazione microbica di cloni 
cellulari con difetti nel funzionamento nel sistema di difesa, come ad esempio, la 
perdita di ‘spacers’ utilizzati per contrastare l’infezione di SSV2 dal locus F. 
Ciononostante, non è possibile escludere il verificarsi di altre possibili mutazioni che 
abbiano potuto inattivare il sistema antivirale, in modo da evitare fenomeni deleteri 
per la cellula ospite. 
 È chiaro che queste evidenze sperimentali possono ripercuotersi 
negativamente sulla possibilità di applicare tali sistemi per la costruzione di ceppi 
resistenti a specifiche infezioni virali, soprattutto per quanto riguarda le infezioni a 
carico di virus integrativi, che potrebbero sfuggire al controllo similmente a quanto 
mostrato per SSV2. A tal proposito, è stato proposto che una valida alternativa, per 
aggirare tali fenomeni di autoimmunità, potrebbe essere quella di sfruttare 
maggiormente sistemi CRISPR-Cas di sottotipo III-B che hanno come target finale 
l’RNA piuttosto che il DNA. Ad ogni modo, questo limiterebbe l’applicabilità ai soli 
ospiti che esprimono questo sottotipo di sistema. Un’altra soluzione potrebbe essere 
quella di utilizzare ceppi con siti d’integrazione mutati, anche se questo implica una 
conoscenza approfondita dell’interazione ospite-virus. Sebbene lo svantaggio 
dell’insorgenza dell’autoimmunità sia stato evidenziato da questo studio, i dati 
riportati sono molto interessanti da un punto di vista evolutivo. Infatti, come 
anticipato, l’adattamento di una delle parti in gioco (il virus) ha determinato 
l’instaurarsi di una pressione selettiva sull’altra parte (l’ospite), dunque confermando 
che: “la corsa evolutiva agli armamenti è una storia infinita!”. 
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1.1 The host-virus arms race: a never-ending story 
 
 Thanks to their amazing capability of adaptation to a variety of environmental 
conditions, prokaryotes (i.e. Bacteria and Archaea) are the most abundant organisms 
on Earth. Nevertheless, it has been predicted that in several niches, bacteriophages 
(infecting Bacteria and referred to hereafter as phages) and viruses (infecting 
Archaea) outnumber their hosts by approximately tenfold [1, 2], thus being formidable 
predators. Arguably, the fight between prey and predator is the oldest conflict acting 
on our planet and represents the most dominant and persistent evolutionary driving 
force in microbial communities [1, 2]. This struggle has led to a never-ending arms 
race, which has requested to either evolve or acquire (through lateral gene transfer) 
an extraordinary toolbox of defence mechanisms acting at multiple levels against 
phage infection [3]. In this regard, it is worth of note that in the 1973 Leigh Van Valen 
proposed the evolutionary arms race hypothesis, also known as Red Queen 
hypothesis, which proposes that environmental competition leads to the 
establishment of a selective pressure acting on the host and, in turn, to counter-
adaptations on the parasite side [4]. This theory explains the competition between 
hosts and parasites by referring to a famous Lewis Carroll's fantasy novel entitled: 
“Through the Looking-Glass, and What Alice Found There”. In this story, the Red 
Queen tells to Alice: 
 
“Now, here, you see, it takes all the running you can do, to keep in the same place. 
If you want to get somewhere else, you must run at least twice as fast as that!” 
 
The original hypothesis posits that in continuous co-evolutionary relationships, 
adaptation on one side (i.e., all the running you can do) would lead to the prospective 
extinction of the other side, unless this latter tries to maintain its fitness through 
counter-adaptation (i.e., run at least twice as fast as that). As a result, both sides live 
in a precarious balance where they have to continuously evolve in order to keep 
almost the same fitness level. This evolutionary trend is even more pronounced if the 
host and the parasite are a microorganism and a phage, respectively. In fact, the 
fast-forwarding evolution of phages is a selective pressure that constantly acts on 
microbial communities, thus guiding in turn their evolution [2]. 
 Generally speaking, the first step of the infection is the adsorption of a viral 
particle onto the host cell surface. This is a very complex event because a phage has 
to recognize a host-specific cell component (such as a receptor) among an 
uncountable number of molecules forming the host membrane and cell wall. 
Moreover, this process is made even more intricate because of the array of barriers 
evolved by prokaryotes to become immune to the infection. There are at least three 
major categories of adsorption-blocking mechanisms, which are: i) mutation or 
blocking of the phage receptor, ii) production of an extracellular matrix and iii) 
secretion of competitive inhibitors [1]. To interfere with the phage propagation, the 
host can modify the structure of the relative receptor or can produce proteins that 
mask it through stable interaction. Moreover, by producing structured extracellular 
polymers, the host cell can physically block the interaction between the phage and 
the receptor. For example, molecules having a role either in the communication with 
other member of the microbial population (quorum sensing) or in the competition with 
other strains (antimicrobial molecules) can interact with specific receptors, thus 
hindering phage adsorption [1]. As anticipated above, phages have to develop 
counterstrategies in order to cope with these host traits. In many cases, it has been 
______________________________________________________Chapter I –Introduction– 
 –10– 
demonstrated that phages have evolved new variants of their receptor-binding 
proteins either for adapting to the mutated receptor or for acquiring novel receptor 
tropism [3]. Tactics of digging for receptors have also been reported in literature. 
For instance, when the host receptor is hidden by components of the cellular 
envelope, phages can get access to them by degrading the extracellular matrix 
thanks to depolymerizing enzymes carried on the tip of the capsid. In some cases, 
the expression of a host-specific receptor is regulated in response to internal or 
external stimuli, thus rendering the phage adsorption a much rare event. Indeed, to 
face this stochastic expression and consequently to increase the chances of infecting 
the host cell, phages can expand their binding specificity through mutations of genes 
encoding receptor-binding proteins, to achieve stochastic recognition of variable 
host receptors [3]. When a viral particle (referred to hereafter as virion) stably 
attaches to the host surface, the viral nucleic acid has to be injected into the host cell. 
In this regard, it has been shown that this process can be a target of many 
superinfection exclusion systems that use membrane- or cell wall-anchored 
proteins to prevent phage DNA entry. Intriguingly, genes encoding for such proteins 
are usually found in provirus (i.e. integrated isoforms of the phage DNA, a.k.a pro-
phage). This suggests their importance in phage-phage rather than in host-phage 
interactions [1]. 
 Once the viral genome has managed to enter into the host cell, still it has to 
face with a multitude of intracellular antiviral barriers. Three major strategies have 
been evolved to challenge the establishment of foreign genetic elements (such as 
viruses and plasmids). One of the first being discovered and the most characterized 
is the restriction-modification system, which is present in 90% of bacterial and 
archaeal genome sequenced; indeed, it is almost a ubiquitous strategy to 
discriminate self from non-self DNA. This system relies on two distinct activities: i) a 
modification enzyme that labels the host DNA, usually through methylation of 
specific bases within a recognition sequence and ii) a restriction enzyme, which is a 
sequence-specific endonuclease acting only on unmodified DNA. Upon injection of 
an unmethylated phage genome, the restriction enzyme rapidly degrades the invader 
DNA. On the other hand, phages have evolved both passive and active mechanisms 
to avoid restriction-modification systems. It is easy to conceive that, for a foreign 
DNA, the chances of being restricted depend on the balance between the activities of 
the modifying and restriction enzymes. If the DNA methyltransferase acts rapidly by 
modifying the phage DNA before it is recognized by the restriction enzyme, the 
invader is protected. Moreover, phages with few or none restriction sites in their 
genome can take over as a consequence of the selective pressure. Alternatively, 
phages have evolved active counter-mechanisms to accelerate genome protection, 
such as acquiring genes encoding for: i) proteins that mask the viral DNA, ii) DNA-
modification enzymes or ii) proteins stimulating the activity of the endogenous 
modification enzymes [3]. 
 An astonishing system that prokaryotes evolved throughout the arms race 
against phages/viruses is the CRISPR (clustered regularly interspaced short 
palindromic repeats)-Cas (CRISPR-associated proteins) defence system [5]. If other 
systems can be compared to the innate immune response of eukaryotes, this latter 
might be considered as the ancestor of the adaptive immune response. Indeed, the 
CRISPR-Cas system is a highly adaptive and heritable resistance mechanism that 
incorporates sequences derived from foreign DNA elements into a small-RNA-based 
repertoire [5]. Briefly, it consists of a multistep process by which specific small 
fragments from the foreign nucleic acids are, at first, recognized as being non-self 
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and then incorporated into the host genome. Subsequently, these fragments 
(referred as spacers), in conjunction with host Cas proteins, are used as a 
surveillance and adaptive immune machinery, by means of which incoming foreign 
nucleic acids are recognized and destroyed or possibly silenced (for further details 
see par. 1.2). Once again, phages/viruses can counteract by: i) acquiring mutations 
that hinder the recognition of the target sequence, ii) expressing anti-CRISPR genes 
that have been suggested to encode for proteins interfering with the formation of the 
endogenous CRISPR-Cas surveillance complex and iii) encoding for CRISPR-Cas 
systems able to inactivate the host antiviral defence system [3]. If all these above-
mentioned protection mechanisms fail, the last chance of the host cell is the abortive 
infection, which is a programmed cell death activated once the host functions have 
definitively been corrupted by the phage. Although this “suicide” may appear as 
nonsense at single cell level, it prevents the spreading of infectious particles thus 
conferring an indisputable advantage to the surrounding microbial community. 
 Noteworthy, comparative genomic studies have recently revealed a high 
abundance of defence systems in the genomes of thermophiles (especially 
hyperthermophiles) if compared with mesophiles and psychrophiles [6]. Moreover, it 
has been observed that this group of defence genes clusters into genomic regions 
known as defence islands, i.e.: “strings of continuous genes, at least one of which 
belongs to a known defence gene families, and are flanked by house-keeping genes” 
[6]. Arguably, these islands are a “playground” for functional shuffling that can readily 
lead to the evolution of new defence systems that still remain to be discovered and 
exploited for biotechnological applications. In this regard, it is notorious that viral 
infections interfere with any industrial process relying on microbial metabolism for the 
production either of biocatalysts or of fermented products [7]. As a result, there is a 
growing interest in developing suitable protocols for the selection of phage-resistant 
microorganisms. In this context, the CRISPR-Cas system represents a powerful tool 
to set up safeguarded bioprocesses in the near future. 
 
 
1.2 CRISPR-Cas system: an overview 
 
1.2.1 Discovery and structural features 
 
 Long before its biological role was unravelled, in the 1987 Ishino and co-
workers made the first report on the CRISPR-Cas system. These authors found that 
immediately downstream the gene encoding for isozyme-converting alkaline 
phosphatase (iap) of Escherichia coli, there was a set of 29-nt repeats interspaced by 
unrelated and non-repetitive short sequences (spacers) [8]. Fast-forward 13 years, 
and the availability of sequenced microbial genomes allowed genome-wide 
computational searches that led Mojica and colleagues to define this sequences as a 
family of repeats recurring in many species of Bacteria and Archaea [9]. Later on, 
Jansen and co-worker coined the term CRISPR (Clustered Regularly Interspaced 
Short Palindromic Repeats) to reflect their characteristic structure [10]. Indeed, a 
typical CRISPR locus is an array of short direct repeats interspersed with spacer 
sequences (Fig. 1). Within a given locus, repeats are identical in length and 
sequence (Fig. 1, grey boxes) whilst spacers are highly variable sequences though 
uniform in length (Fig. 1, coloured boxes). 
 Repeat-spacer units range from as few as one to as many as several 
hundred, with an average of twenty. Soon after, computational analyses of spacers 
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revealed that they match sequences from extrachromosomal elements, such as 
plasmids and viruses. Moreover, other studies found a correlation between the 
sensitivity to the infection by a specific virus and the absence of spacers matching 
the genome of that particular virus, thus suggesting for CRISPR loci a plausible 
function as defence system [8]. Subsequently, by studying the lactic-acid bacterium 
Streptococcus thermophilus, it was finally validated that the CRISPR-Cas system 
plays a role in challenging foreign genetic elements. In particular, different spectra of 
phage sensitivity were detected for strains of S. thermophilus showing CRISPR loci 
with different number and type of spacers. Additionally, it was shown that the 
acquired resistance could be lost if mutations occur either in the spacer or in the 
complementary sequence within the targeted phage DNA, i.e. the protospacer [7]. 
 Sequence analysis of genomes containing multiple CRISPR loci uncovered an 
additional conserved region, namely the leader sequence, which precedes the 
repeat-spacer array (Fig. 1, black box). This conserved element is an AT-rich region 
with intra-species but not inter-species conservation. Indeed, it is up to 80% identical 
within a given genome but it is quite dissimilar among different species. The leader 
extends over several hundred base pairs, it lacks coding potential and is always 
found at one side of the CRISPR in a fixed orientation [11]. Recent studies have 
assigned to the leader sequence a role in guiding the expression of the downstream 
CRISPR locus as well as in the acquisition of new spacers, a process known as 
adaptation. 
 CRISPR-associated (cas) genes, a set of conserved protein-coding genes 
associated with the loci, are usually located at one side of the repeat cluster (Fig. 1, 
coloured arrows). Extensive bioinformatics analyses have shown that the genomes of 
various CRISPR-containing microorganisms encode approximately 65 distinct sets of 
orthologous Cas proteins with nucleases (RNase and/or DNase activity), helicases, 
polymerases and RNA-binding activities. Unfortunately, the nomenclature of these 
genes depends on the classification criteria used and can easily create confusion 
[12]. 
 
 
 
 
 
 
 
 
 
 
Figure 1. Structure of a CRISPR-Cas locus. Repeat sequences (grey boxes) are interspaced by 
spacers (coloured boxes) of approximately the same size. The number of repeat-spacer units varies 
greatly among different microorganisms. An AT-rich leader sequence (black box) is several hundred 
base pairs long and located at one side of the array. CRISPR-associated cas genes are usually 
located at one side of the locus. 
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1.2.2 Mechanism of action 
 
 CRISPR activity can be ideally divided into three steps: adaptation, 
expression and interference. 
 
 Adaptation: incorporation of new spacers 
 An essential prerequisite of any adaptive immune system is the ability of 
acquiring a memory of past invaders in order to face future infections. Therefore, the 
first step of CRISPR-Cas defence systems consists in the recognition of short DNA 
sequences on foreign genetic elements (i.e. protospacers) and their incorporation 
into a CRISPR array, as new spacers (Fig. 2) [13]. This event will provide resistance 
(immunization) against foreign genetic elements carrying the protospacer. With few 
exceptions, new spacers are inserted at the leader-proximal region of the CRISPR 
locus, with most integrations occurring at the first position in the cluster. The 
integration is coupled with the duplication of a repeat, thus allowing the maintenance 
of the typical pattern of spacer-repeat units (Fig. 2). Nevertheless, the loss of one or 
more repeat-spacer unites has also been observed and may be part of control 
mechanisms evolved to avoid the continuous growth of the locus [11]. Although our 
current knowledge of the adaptation process is still in its infancy, a crucial role has 
been assigned to the universally conserved Cas1 and Cas2 proteins (Fig. 2) [13]. 
However, several conserved cas genes as well as accessory factors might be 
involved in spacer acquisition [14]. As concerns the selection of the protospacer it 
has been experimentally demonstrated that, in some cases, it is not a random event 
but it depends on the presence of a sequence termed Protospacer Adjacent Motifs 
(PAMs), i.e., a 2-3 nucleotides motif located at one end of the protospacer sequence 
[14]. 
 
 Transcription and processing 
 Once a spacer is inserted in a CRISPR locus, it is essential to transcribe the 
repeat-spacer array to generate a long precursor, i.e. a pre-crRNA (precursor 
CRISPR RNA). In general, transcription of the CRISPR loci is constitutive and 
unidirectional, even if exceptions have been reported in Sulfolobus spp. [12]. 
Additionally, experiments in T. thermophilus suggested that the CRISPR-Cas 
pathway is activated under carbon source limitation, thus allowing speculations about 
mechanisms of transcription regulation depending on the host metabolism [11]. The 
initial processing of the pre-crRNA involves endoribonucleolytic cleavages within the 
repeats to release small crRNAs (Fig. 2). Further trimming of these short RNAs 
leads to the production of mature crRNAs that sequence-specifically guide the 
interference machinery towards invasive targets. Several modalities of maturation 
and targeting have been described, leading to the classification of CRISPR systems 
in three main types, i.e. type I, II and III (for further details see par. 1.2.3). 
 
 The interference phase 
 Once generated, mature crRNAs form crRNA-Cas ribonucleoprotein 
complexes (crRNP) and guide, through base-pairing, the recognition of the invasive 
genetic element (Fig. 2). Several lines of evidence indicated that, in numerous 
species, the CRISPR machinery recognizes DNA rather than RNA targets, though in 
P. furiosus these systems showed to be able to target RNA [13, 14]. Efficient immune 
mechanisms must distinguish self from non-self to avoid autoimmunity and 
CRISPR-Cas systems are not an exception. In this case, discrimination occurs during 
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the interference phase. The spacer region of a mature crRNA, which is embedded in 
a CRISPR-Cas surveillance complex, is not sufficient for such discrimination since it 
is also complementary to its template in the CRISPR locus on the host chromosome. 
Nevertheless, the aforementioned PAM motif has been demonstrated to play a 
relevant role in this process. This short sequence is located at one end of the 
protospacer sequence (on the invasive genetic element) but is no longer present in 
the spacer sequence at level of the CRISPR locus. Arguably, the partial mismatch 
between the crRNA and the protospacer causes a conformational change that leads 
to the cleavage of the target, whereas the full complementarity between the crRNA 
and the spacer of the endogenous CRISPR locus spares the host chromosome from 
interference [15]. 
 
 
 
Figure 2. Overview of the CRISPR-Cas mechanism of action. Upon infection, spacers derived from 
the invading DNA are incorporated into a CRISPR locus (adaptation). The repeat-spacer array is then 
transcribed into a pre-crRNA, which is processed to short crRNAs (transcription and processing). 
Upon subsequent infections, mature crRNAs provide sequence-specificity to the ribonucleoprotein 
complex, which detects and cleaves the foreign nucleic acid. 
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1.2.3 A new classification 
  
 An initial classification, based on the analysis of 40 bacterial and archaeal 
genomes, divided the CRISPR loci into twelve classes and named cas genes using a 
simple three-letters code. For example, to an E. coli cas gene could be assigned the 
cse code (CRISPR system of E. coli gene), where a number indicates its position 
within a cas gene cassette (e.g., cse1, cse2) [12]. Although this system offered a 
simple classification code, it did not take into account the phylogenetic relationship 
among cas genes. Recently, a new polythetic classification was proposed to 
integrate CRISPR loci and cas genes phylogenies and introduced three major types 
of CRISPR systems (i.e., type I, II, and III) that can be further divided into subtypes 
(i.e., type I-(A-F), type II-(A-B), and type III-(A-B)) [16]. 
 
 Type I CRISPR–Cas systems 
 A hallmark of all type I CRISPR-Cas systems is the cas3 gene, which encodes 
for a protein with helicase and phosphohydrolase activities. In some subtypes (A, B, 
and D), separate genes encode for the nuclease and helicase domains of Cas3. To 
protect the host from the infection, Cas3 interacts with a crRNA-guided surveillance 
complex formed by other Cas proteins as well as by RAMP proteins (Repeat 
Associated Mysterious Proteins) (Fig. 3). The first CRISPR-associated complex 
being isolated and characterized is that of E. coli K12 (type I-E), which was termed 
CASCADE complex (CRISPR-associated complex for antiviral defence). The crystal 
structure of Cas7 (one of its component) revealed that this protein assembles along 
the ribose-phosphate backbone of the mature crRNA and keeps it in an under-wound 
and stretched conformation. The CASCADE complex, recently isolated and studied 
also in Sulfolobus solfataricus (type I-A), cleaves long pre-crRNA into mature 61-nt 
crRNAs. In the interference phase, the recognition of the target sequence by the 
ribonucleoprotein complex leads to conformational changes that, in turn, allow the 
recruitment of Cas3 to cleave the invader DNA (Fig. 3) [12, 16]. 
 
 Type II CRISPR–Cas systems 
 To date, CRISPR-Cas systems belonging to the type II have been found only 
in Bacteria. The cas gene cluster generally consists of four genes, i.e., cas1, cas2, 
cas9 and either csn2 (type II-A) or cas4 (type II-B). Likewise the type I, the final 
target of the interference complex is the DNA. The multifunctional protein Cas9 has 
been shown to play a role in both mature crRNAs biogenesis and in the degradation 
of invading DNA (Fig. 3). Nonetheless, crRNAs maturation for the type II systems 
requires also: i) a tracrRNA (trans-encoded small RNA), which is complementary to 
the repeat sequences of the pre-crRNA and ii) an endogenous RNase III enzyme 
(Fig. 3). Briefly, Cas9 binds to a pre-crRNA and recruits the tracrRNA that           
forms a local dsRNA (double-stranded RNA). This is followed by the endonucleolytic 
cleavage catalyzed by the RNase III. A further maturation might be carried out by 
Cas3, which trims the crRNA at a fixed distance within the spacer sequence.           
At last, the mature crRNA-Cas9 complex can detect and degrade the exogenous 
DNA (Fig. 3) [16]. 
 
 Type III CRISPR–Cas systems 
 This kind of systems are widespread in Archaea and, unlike those of types I 
and II, involve both Cas and RAMP proteins. The first step is the binding of Cas6 (a 
CRISPR-specific endoribonuclease) to the pre-crRNA that is cleaved at the 3’-end of 
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the repeat (Fig. 3). The crRNA is likely transferred to a distinct complex, i.e.: i) to the 
Csm complex for the subtype III-A (also known as CASS6) or ii) to the Crm 
complex for the type III-B (also known as RAMP module). In subtype III-B systems, 
the 3!-end of the crRNA is further trimmed within the spacer sequence (Fig. 3). 
Whereas for type I and II complexes the final target is the DNA, a type III complex 
detects and cleaves either DNA (subtype III-A systems) or RNA (subtype III-B 
systems) (Fig. 3). Type III gene cassettes may lack cas1 and cas2 genes, but in all 
these cases at least an additional CRISPR locus (of either type I or type II) is present 
and probably provides in trans Cas1 and Cas2 functions [16]. 
 
 
 
Figure 3. Three major types of CRISPR-Cas systems. With the exception of the type III, the 
selection of a protospacer from the invading nucleic acid depends on the presence of a PAM motif. 
During the expression stage, the CRISPR locus is transcribed into a long primary CRISPR transcript 
(the precrRNA). In type I systems, the CASCADE complex recognizes the pre-crRNA and cleaves it 
by means of Cas6. The resulting short crRNAs is used to detect and degrade the invading DNA. 
Instead, type II systems use a trans-encoded small RNA (tracrRNA) and the housekeeping RNase III 
to bind and process the pre-crRNA into mature crRNA, which are further trimmed by Cas9 within the 
spacer. In type III systems, although Cas6 is responsible for the initial processing, the crRNAs seem to 
be transferred to a distinct Cas complex (Csm or Crm). 
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1.2.4 Self-targeting spacers: dangerous weapons? 
  
 The finding that CRISPR spacers mainly match to sequences from foreign 
genetic elements has directed early experimentations to the elucidation of its role as 
defence system. However, a recent analysis carried out by Stern and colleagues 
have shown that self-targeting spacers occur in 18% of all CRISPR-bearing 
microorganisms [17]. Although this evidence could lead to hypothesize that CRISPR 
systems participate to unexplored gene regulation mechanisms [18], Stern’s results 
point out that the incorporation of self-targeting spacers leads to autoimmunity and, in 
turn, to the loss of CRISPR function [17]. Indeed, several lines of evidences cast 
doubts on the hypothesis that the self-targeting spacers serve to regulate gene 
expression, i.e.: i) self-targeting spacers do not confer a selective advantage, indeed, 
they are not conserved over a phylogenetic lineage; ii) many of them have been 
found at the leader-proximal region of the CRISPR loci, thus indicating that they 
‘survive’ only over a short time window because they are detrimental for the host; 
moreover, iii) acquisition of self-targeting spacers are frequently associate with the 
partial or complete loss of CRISPR-Cas functionality [17]. Accordingly, it has been 
demonstrated that when S. solfataricus is transformed with a plasmid that carries an 
essential gene and is also a target of the CRISPR system, surviving transformants 
show mutations that eliminate the plasmid-targeting spacer [19]. Intriguingly, these 
evidences open the way to hypothesize that the CRISPR system might be dangerous 
for the host itself [20]. 
 
 
1.2.5 Current and prospective applications 
 
 Spoligotyping: a spacer-oligotyping method  
 In the adaptation stage new spacers are incorporated into the CRISPR loci, 
thus explaining rapid changes in their structure. As a result, within a microbial 
community, several subpopulations differ in the content and type of spacers. This 
observation led Kamerbeek and colleagues to develop a spacer-based method for 
the genotyping of Mycobacterium tuberculosis strains, also known as spoligotyping. 
This method is based on a DNA hybridization approach that allows discriminating 
different strains by means of their spacer repertoires [8]. Later on, spoligotyping has 
become a consolidated procedure for studying the evolution of bacterial populations 
and species in the context of genome sequencing projects. Nevertheless, its 
applicability has to be evaluated case-by-case, because of the high dynamism of 
CRISPR loci [21]. 
 
 
 Engineered defence against viruses 
 Bacteriophages have the potential to interfere with any industrial workflow that 
produces bacteria as an end product (such as starter cultures, live mucosal vaccines 
or probiotics) or use them as biocatalysts for the production of fermented food as well 
as of bioactive molecules (such as enzymes or metabolites). Viral infections can 
readily lead to cultures losses during industrial bioprocesses that rely on microbial 
metabolism. For this reason, companies (such as dairy and wine industries) are 
currently investing on research projects devoted to find new solutions in order to 
combat phage infections. In this regard, CRISPR systems might be exploited to 
design powerful methods to meet this need. For example, it would be possible to 
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boost the immunity of starter cultures by naturally or artificially adding new spacers 
into CRISPR loci [7, 8]. 
 
 
 Specific silencing of endogenous genes 
 Functional genomics analyses of molecular components of CRISPR-Cas 
systems pointed out to a certain degree of analogy with those involved in the 
eukaryotic pathway of RNA interference (RNAi) [22]. Although this hypothesis needs 
to be experimentally confirmed, it is expected that enzymatic activities from CRISPR-
Cas systems would represent a potential toolbox to knock-down specific gene 
functions. Interestingly, several independent studies on model systems, such as 
Streptococcus pneumonia, Escherichia coli, Streptococcus pyogenes and 
Staphylococcus aureus, have demonstrated that type II CRISPR systems can be 
reprogrammed to engineer bacterial genomes [23, 24]. For example, several E. coli 
genes encoding enzymes with β-lactamase activity were targeted, thus narrowing the 
spectrum of antibiotic resistance of the microbial population [23]. 
 
 
1.3 CRISPR-Cas systems of the themophilic archaeon Sulfolobus solfataricus 
  
 Unlike other Archaea and Bacteria showing one type of effector complex, 
genome sequence analysis revealed that S. solfataricus P2 harbours: i) six CRISPR 
loci (named from A to F), showing two families of repeats; ii) four cas6 genes, 
important for the maturation of the pre-crRNA; iii) three acquisition cassettes and 
iv) seven interference cassettes coding for different effector complexes, i.e. three of 
subtype   I-A (CASCADE complex), one of subtype III-A (CSM complex) and three 
of subtype III-B (CMR complex) (Fig. 4). Altogether these features make this 
thermophilic archaeon an exceptional model for studying the interplay among 
different types of CRISPR-Cas systems [25]. Leader and repeat sequences are 
similar for the loci A and B (repeats family II), which have in their proximity two 
acquisition cassettes (Fig. 4). Similar gene cassettes are also located nearby the loci 
C, D and E (repeats family I), which share both repeat and leader sequences as well 
[27]. An exception is the locus F that lacks a leader sequence, thus being inactive in 
new spacer acquisitions (Fig. 4) [25, 26]. The association between a certain repeats 
family and an acquisition cassette led to speculate that specific Cas1/Cas2 couples 
are required in the adaptation phase of the related loci. Nevertheless, it has been 
demonstrated by in vivo experiments that no spacers were acquired by CRISPR loci 
A and B, although they have nearby a complete integration cassette (Fig. 4) [28]. 
However, their inactivity in new spacers integration is not correlated with an impaired 
capability of performing interference, indeed, loci A and B have been shown to be 
functional during the interference process [19, 26]. 
 The biogenesis of mature crRNAs in S. solfataricus is potentially a complex 
process; indeed, four cas6 paralogues have been identified in its genome (Fig. 4). 
For two of them (encoded by sso1437 and sso2004), it has been shown that the cut 
of the crRNA occurs at 8-nucleotides from the 3’-end [25]. As for the cas1/cas2 gene 
couples, the proximity of each cas6 gene to a different cas operon encoding 
CASCADE and/or CSM complexes, reinforces the idea of a functional association 
between a distinct Cas6 and a certain ribonucleoprotein complex [26]. Nevertheless, 
another possibility is that single Cas6 proteins can process pre-crRNA derived from 
all different CRSIPR loci. This would explain why, in the study by Lintner and 
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colleagues, a single CASCADE complex was able to interact with crRNAs derived 
from all the CRISPR loci [29]. Mature crRNAs produced by Cas6 may be loaded into 
three types of effector complex, although a stable interaction between Cas6 and 
these complexes has never been demonstrated. Three interference cassettes on the 
S. solfataricus genome (Fig. 4, IA-1, - IA-2 and IA-3) encode for CASCADE 
complexes showing high similarity to those of the E. coli [29]. In all these operons, 
gene position is conserved, i.e. they harbour in the following order: i) a csa5 gene, 
coding for the so-called ‘small’ subunit, followed by ii) cas7 and cas5 that probably 
assemble in a stable heterodimer and form the core of the complex and iii) cas3’ and 
cas3’’ coding for the helicase and nuclease subunits of Cas3, respectively [29]. 
Moreover, the gene cluster lying between loci A and B contains a member of the 
Cas8a2 family (Fig. 4, IA-1). As shown by many authors, the final target of these 
CASCADE complexes is DNA rather than RNA molecules [19, 28, 30]. 
  
 
 
Figure 4. CRISPR-Cas systems organization in S. solfataricus P2. Genes encoding for effector 
complexes are boxed and color-coded accordingly to the above key. 
 
 Whereas in E. coli and other Bacteria the interference activity can be readily 
inactivated by the occurrence of one or very few mismatches between the spacer (on 
the crRNA) and the protospacer (on the foreign nuclei acid), for S. solfataricus an 
unexpected permissiveness has been experimentally demonstrated [30]. Indeed, its 
CASCADE complexes can tolerate up to 15 mismatched at the 3’-half of the crRNA 
(50-60 nt long), being still able to trigger 50% of target degradation. Nevertheless, 
likewise in E. coli, it was also confirmed the importance in the interference process of 
the seed sequence (i.e. the first 8-nucleotides at the 5’-end of the crRNA) [30]. S. 
solfatarcus encodes also for three CMR complexes, the structure of which consists of 
seven subunits Cmr1–Cmr7 (formerly known as RAMP proteins) that assemble 
around a central crRNA. Whereas Cmr7 is over-represented, the other subunits are 
likely present as single copies in the complex [25, 26]. In this subtype IIIB system, the 
______________________________________________________Chapter I –Introduction– 
 –20– 
crRNA guides, in a sequence-specific manner, the CMR complex to cleave an RNA 
target. 
 The wide plethora of CRISPR loci, cas genes and interference complexes 
encoded by S. solfataricus suggests a specialization of these complexes in targeting 
heterogeneous genetic elements. Moreover, as mentioned above, pull-down assays 
have demonstrated that crRNAs coming from all different CRISPR loci can interact 
with a single type of CASCADE complex, thus forming “mixed” complexes [29]. This 
further expands the already intricate “arsenal” of defence strategies employed by     
S. solfataricus. Arguably, the extensive versatility of its CRISPR systems may be 
related to the huge abundance and diversity of viruses inhabiting the same niches. 
 In fact, archaeal viruses show morphtypes that have not been observed before 
for viruses infecting Bacteria and Eukarya. Furthermore, the lack of sequence identity 
between their genomes and those deposited in public database, have made even 
more difficult their classification. Indeed, eight novel viral families have been 
introduced in order to classify these viruses, i.e. Fuselloviridae, Lipothrixviridae, 
Rudiviridae, Guttaviridae, Globuloviridae, Bicaudaviridae, Ampullaviridae and 
Clavaviridae [ref 31]. However it is expected that there are still several unique 
archaeal viruses to be discovered. Among these, many analyses of environmental 
samples have shown that spindle-shaped viruses (SSVs) are abundant and occupy 
several niches, where they frequently outnumber head-tailed viruses. Notably, this 
unique virion morphotype seems to be a hallmark of viruses infecting Archaea, since 
it has never been observed for bacteriophages and eukaryal viruses [31]. To date, 
the Fuselloviridae family comprises nine members (SSV1, SSV2, SSV4, SSV5, 
SSV6, SSV7, SSV8, SSV9 and ASV1) isolated from several geographic locations. 
SSV1 is the most extensively characterized member of the family. Moreover, it is the 
only fusellovirus showing a UV-inducible life cycle, thus being an exceptional model 
study to investigate on virus-host interactions in Archaea. On the other hand, 
although SSV2 resemble SSV1 in virion morphology and genome organization, its 
replication is triggered by the physiological state of the host cell rather than by an 
external stimulus as for SSV1. A complete dissertation on fuselloviruses is available 
in the review appended below. 
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1.4 Molecular biology of fuselloviruses and their satellites 
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1.5 Aims of the project 
 
 All bioprocesses that use microorganisms to produce value-added products 
are potentially subjected to great losses of the transforming biomasses caused by 
naturally occurring viral infections. The arms race among microorganisms and 
viruses has led to a continuous evolution (on the host side) of efficient mechanism to 
cope with infections and, in turn, to attempts (on the viral side) to defeat the host 
defences. Of course, microorganisms evolve towards the improvement of their fitness 
rather than in favor of the biotechnological efficiency. As results, in order to achieve 
safeguarded bioprocesses, natural defense systems have to be engineered to 
generate infection-insensitive microorganisms. Otherwise, natural selection of such 
immune-boosted strains would take a very long time. 
The model organism used in this project is S. solfataricus P2, i.e., a well-
characterized strain isolated from the sulphuric hot spring of Pisciarelli, near Naples 
[33]. As mentioned above, the CRISPR-Cas response of this archaeon is very 
complex, due to the co-presence of the type I and III systems and the abundance of 
CRISPR loci [25]. Consequently, S. solfataricus offers a valuable opportunity to study 
the activity of the CRISPR-Cas system in a heterogeneous context. As viral models, 
two fuselloviruses have been chosen, i.e., SSV1 and SSV2. Interestingly enough, 
even though these two viruses show morphological and genetic similarities, they 
display very different life cycles. SSV1 was originally isolated from its natural host 
Sulfolobus shibatae strain B12 (Beppu, Japan), but is able to infect S. solfataricus as 
well. It is a temperate virus that maintains a low copy number in both the hosts and 
establishes a harmonious consistence with the infected cell until its replication is 
induced by UV-light exposure [34]. On the other hand, the replication induction of 
SSV2 is regulated by the physiological state of the host cell and rather than by an 
external stimulus as for SSV1. Once infected the native host S. isandicus REY15/4 
isolated from a sulfuric hot spring in Reykjanes (Iceland), the SSV2 copy number is 
kept constant and low (around 1-3 copies per cell) until the host enters into the 
stationary phase of growth when a steep increase of the copy number occurs (25-50 
copies per cell) [34]. Noteworthy, this effect has not been observed for the permissive 
host S. solfataricus P2, in which SSV2 shows a copy number comparable to that of 
the induce state of the natural host throughout the growth of S. solfataricus. This led 
to hypothesize that a transcription factor encoded by the natural host S. islandicus 
(and not by S. solfataricus) was likely involved in the regulation of the viral replication 
induction in the natural host. 
 Thanks to the combination of similarities and differences, these two viruses 
are suitable to investigate the S. solfataricus response against infections, particularly 
as concerns the CRISPR-Cas systems activation. The main aim of this project is to 
study virus-host and virus-virus relationships, in order to gain insight useful to lay the 
bases for the setting up of procedures to generate Virus Insensitive Thermophilic 
Strains (VITSs). 
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2.1 Summary 
 
 Sulfolobus spindle-shaped virus 1 (SSV1) is the founding member of the 
Fuselloviridae family, which compresses to date 10 viruses (SSV1-SSV9 and ASV1) 
that generally exhibit a spindle-shaped capsid of ca. 60 by 100 nm. Notably, this 
unique virion morphology seems to be a hallmark of viruses infecting Archaea, since 
it has never been observed for bacterial and eukaryal viruses. For the past three 
decades, SSV1 has served as a model for studying host-virus interactions as well as 
for developing genetic tools. It is the best-characterized member of Fuselloviridae 
and is the only one showing an UV-inducible life cycle. SSV1 exhibits a genomic 
region similar to that of the bacteriophage lambda, whose lytic cycle is induced by 
UV-light exposure as well. Upon infecting a host cell, this fusellovirus integrates one 
copy of its genome into the host chromosome at an arginyl-tRNA gene, thus forming 
a provirus. However, unlike the well-characterized lambda phage, for which lysogenic 
cells harbour only the provirus, SSV1 lysogens carry also some copies of the 
episomal DNA. This has led to the hypothesis that SSV1 expresses a minimal set of 
genes to ensure a basal level of replication that is required for maintaining its carrier 
stage. Moreover, structural proteins (VP1, VP2 and VP3) have been shown to be 
constitutively expressed under conditions in which viral replication is not induced, 
thus allowing the production of viral particles by lysogenic cells. Upon exposure to 
UV light, SSV1 exhibits a temporally coordinated pattern of gene expression. At first, 
it activates the expression of a UV-inducible transcript (Tind), followed by the 
transcription of the early (T5, T6 and T9), late (T1/2, T3, Tx, and T4/7) and late-extended 
(T4/7/8) RNAs. This cascade of events leads, in turn, to the induction of the SSV1 
genome replication and eventually to a steep increase of the viral titre. However, 
since the SSV1 genome encodes for a number of quasi-orphan proteins that do not 
have detectable homologues in the databases, it was possible only to speculate 
about their functions basing on their time of appearance in the aftermath of the UV 
irradiation. This has led, in turn, to the necessity of performing structural and 
functional analyses to unravel their functions. For instance, the structure of several 
SSV1 transcription factors (TFs) has been solved revealing that, despite the lack of 
homology, most of these viral TFs are bacterial like. Nevertheless, the lack of 
functional characterization of these proteins has limited the dissection of fundamental 
processes, such as: i) the virion uptake, assembly and release, ii) the transcriptional 
regulation, iii) the genome replication and iv) the switch from lysogeny to induction. 
 Intriguingly, unless the host is stressed by the exogenous stimulus (i.e. the 
UV-light exposure), SSV1 seems to establish a harmonious co-existence with the cell 
and does not induce the activation of the CRISPR-Cas system in S. solfataricus (see 
Chapter III). With the aim of investigating how SSV1 can maintain this stable 
relationship with the host, experiments were carried out to dissect molecular 
mechanisms underpinning the transition from the lysogenic to the induced state of 
SSV1. As model host it was chosen S. solfataricus P2, because its genome was 
completely sequenced and microarrays were available for whole-transcriptome 
analysis (see Chapter III). Indeed, preliminary microarray data showed that a region 
of the SSV1 genome located nearby the Tind transcript, and previously considered not 
transcribed was, indeed, actively expressed during the carrier stage. This led to the 
identification of a novel uncharacterized transcript, named Tlys, which encodes for a 
6.3-kDa protein, termed F55. This latter shows sequence identity with negative 
regulators that fold into the ribbon-helix-helix DNA-binding motif (RHH motif), thus 
suggesting that it might function as transcription repressor. DNA band-shift assays 
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demonstrated that F55 is indeed a DNA-binding protein that is able to site-specifically 
recognize target sequences in the promoters of the early-induced T5, T6, and Tind 
transcripts, as well as in its own promoter. Interestingly, the strongest affinity was 
observed with promoters of T5 and T6, and an apparent cooperativity was observed 
for the binding to that of Tind. Moreover, these target sequences encompass both the 
transcription start sites (TSSs) and the B recognition elements (BREs) of the 
corresponding promoters. These results suggested that, likewise the lambda 
repressor CI, F55 may be the key regulator of the lysogenic/induction switch (for 
further details see par. 2.2). 
 Nevertheless, its activity needed to be studied in vivo in the aftermath of the 
UV irradiation. However, in peer reviewed published literature, it was not clear how 
the fluence (or UV dose) and the irradiance have been measured. Indeed, to date, 
the fluence (J m−2) administered to the cells has been only empirically determined 
and no attention has been paid to monitor the irradiance (J m−2 s−1). Furthermore, the 
negative effect on the host viability, that the UV treatment implies, has been so far 
underestimated. For these reasons, it was resolved to set up an irradiation protocol 
based on instrumentally measured parameters. By doing so, it was not only 
demonstrated a clear dose-response relationship between the strength of the UV 
irradiation and the host survival percentage, but also that cells lethality is significantly 
reduced by tuning the irradiance. In particular, a fluence of 45 J m−2 combined with a 
mild irradiance of 0.5 J m−2 s−1, turned out to be suitable to preserve host viability 
and, in turn, to obtain a high increase of the viral copy number as well as of the viral 
titre (viral particles per milliliter of culture). Hence, it seemed the best condition in 
which the role of F55 could be investigated (for further details see par. 2.3). 
 Even though F55 is the only putative transcription repressor for which a 
defined role in the regulation of a fuselloviral life cycle has been proposed, an in vivo 
survey was sorely needed to investigate molecular events occurring at the UV-
inducible region of the SSV1 genome upon irradiation. Several lines of evidence 
indicated that F55 is indeed the key regulator of the lysogeny/induction transition of 
SSV1, i.e.: i) F55 is the only transcriptional regulator expressed by SSV1 in the 
lysogenic state; ii) it binds in vivo to the promoters of Tind, Tlys, T5 and T6 in the 
absence of UV stimulus; iii) the expression of the UV-inducible transcript Tind is shut 
down when F55 binds to its promoter, and iv) transcription activation of Tind occurs 
only upon releasing of F55 in the immediate aftermath of the UV irradiation. In 
particular, it was demonstrated that F55 dissociates upon UV irradiation first from the 
Tind (2 hours post-treatment) and subsequently from the T5 and T6 promoters (4 hours 
post-treatment). This is in a perfect agreement with its differential affinity towards 
these regulatory sequences in vitro (T5 = T6 > Tind). Intriguingly, the transcription of T5 
and T6 is repressed during the SSV1 carrier stage and is activated in UV-irradiated 
cells four hours post-treatment. These data strongly indicate that F55 regulates the 
transcriptional activity of these mRNAs in a fashion similar to that of Tind, i.e. by 
repressing their expression during the lysogenic growth and allowing their 
transcription activation through clearance of their target sites. Altogether these data 
demonstrate that F55, likewise the CI repressor of lambda, acts as the key switch 
regulator involved in the lysogeny/induction transition of SSV1. However, some 
differences between lambda and SSV1 have been revealed. For example, lambda 
lysogens harbour the viral DNA exclusively as provirus and the only viral gene 
expressed is the cI. The lysogenic/lytic cycle is strictly regulated since viral progeny 
is produced only upon UV irradiation and causes cell lysis. By contrast, in SSV1 
lysogens the provirus co-exists together with some episomal copies and a 
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constitutive extrusion of viral particles occurs. Therefore, the lysogeny of SSV1 could 
be better defined as a carrier stage. Indeed, the UV irradiation only enhances the 
rate of SSV1 replication and progeny extrusion without causing cell lysis. This 
difference is mirrored by the expression regulation of F55, which is not as stringent 
as for the functional homolog CI of lambda. From an evolutionary point of view, this 
kind of host-virus relationship, which is typical for all Fuselloviridae, could be co-
evolved as consequence of the non-lytic nature of these viruses (for further details 
see par. 2.4). 
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2.2 Tlys, a newly identified Sulfolobus spindle-shaped virus 1 transcript 
expressed in the lysogenic state, encodes a DNA-binding protein interacting at 
promoters of the early genes 
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2.3 A standardized protocol for the UV induction of Sulfolobus spindle‑shaped 
virus 1 
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2.4 Unravelling the role of the F55 regulator in the transition from lysogeny to 
UV induction of Sulfolobus spindle-shaped virus 1 
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Abstract 
 Sulfolobus spindle-shaped virus 1 represents a model for studying virus-host 
interaction in harsh environments and it is so far the only member of the 
Fuselloviridae family that shows a UV-inducible life cycle. Although the virus has 
been extensively studied, mechanisms underpinning the maintenance of lysogeny as 
well as those regulating the UV induction have received little attention. Recently, a 
novel SSV1 transcription factor, F55, was identified. This factor was able to bind in 
vitro to several sequences derived from the early and UV-inducible promoters of the 
SSV1 genome. The location of these binding sites together with the differential 
affinity of F55 towards these sequences, led to the hypothesis that this protein might 
be involved in the maintenance of the SSV1 lysogeny. Herein, it is reported an in vivo 
survey of the molecular events occurring at the UV-inducible region of the SSV1 
genome, with a focus on the binding profile of F55 before and after the UV irradiation. 
The binding of F55 to the target promoters correlates with transcription repression, 
whereas its dissociation is paralleled by transcription activation. Therefore, we 
propose that F55 acts as molecular switch for the transcriptional regulation of the 
early viral genes. 
 
Importance 
 Functional genomic studies of SSV1 proteins have been hindered by the lack 
of similarity with other characterized proteins. As a result, only few insights into their 
in vivo roles have been gained throughout the last three decades. Herein, we report 
the first in vivo investigation of a SSV1 transcription regulator, F55, that exerts a key 
role in the transition from the lysogenic to the induced state of SSV1. We show that 
F55 regulates the expression of the UV-inducible as well as of the early genes. 
Moreover, the differential affinity of this transcription factor towards these targets 
allows a fine-tuned and temporal coordinated regulation of transcription of viral 
genes. 
 
Introduction  
The majority of viruses isolated from Archaea, the third domain of life, show 
virion morphotypes that have not been observed for viruses infecting Bacteria and 
Eukarya. Consequently, eight novel viral families have been introduced in order to 
classify these novel viruses, i.e. Fuselloviridae, Lipothrixviridae, Rudiviridae, 
Guttaviridae, Globuloviridae, Bicaudaviridae, Ampullaviridae and Clavaviridae but so 
far, there are still several unique archaeal viruses that remain to be classified (1-3). 
Many analyses of environmental samples have shown that spindle-shaped viruses 
are abundant and occupy several niches, including deep sea hydrothermal vents (4, 
5), hypersaline environments (6,7), anoxic freshwaters (8), cold Antarctic lakes (9), 
terrestrial hot springs (10-12) and acidic mines (13, 14), where they frequently 
outnumber head-tailed viruses. Notably, this unique virion morphotype seems to be a 
hallmark of viruses infecting Archaea, since it has never been observed for 
bacteriophages and eukaryal viruses (15). To date, the family of Fuselloviridae 
comprises nine members (SSV1, SSV2, SSV4, SSV5, SSV6, SSV7, SSV8, SSV9 
and ASV1) isolated from several geographic locations (2). The lack of structural and 
functional characterization of proteins encoded by the fuselloviral genomes has 
limited the dissection of fundamental processes, such as: i) virion uptake, assembly 
and release, ii) transcriptional regulation, iii) genome replication and iv) 
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lysogeny/induction switch. Indeed, with the exception of few proteins (16-23), 
structural and functional annotations in main databases are not available for 
fuselloviral gene products (2, 22). 
SSV1 is the most extensively characterized member of this viral family and is 
the only one showing a UV-inducible life cycle. Upon infecting a host cell, SSV1 
integrates one copy of its genome into the host chromosome at an arginyl-tRNA 
gene, forming a provirus (24). However, unlike the well characterized lambda phage, 
for which lysogenic cells harbour only the provirus, SSV1 lysogens carry also ~5 
copies of the episomal DNA per cell. This led to the hypothesis that SSV1 expresses 
a minimal set of genes to ensure a basal level of replication that is required for 
maintaining the carrier stage (23). Moreover, structural proteins (VP1, VP2 and VP3) 
are constitutively expressed under conditions for which viral replication is not induced 
(23), allowing the production of viral particles by the lysogenic cells. Upon exposure 
to UV light, SSV1 exhibits a temporally coordinated pattern of gene expression. At 
first, it activates the expression of a UV-inducible transcript (Tind), followed by the 
transcription of the early (T5, T6 and T9), late (T1/2, T3, Tx, and T4/7) and late-extended 
(T4/7/8) RNAs. This cascade of events leads, in turn, to the induction of the SSV1 
genome replication and eventually to a steep increase of the viral titre (25).  
Despite the extensive characterization that SSV1 has received over the last 30 
years (25-28), mechanisms underpinning the transition from the lysogenic growth to 
the viral induction are still murky. Very recently, a new mRNA (Tlys) was discovered, 
which was transcribed in the opposite direction of the UV-inducible Tind (23). Since 
Tlys is one of the most abundant SSV1 transcripts during lysogenic growth, it was 
suggested that the encoded protein could play a fundamental role in the maintenance 
of the carrier stage. Indeed, Tlys encodes for a 55-amino acids protein (F55) that 
interacts, in a concentration-dependent manner, with tandem-repeated sequences 
clustered within the UV-inducible region of the viral genome. Moreover, F55 could act 
as a transcription repressor since these operators encompass both the transcription 
start sites (TSSs) and the B recognition elements (BREs) of the T5, T6, Tind and Tlys 
promoters (23). So far, F55 is the only transcription repressor for which a defined role 
in the regulation of a fuselloviral life cycle has been proposed. Herein, we report an in 
vivo survey of the molecular events occurring upon irradiation at the UV-inducible 
region of the SSV1 genome, with a focus on the pleiotropic effect of F55 on several 
SSV1 promoters. We show that F55 acts as the molecular switch controlling the 
SSV1 life cycle.  
 
Materials and methods 
Strains, media, growth conditions and UV irradiation  
A SSV1 lysogenic strain of Sulfolobus solfataricus (SSV1-InF1) was generated, 
by infecting the uracil auxotrophic mutant InF1 (29) as described elsewhere (30). An 
aliquot from a frozen sample of SSV1-InF1 culture was thawed and a few microliters 
were spotted onto an SCVYU-Gelrite plate and incubated at 75°C. After 3-5 days of 
incubation, local growth-areas (spots) were inoculated into 50 ml of SCVYU medium, 
i.e. a glycine-buffered Brock’s basal salt solution, supplemented with 0.2% sucrose 
weight volume-1 (wt vol-1), 0.2% casamino acids (wt vol-1), 1× vitamins (31), 0.005% 
yeast extract (wt vol-1) and uracil 0.02 mg ml-1, with pH adjusted to 3.5 with 
concentrated H2SO4. Cultivation of the Sulfolobus strains was conducted in a 250-ml 
Erlenmeyer flask with a long neck at 75°C with a shaking rate of 180 rpm using a 
MaxQ™ 4000 Benchtop Orbital Shakers (Thermo Scientific). Cell growth was 
monitored spectrophotometrically at 600 nm (OD600) by means of a Variant Cary® 50 
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Bio UV/Visible Spectrophotometer (McKinley Scientific). Once the culture reached 
the logarithmic phase of growth, it was diluted to an optical density value of 0.05 
OD600 in 50 ml of fresh SCVYU medium and let to grow up to 0.5-0.8 OD600. 
The SSV1-InF1 culture was UV-irradiated by using a fluence of 45 J m-2 and an 
irradiance of 0.5 J m-2 s-1, as described elsewhere (32). Growth was 
spectrophotometrically monitored before and after the treatment to construct 
comparative growth curves. Samples were taken after 2, 4, 6, 8 and 10 hours post-
treatment and pellets for each time point were obtained through centrifugation at 
3,000 × g for 10 min using the Centrifuge 5810R (Eppendorf). Pellets were treated for 
total DNA, RNA and protein preparations (see below).  
 
Semi-quantitative PCR and EcoRI total DNA digestions  
SSV1-InF1 cell pellets, obtained as described previously, were treated for highly 
pure total DNA preparation using the DNeasy tissue kit (Qiagen), following the 
manufacturer’s instructions. The concentration of the DNA samples was 
spectrophotometrically determined using a Nanodrop 2000 Spectrophotometer 
(Thermo-Scientific), by performing the measurements in triplicates. Their purity was 
assessed by the 260nm/280nm adsorption ratio and only DNA samples with a value 
of 1.8 or higher were used for subsequent experiments. 
In order to detect variations of the viral DNA content among the different 
samples, total DNA samples from irradiated SSV1-InF1 cultures were analysed by 
semi-quantitative PCR (sqPCR). With this aim, two primer couples were designed 
using Primer3 software (available at the website: http://bioinfo.ut.ee/primer3-0.4.0/), 
in order to amplify: (i) a 155-bp region of the SSV1 single-copy gene vp2 and (ii) a 
108-bp region of the host single-copy gene orc1 (Table 1). 
 
Table 1 
Primers used for the semi-quantitative PCR assays on ChIP samples 
 
Name Sequence (5’-3’) Length (nt) 
T5-fw CCCAAACACTGTGTATATAGAG 22 
T5-rv AGTTTGTGCCATATTCCCAT 20 
T6-fw ATGATAATATTAAATGATTCACGAT 25 
T6-rv TTTCGGGTTTGGGGTGAAAC 20 
Tind-fw CTGCTGTCTGACAAGAGTTT 20 
Tind-rv GATTTTGCACATCCCATATT 20 
Tlys-fw ATCGTGAATCATTTAATATTATCAT 25 
Tlys-rv ATTGGAATCGAAACGGTCAC 20 
orc1-fw TATAAATTGTTATAGACATAGAACGCTGTA 30 
orc1-rv TTAAATACTTCTTGTGCCGATAGTCC 26 
vp2-fw GGAGGGTACATCGCTACCTTATGA 24 
vp2-rv CAGTAGGGCTGACAGTAAACTACG 24 
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A sqPCR master mix was set up as follows: 1× Taq buffer, 2.5 mM MgCl2, 0.2 
mM dNTP mix, 0.6 µM orc1-fw, 0.6 µM orc1-rv, 0.6 µM vp2-fw, 0.6 µM vp2-rv and 
50U ml-1 of Taq DNA Polymerase (Thermo Scientific) in a total volume of 500 µl. The 
master mix was then separated into seven aliquots of 60 µl each in different tubes 
and labelled as control sample (mock-treated collected at 0.5 OD600), 2h, 4h, 6h, 8h 
and 10h (UV-treated samples). To each tube, 100 ng of total DNA from mock-treated 
or UV-irradiated samples, were added as template. The aliquots were then split up 
into three sub-aliquots (20 µl each), labelled (20th-25th-30th) and placed into a 
Mastercycler Personal (Eppendorf®). A negative (no template) and two positive 
controls of the amplification conditions were also included in the analysis. The 
thermal cycling protocol was as follows: an initial denaturation step of 5 min at 95°C, 
followed by 30 cycles of 40 sec at 95°C, 40 sec at 62°C, and 1 min at 72°C. A 5 final 
step at 72°C has been carried out for 10 min at the end of the 30th cycle. For each 
time point, tubes were taken from the thermocycler at the 20th, 25th and 30th cycle of 
amplification. PCR products were run a 2% agarose gel (wt vol-1) in 1× TAE buffer 
(40 mM Tris, 20 mM acetic acid and 1 mM EDTA). The same DNA samples were 
enzymatically digested using the sequence-specific endonucleases EcoRI, whose 
target sequence recurs four times in the SSV1 genome. In brief, 2 µg of each total 
DNA sample were digested overnight with 20 units of EcoRI (Roche) at 37°C and run 
on a 1% agarose gel (wt vol-1). 
 
Northern blot analysis  
High pure total RNA samples were prepared from mock-treated and UV-
irradiated SSV1-InF1 cultures by means of the TRIzol reagent (Sigma Aldrich®), 
according to the manufacturer’s instructions. RNA pellets were dissolved in nuclease-
free water and concentration was determined by means of a Nanodrop 1000 
Spectrophotometer (Thermo Scientific). Samples purity was checked through the 
determination of the 260nm/280nm adsorption ratio and only samples showing a ratio 
of 1.9 or higher were used for subsequent experiments. 
For each sample, 20 µg of total RNA were run on a denaturing, formaldehyde-
containing 2.0% agarose gel (wt vol-1) and then transferred onto a nylon membrane 
(Hybond-XL; Amersham-Pharmacia). T4 polynucleotide kinase (Fermentas Life 
Sciences) was used to label 5’ ends of single-stranded oligonucleotides Tlys-rv (5’-
AAGTTCTTCAATGCGTCTTCTGATT-3’), Tind-fw (5’- TCTGAGCTACTAATACTGCTT 
GAAT-3’) and 16S-rv (5’-CTCTCCTACTCGGGTGGAGCAAC) with radioactive [γ-32] 
ATP, following the manufacturer’s instructions. Purification of radiolabeled 
oligonucleotides was achieved by gel filtration chromatography using Illustra Nick 
columns (Amersham Biosciences) and hybridizations with single-stranded DNA 
probes were carried out as described elsewhere (33). Probes were eventually 
removed by boiling in 0.1% (wt vol-1) sodium dodecyl sulphate (SDS) for 10 min in 
order to reuse the membrane for subsequent hybridizations. Radioactive signals 
were quantified by means of a Molecular Dynamics Bio-Rad PhosphorImager 
(Quantity One software) to determine the relative abundance of the transcripts (16S, 
Tlys and Tind). Determination of Tlys/16S and the Tind/16S ratio was performed to 
normalize RNA signals and compensate for operator errors. The size of the Northern 
blot signals was determined using the RNA molecular weight markers (Roche) as 
standards. 
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Western blot analysis  
Cells from 30 ml of mock-treated and UV-irradiated SSV1-InF1 cultures were 
harvested by centrifugation, and pellets were suspended in 2 ml of 10 mM Tris-HCl 
pH 8.0 (lysis buffer), containing Complete 600 protease inhibitor cocktail tablets 
(Roche). Cells were lysed by sonication at 20% of the maximal amplitude for 3 min, 
alternating 20s of pulse-on and 20s of pulse-off, by means of an ultrasonic liquid 
processor (Heat System Ultrasonic, Inc.). Lysates were centrifuged at 30,000 × g 
(SW41 rotor; Beckman) for 30 min in order to clarify crude protein extracts. Protein 
concentration was spectrophotometrically determined by standardized Coomassie 
(Bradford) Protein Assays and normalized for each sample, as described elsewhere 
(34). In brief, Bradford assays were performed on bovine serum albumin as standard 
(BSA, Thermo Scientific) to construct a calibration curve. In particular, known protein 
concentrations (1, 2, 4, 6, 8 µg/ml) were plotted against their absorbance at 595nm. 
Concentration of protein samples was determined by means of the standard curve 
and samples quality assessed by SDS-PAGE followed by Coomassie staining. 
A serum sample (15 mg of total protein) from an F55-immunized rabbit 
(Innovagen AB) was loaded on a 1-ml HiTrap Protein A column (GE Healthcare) 
connected to a fast-performance liquid chromatography system (ÄKTA, GE 
Healthcare) and total IgGs were purified following the manufacturer’s instructions. 
Antibodies-containing fractions were pooled, dialyzed against 20 mM sodium 
phosphate buffer pH 8.0 and protein concentration (0.4 mg ml-1) determined by the 
Coomassie (Bradford) Protein Assay, as described above. Antibodies integrity was 
checked by running 10 µg of total IgG sample on 15% SDS-PAGE. For western blot 
hybridizations, total protein samples (10 µg) were run on 15% SDS-PAGE and 
electro-transferred onto an Immobilon-PVDF membranes (Millipore). Subsequently, 
membranes were treated as follows: i) incubated for 1 hours at room temperature in 
blocking solution, i.e. 1× TBS-T (50 mM Tris pH 7.5, 150 mM NaCl and 7 0.1% 
Tween-20) containing 5% BSA (wt vol-1) (Sigma); ii) incubated for 16 hours at 4°C 
with total IgG sample (see above) diluted (1:1000) in blocking solution; iii) washed 
three times for 15 min with 1× TBS-T at room temperature; iv) incubated for 1 hour at 
room temperature with horseradish peroxidase conjugated goat anti-rabbit IgG 
(Roche) diluted (1:10000) in 1× TBS-T and finally v) washed twice for 15 min with 
TBS-T and vi) washed once with TBS. Detection by enzyme-linked 
chemiluminescence was performed by means of the kit ImmobilonTM Western 
Chemiluminescent HRP Substrate (Millipore) and using a ChemiDoc™ XRS+ System 
(BioRad), according to the manufacturer’s instructions. The F55 concentration in the 
analysed samples was determined using a calibration curve, which was constructed 
by plotting known amounts of F55 (from 10 to 35 ng) against densitometric values 
measured using the Quantity One software (BioRad). The Western blot data were 
validated by repeating the experiments in triplicates. 
 
Chromatin immunoprecipitation assay and semi-quantitative PCR (ChIP-sqPCR 
analysis)  
SSV1-InF1 cells were cultivated in 900 ml of SCVYU medium into a 2-L Erlenmeyer 
flask and grown to 0.6 OD600. A 300-ml control sample was harvested before UV-
treating the remaining volume (600 ml). Samples were harvested after 2 and 4 hour 
of incubation and rapidly cooled down at 37°C, before adding 1% formaldehyde (wt 
vol-1) (Sigma) for DNA-proteins crosslinking. Incubation at 37°C was performed for 5 
min with a shaking rate of 120 rpm. The crosslinking reaction was then quenched by 
adding glycine (125 mM final concentration) to the cultures, followed by an additional 
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incubation of 5 min at 37°C. Afterwards, cells were collected by centrifugation at 
3,000 × g for 15 min (JA-14 rotor; Beckman). Pellets were washed twice with 1× PBS 
(137 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4 • 2 H2O, 1.76 mM KH2PO4, pH 7.4) 
and finally resuspended in 6 ml of 1× DNase Buffer (400 mM Tris-HCl, 100mM NaCl, 
60 mM MgCl2 and 10 mM 8 CaCl2, pH 7.9). Cells were lysed by sonication at 20% of 
the maximal amplitude for 18 min, alternating 3 s of pulse-on and 9 s of pulse-off, by 
means of an ultrasonic liquid processor (Heat System Ultrasonic, Inc.). Lysates 
containing cross-linked DNA-proteins complexes were clarified by centrifuging for 30 
min at 30,000 × g (SW41 rotor; Beckman). In order to further narrow down the length 
of the DNA fragments, DNase I RNase free (Roche) was added at the final 
concentration of 30U/ml, followed by incubation of 30 min at 37°C. To recover DNA-
protein complexes, samples were subjected to phenol extraction, by adding 1 volume 
of phenol:chloroform:isoamyl alcohol (25:24:1, Sigma) and centrifuging for 10 min at 
3,000 × g. The DNA-protein complexes were recovered by ethanol precipitation and 
centrifugation for 10 min at 15,000 × g. Pellets were dissolved in 20 mM sodium 
phosphate buffer pH 8.0 and treated with 100 µg ml-1 of RNase A (Invitrogen) for 1 h 
at 37°C. Cross-linked F55-DNA complexes were enriched by affinity chromatography 
using the 1-ml HiTrap Protein A column (GE Healthcare) connected to a fast-
performance liquid chromatography system (ÄKTA). In brief, the column was 
equilibrated in binding buffer (20 mM sodium phosphate buffer pH 8.0), loaded with 
purified IgG from F55-immunized rabbit (Innovagen AB) and washed with 5 ml of 
binding buffer. DNA-protein samples were loaded onto the column and 5 ml of 
binding buffer were used to elute unspecific complexes. F55-DNA specific complexes 
were then eluted from the column by washing with 0.1 M citrate buffer pH 6.2 (elution 
buffer). In order to de-crosslink F55-DNA complexes, the eluted fractions were 
pooled and incubated at 65°C for 16 hours with a shaking rate of 180 rpm. Free-
protein DNA was obtained by purification using the MinElute PCR purification kit 
(Qiagen), according to the manufacturer’s instructions. The concentration of the DNA 
samples was measured using a Nanodrop 2000 Spectrophotometer, as described 
above. To check the enrichment of DNA fragments containing F55 target sequences, 
semi-quantitative PCR reactions (ChIP-sqPCR) were set up using the primer couples 
listed in Table 1. Master mixes were prepared as follows: 1× Taq Buffer, 2.5 mM 
MgCl2, 0.2 mM dNTP mix, 0.3 µM primer-fw, 0.3 µM primer-rv, and 50U ml-1 of Taq 
DNA Polymerase (Thermo Scientific) in a total volume of 250 µl. Two aliquots of 50 µl 
each were used to perform negative and positive controls of the amplification, whilst 
to the remaining 150 µl was added 1 ng of enriched DNA obtained by ChIP (see 
above). The aliquot of 150 µl was then spit up into three tubes (50 µl each), labelled 
(20th-25th-30th) and placed into a Mastercycler Personal (Eppendorf®). The thermal 
cycling protocol was as follows: an initial denaturation step of 3 min at 95°C, followed 
by 30 cycles of 40 sec at 95°C, 40 sec at 50°C, and 1 min at 72°C. For amplification 
of the host sequence orc1 the annealing temperature was 62°C. Tubes were taken 
from the thermocycler at the 20th, 25th and 30th cycle of amplification. PCR products 
were run on a 2% agarose gel (wt vol-1) in 1× TAE buffer. The same procedure has 
been carried out by using as templates the enriched DNA samples from mock-treated 
and UV-irradiated SSV1-InF1 cells collected after 2 and 4 hours post-irradiation. 
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Results  
Host response to the UV irradiation  
In order to investigate the role of F55 in the SSV1 life cycle, a S. solfataricus 
InF1 strain carrying the virus (SSV1-InF1) was treated by UV irradiation as described 
elsewhere (32). The effect of the treatment on its physiology was assessed by 
measuring the generation time and cell viability of the mock- and UV-treated cultures. 
We found that, in the immediate aftermath of the treatment, cell viability of the UV-
treated culture was approximately 35% of that of the untreated control. Furthermore, 
the growth rate of the UV-irradiated sample was slower than that of the mock-treated 
control, probably as a consequence of the stress caused by both the irradiation itself 
and the viral induction (Fig. 1), as also observed in previous experiments (32). 
 
 
 
Figure 1. Growth curves of mock- and UV-treated SSV1-InF1 cultures. The OD600nm values were 
measured every two hours and plotted versus the incubation time. Before being mock- or UV-treated, 
cells were grown exponentially until 0.5 OD600nm (21th hour of incubation). Afterwards, the culture was 
split in two halves and incubated back to 75˚C to estimate the effect of the treatment. Error bars show 
the standard deviation of experimental point (n = 3) * p value < 0.05. 
 
 
Time-course of the SSV1 replication induction upon UV irradiation  
Induction of SSV1 replication upon UV irradiation was investigated in a time course 
experiment of a 10-hours window, following an UV irradiation protocol reported 
recently (32). Samples were withdrawn from both mock-treated and UV-irradiated 
SSV1-InF1 cultures every two hours during incubation and the relative amount of 
SSV1 was estimated using semi-quantitative PCR analysis of total DNAs extracted 
from cell samples. Two single copy genes were chosen for this analysis, i.e. the viral 
vp2 representing the SSV1 genome and orc1 for the host genome. PCR was 
conducted for 20, 25 and 30 cycles of amplification and the yielded PCR products 
were analysed by agarose gel electrophoresis. We found that, when amplified for the 
same numbers of PCR cycle, the intensity of the PCR product of the internal control 
orc1 (108 bp) was very similar in all the samples. However, the intensity of the vp2 
amplicon (155 bp) is significantly increased in the samples after UV-irradiation, 
starting from hour 2 and peaking at hour 8 post-irradiation (Fig. 2). We reasoned that 
the increase of viral DNA, before completion of viral gene expression (Fig. 2, 2h post-
treatment), resulted from the irradiation-mediated cell division arrest (Fig. 1) that did 
not affect the basal viral replication.  Thereafter, transcriptional activation was 
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completed for all viral genes (25) and the induction of the SSV1 replication accounted 
for the further increase of relative amounts of viral DNA in UV-irradiated cultures (Fig. 
2, 6-10 hours) 
 
Figure 2. Time course of the viral replication induction after UV irradiation by semi-quantitative 
PCR. Black-straight arrows point out to molecular weight markers as well as to the host (orc1 = 108 
bp) and the viral (vp2 = 155 bp) PCR products. Total DNA samples were prepared from mock-treated 
cells (control) and UV-treated cultures collected at 2, 4, 6, 8 and 10 hours post irradiation. The 
maximum amount of SSV1 DNA is detectable for the sample collected 8 hours post treatment (dashed 
white box). 
 
 
To confirm the temporal onset of UV-induced viral replication, the total DNA 
extracted was digested with EcoRI and analysed by agarose gel electrophoresis. As 
shown in figure 3, the EcoRI fragments of the SSV1 genome (7.9, 2.9, 2.4 and 2.1 
Kb), become dominant in the UV-irradiated cells with the highest amount detectable 
8-10 hours post-irradiation. Altogether, the above data indicated that the previously 
established procedure for UV irradiation was suitable for studying the induction of 
SSV1 replication (32). 
 
Figure 3. Detection of the viral DNA after UV irradiation by EcoRI restriction analysis. 
The restriction profile of total DNA samples from control culture, SSV1-InF1 irradiated cells as well as 
from SSV1 episomal DNA digested with EcoRI, is shown. Black straight arrows point out to the 
molecular weight markers and to the SSV1-derivated fragments (7.9, 2.9, 2.4 and 2.1 Kbp). The 
intensity of the SSV1 fragments is higher for the sample collected 8-10 hours post irradiation. 
 
 
Tind and Tlys transcription patterns in mock- and UV-treated cells  
In order to reveal the molecular circuit regulating the maintenance of SSV1 
lysogeny and to identify the molecular switch to the induced state of SSV1, a 
transcriptional analysis was carried out on the head-to-head oriented transcripts Tind 
and Tlys, the main players of the SSV1 UV-inducible expression (Fig. 4A). Total RNAs 
samples were prepared from mock- and UV-treated SSV1-InF1 cells and analysed 
by Northern hybridization to detect Tind and Tlys transcripts (Fig. 4B). Normalization for 
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all samples was performed by measuring the signal of the housekeeping gene 16S 
and by calculating the Tind/16S and Tlys/16S signals ratio. 
Tind was not detectable in mock-treated cells, which is consistent with the 
transcript being repressed in the carrier state (lysogeny). Conversely, soon after UV 
irradiation (2 hours post-treatment) two typical Tind hybridization signals (25) were 
detected (200 nt and 300 nt). Then, the Tind/16S ratio increased by 3-fold 4-6 hours  
after UV irradiation. Thereafter, the intensity of the Tind signal dropped sharply, and 
became undetectable 6 hours post-treatment  (Fig. 4B). 
On the other hand, the antagonistic transcript Tlys showed a down-regulation of 
its expression in the mock-treated culture between 4 and 8 hours, as judged by the 
50% decrease of the signal ratio Tlys/16S. Interestingly, this value did not change 
between the 2nd and the 4th hour post-irradiation (Fig. 4B), despite the increase of the 
SSV1 copy number in the same time window, as evidenced by sqPCR (Fig. 2).This 
suggests that there could exist a fine-tuning mechanism regulating the expression of 
these two convergent genes. Furthermore, the 300-nt Tlys signal did not occur as a 
discrete band but formed a continuous smearing with smaller RNA products mainly 
visible between 8 -10 hours post-treatment (Fig. 4B). This indicated that Tlys could be 
degraded by a post-transcriptional regulation mechanism. If so, the apparent 
increase of Tlys signal should not reflect the actual change of content of the encoded 
transcriptional regulator (F55) in the UV-irradiated cells (see below). 
 
 
 
Figure 4. Transcription analysis of Tlys and Tind. (A) Schematic representation of the head-to-head 
oriented transcripts Tind and Tlys. (B) SSV1-InF1 total RNAs isolated from mock- and UV-treated cells 
at different time points were analyzed by Northern hybridization to detect Tlys and Tind transcripts. The 
hybridization signals were normalized using the housekeeping gene 16S. The Tind transcript was 
expressed over a short time window and only in UV-irradiated cells whereas Tlys was detectable in 
both mock-treated and UV-irradiated cells. A Degradation occurs around the 8-10th hour only for the 
Tlys transcript. 
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In vivo expression and DNA-binding activity of F55  
To determine the representatively of the putative lysogeny regulator F55 after UV 
irradiation, the content of F55 in UV-induced and mock-treated cells was analysed by 
densitometric analysis on immunoblots (Fig. 5A) and compared to known amounts of 
recombinant F55 as a reference (Fig. 5B). The intensity of the chemiluminescent 
signal obtained from the standards was linear in the range considered. Interestingly, 
throughout the whole time window analysed, the concentration of F55 in UV-treated 
cells was lower than that in the corresponding mock-treated samples (Fig. 5C). 
Furthermore, a 50% drop of the F55 cellular concentration (Fig. 5C, 2h grey bar) 
coincided with the onset of the Tind transcription (Fig. 4B, lanes 2h UV-treated). 
Together these results support the hypothesis that F55 plays a role in maintaining the 
lysogeny. Furthermore, the simultaneous reduction of F55 protein and the 
augmentation of Tlys signal at 8th-10th hour (Fig. 4B) suggest that the regulation of Tlys 
expression must occur at the post-transcriptional level. 
 
 
 
 
 
Figure 5. Western blot analysis of F55 in mock- and UV-treated InF1-SSV1 cells. (A) Western blot 
of cell extracts from control, mock- and UV-treated samples. (B) F55 quantification has been 
performed using a standard curve. (C) Quantitative data are reported as histograms. Error bars show 
the standard deviation of experimental point (n = 3) and a control sample (grey bar) is used as 
reference. The amount of F55 in the UV-treated culture is significantly lower than the mock one at 
every time point analysed (*p value < 0.05). 
  
 
 It was previously demonstrated that F55 binds in vitro, with differential affinity, 
to DNA sequences derived from the promoters of T5, T6, Tind and Tlys transcripts. 
Based on the location of the binding sites, i.e. partially overlapping the BRE or 
encompassing the TSS, it was hypothesized that this regulator could function as 
transcriptional repressor (23). To investigate binding of F55 to the aforementioned 
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promoters in vivo (Fig. 5A), DNAs were recovered by ChIP assays before and after 
the UV treatment and subjected to sqPCR analysis (ChIP-sqPCR) as described 
above. In lysogenic cells, promoter regions of T5, T6, Tind and Tlys were detected in 
ChIP-sqPCR already after 25 cycles (Fig. 6B, control panel), indicating that F55 
binds to these promoters in vivo. Two hours after UV irradiation, binding of F55 to its 
own promoter was depleted whereas the interaction with that of Tind was greatly 
weakened (Fig. 6B, panel 2 hours post-irradiation). Subsequently, the promoter 
regions of the early transcripts T5 and T6 were released by F55, indeed, the relative 
ChIP-sqPCR signals fall to an undetectable level (Fig. 5B, panel 4 hours post-
irradiation). Altogether these results indicate that the cascade expression of the 
SSV1 early genes is regulated through a differential binding of F55 to its target 
operators.  
 
 
 
 
 
 
 
Figure 6. Chromatin immunoprecipitation (ChIPs) on the UV-inducible region of SSV1 using 
F55 specific antibodies. A) Scheme of the UV-inducible region of SSV1 genome. The amplified 
regions of the target promoters that are recognized by F55 are blue-, yellow-, green- and red-
highlighted. All the promoters contain two F55 binding sites, except for that of Tlys. B) Total DNA 
samples prepared from control and UV-treated cultures and collected at 2 and 4 hours post irradiation 
were used as template for semi-quantitative PCR reactions. Two negative control, vp2 (viral) and orc1 
(host), were included to assess method specificity. N is the negative control for PCR reactions. 
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Discussion  
Numerous transcription analyses of the UV-inducible fusellovirus SSV1 have 
been carried out in S. solfataricus to dissect viral gene expression patterns before 
and after UV irradiation. Nevertheless, it was still unclear how this fusellovirus 
regulates the transition from the lysogeny to the induced status during its life cycle. 
Our recent work has assigned a key role in this process to the DNA-binding protein 
F55, which is encoded by the most abundant RNA (Tlys) expressed by SSV1 in the 
carrier stage (23). In order to shed further light on the role of F55 in the regulation of 
the SSV1 life cycle, an in vivo analysis of the events occurring soon after the UV 
irradiation has been carried out. Several lines of evidence indicate that F55 is indeed 
the key regulator of the lysogeny/induction transition of SSV1, including: i) F55 is the 
only transcriptional regulator expressed by SSV1 in the lysogenic status; ii) it binds in 
vivo to the promoters of Tind, Tlys, T5 and T6 in the absence of UV stimulus, as shown 
by the ChIP-sqPCR experiments; iii) Tind expression is shut down when F55 is bound 
to its promoter as shown by Northern blot analysis, and iv) transcription activation of 
Tind occurs only upon releasing of F55 in the immediate aftermath of the UV 
irradiation, i.e. within 2 hours. Notably, the transcriptional regulation of Tind is crucial 
for the lysogeny/induction switch since it is the first RNA whose expression is 
unlocked in UV-irradiated cells (25). 
ChIP-sqPCR data demonstrated that F55 dissociates upon UV irradiation first 
from the Tind (2 hours post treatment) and subsequently from the T5 and T6 promoters 
(4 hours post treatment) (Fig. 6B). This is in a perfect agreement with its differential 
affinity towards these regulatory sequences in vitro (T5 = T6 > Tind) (23). Intriguingly, 
the transcription of T5 and T6 is repressed during the SSV1 carrier stage and is 
activated in UV-irradiated cells at four hours post-treatment (25). These data strongly 
indicate that F55 regulates the transcriptional activity of these mRNAs in a fashion 
similar to that of Tind, i.e. by repressing their expression during the lysogenic growth 
and allowing their transcription activation through clearance of their target sites upon 
UV irradiation. Although the release of F55 from its targets coincides with the 
transcriptional activation of the relative genes, it is not possible to exclude the 
contribution of other factors to enhance their expression levels. 
Quantification of the western blot signals demonstrates that the concentration of 
F55 drops of about 50% in UV-treated cells, if compared to the control sample, and 
does not dramatically change up to 10 hours post-treatment (Fig. 5). How can these 
target promoters be progressively released by F55 without fluctuation of the protein 
levels in the aftermath of UV irradiation? A reasonable hypothesis is that the 
intracellular concentration of F55 becomes progressively sub-optimal to saturate all 
the regulative binding sites in the UV-induced cells. Indeed, in the carrier stage, 
SSV1 constantly replicates in actively dividing cells to keep its copy number around 5 
copies per cell (23). In these conditions, F55 saturates 14 sites per SSV1 genome, 
i.e., 4 sites for each of the Tind, T5 and T6 promoters and 2 for that of Tlys (Fig. 7), for a 
total of about 70 binding sites per cell. Upon UV irradiation, whereas the cell division 
slows down (Fig. 1), the basal viral replication proceeds consistently leading to an 
increase of the SSV1 copy number starting from the 2nd hour post-treatment (Fig. 2). 
Thereafter, the episomal SSV1 content reaches ≅160 copies/cell (32) and the total 
number of sites that has to be bound by F55 rises of about 32 folds. Since in UV-
irradiated cells the intracellular level of F55 is constant, the ratio between the number 
of the binding sites (BS) and the F55 concentration (BS/F55) increases. This 
variation in the BS/F55 ratio, allows the progressive dissociation of F55 from SSV1 
genome that eventually leads to transcription derepression of the target genes (Fig. 
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6). The proposed mechanism strictly depends on the maintenance of a low and 
constant F55 concentration in UV-irradiated cells. In this regard, it has been 
observed in Northern blot experiments that an additional level of control acts post-
transcriptionally by degrading Tlys (Fig. 4B), probably to compensate the “sloppiness” 
of the transcriptional control. 
Regarding to the transcription regulation of Tlys, we did not observe an 
immediate derepression of its expression although its promoter, likewise that of Tind, 
is released 2 hours post-irradiation. Indeed, up-regulation of Tlys occurs only when 
Tind transcription is abrogated  (8-10 hours post-irradiation, Fig. 4B). It must be taken 
into account that Tlys and Tind RNAs are transcribed in a convergent orientation (Fig. 
4A) and therefore the relative genes can be susceptible of transcriptional 
interference, which is typical of head-to-head oriented gene couples. This 
architecture strongly resembles that of the non-lambdoid UV-inducible coliphage 186 
(35, 36), although a different mechanism may be evoked. Indeed, it has been proved 
in both eukaryotes (37-39) and prokaryotes (40-42) that transcription of genes distant 
of a few kilobases is not independent, but coupled by torsional stress that, by 
influencing the opening properties of the promoters, facilitates or hinders transcription 
initiation. This kind of influence reduces the expression of convergent gene couples 
(43), such as in the case of Tlys and Tind. This hypothesis seems reasonable in the 
light of the reported Northern blot and ChIP-sqPCR data. Indeed, the up-regulation of 
the Tlys transcription takes place only after the abrogation of Tind expression. 
Altogether these data demonstrate that F55, likewise the CI repressor of 
lambda, acts as the key switch regulator involved in the lysogeny/induction transition 
of SSV1. However, some intriguing differences between lambda and SSV1 need to 
be discussed. Lambda lysogens harbour the viral DNA only as provirus and the only 
viral gene expressed is the cI. The lysogenic/lytic cycle is strictly regulated since viral 
progeny is produced only upon UV irradiation and causes cell lysis. By contrast, in 
SSV1 lysogens the provirus co-exists together with some episomal copies and a 
constitutive extrusion of the viral particles occurs. Therefore, the lysogeny of SSV1 
could be better defined as a carrier stage. In this case, the UV irradiation only 
enhances the rate of SSV1 replication and progeny extrusion without causing cell 
lysis. This difference is mirrored by the expression regulation of the key regulator 
F55, which is not as stringent as for the functional homolog CI of lamda phage. From 
an evolutionary point of view, this kind of host-virus relationship, which is typical for 
all Fuselloviridae, could be co-evolved with the non-lytic nature of these viruses. 
 
 
 
 
___________________________________________________________Chapter II –SSV1– 
 –79– 
 
 
Figure 7. A suboptimal concentration of F55 allows the derepression of the target genes. 
Schematic representation of the infected cell and of the UV-inducible region of SSV1 genome, are 
reported. The operators recognized by F55 are green-, yellow- and blue-filled. Black-bent arrows are 
the transcription start sites and dashed lines represent transcripts. Dimers of F55 are purple-filled 
ovals. In the lysogenic cell, the amount of F55 is suitable to saturate most of its binding sites and to 
keep SSV1 in a steady carrier stage. 2 hours post-irradiation, a drop of about 50% of the F55 
concentration and a concurrent increase of the viral copy number, lead to the dissociation from the 
less-affine operators in the promoter of Tind and Tlys. Later one, 4 hours post-irradiation, the dilution 
effect is enhanced by a further accumulation of the viral DNA, which has as consequence the release 
of the early promoters (i.e. those of T5 and T6), thus allowing transcription derepression. 
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2.5 Conclusions 
  
 To investigate the relationship between SSV1 and S. solfataricus P2, a 
preliminary whole-transcriptome microarray analysis was carried out in order to 
study: i) viral gene expression in the carrier stage and ii) the host response to the 
stable infection of SSV1. As concerns the host, no activation of the CRSIPR-Cas 
system was observed, thus indicating that this was not challenging the viral infection 
(further detail are discussed in Chapter III). On the other hand, it was intriguingly the 
discovery of a new gene on the SSV1 genome, which is actively transcribed and 
encodes for a putative transcription repressor (F55). Structure prediction of this 
protein suggested that it could fold into the RHH motif, which is typical of regulator 
exerting transcription repression of target genes. Functional characterization of F55 
revealed that this protein is able to bind in vitro to operator sequences located at 
promoter regions of early-induced genes as well as of its own promoter. Moreover, it 
has bee proved in vivo that the binding of this regulator is associated with 
transcription repression of the corresponding genes, whereas dissociation of F55 is 
accompanied by transcription derepression. The above-reported data show how 
SSV1 controls its gene expression in the carrier stage toward the DNA-binding 
activity of F55, thus making this virus self-consistent in the regulation of its life cycle 
in response to external stimuli. Have this ability helped SSV1 to skip the host 
CRISPR-Cas response? Further evidences will be discussed in the chapter III. 
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3.1 Summary 
 
 To study host-virus and virus-virus interactions, a whole-transcriptome 
analysis was carried out on SSV1-, SSV2- and SSV1/SSV2-infected strains of 
Sulfolobus solfataricus P2. As a control, gene expression variations physiologically 
occurring in an uninfected strain were taken into account. The fuselloviruses SSV1 
and SSV2 were chosen because, although they are very similar in morphology, 
genome organization and gene synteny, their replication induction is induced by 
different stimuli. In fact, whereas the SSV1 replication is triggered by UV-light 
exposure (see Chapter II), that of SSV2 is dependent upon the physiological state of 
the harbouring cell, at least in the natural host S. islandicus REY 15/4. 
 In SSV1-lysogens, the virus expressed few genes including those encoding for 
structural and structural-related proteins. Moreover, that encoding the transcription 
repressor F55 was one of the most transcribed. By doing so, SSV1 is able to keep a 
low copy number by repressing the expression of UV-inducible and early-genes and, 
at the same time, it produces infecting viral particles throughout the host growth. As 
concerns the host-counterpart, it was shown that the infection by SSV1 does not 
significantly affect gene expression of S. solfataricus.  
 On the other hand, it was found that SSV2 gene expression pattern was 
almost completely overlapping to that of SSV1, except for genes encoding the 
putative transcription regulator D79 and the DnaA-like protein B223 that is involved in 
the initiation of the replication. The expression of this latter could be interpreted as an 
attempt of SSV2 to take the control over the host replication machinery, thus 
fostering its own replication. Interestingly enough, SSV2 infection caused a huge 
remodulation of the host expression that involved also the transcriptional activation of 
almost all CRISPR-Cas loci as well as of several cas genes. Even more surprisingly 
was that the host response was completely reverted by the co-presence of both 
viruses in the double-infected strain SSV1/SSV2-InF1. 
 Herein it is shown that the S. solfataricus CRISPR-Cas response is consistent 
with the isolation of single clones showing low SSV2 viral titre and intracellular copy 
number. Moreover, it is highlighted an interesting aspect of the host-viral interaction 
in the frame of the CRISPR-response, i.e., host cells containing an integrated 
provirus are forced to develop a surviving strategy in order to avoid self-attack by the 
CRISPR-system. Indeed, for the first time, it was shown that S. solfataricus cells 
developed a specific strategy to safeguard host genome integrity, i.e. through 
deletion of self-targeting spacers. This has cast doubts on the applicability of 
CRISPR-Cas systems to gain infection-insensitive strains, at least for those viruses 
that integrate into the host chromosome. 
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3.2 Transcriptome analysis of Sulfolobus solfataricus infected with two related  
fuselloviruses reveals novel insights into the regulation of CRISPR-Cas  
system 
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Abstract 
 The fuselloviruses SSV1 and SSV2 are model systems to investigate on virus-
host relationship in stably infected cells thanks to their temperate nature. Although 
they are very similar in morphology, genome organization and gene synteny, 
replication induction is regulated by different stimuli, i.e.: by UV-light exposure (for 
SSV1) and by the physiological status of the host (for SSV2). In this study, we have 
analysed global gene expression in SSV1- and SSV2-lysogens of Sulfolobus 
solfataricus P2 in the absence of any stimuli Additionally, the interplay among SSV1, 
SSV2 and S. solfataricus has been investigated in a double-infected strain to explore 
both virus-host and virus-virus interactions. Whereas SSV1 did not induce major 
changes in the host gene expression, SSV2 elicited a strong host response, which 
includes the transcriptional activation of CRISPR loci and cas genes. As a 
consequence, a significant decrease of the SSV2 copy number has been observed, 
which in turn led to provirus-capture into the host chromosome. This study has 
revealed novel aspect of the host-viral interaction in the frame of the CRISPR-
response that is herein presented. 
Introduction 
The majority of organisms are susceptible to viral infection and accordingly it 
has been predicted that more than a thousand of different viruses inhabit several 
niches worldwide (Suttle 2007; Comeau et al., 2008). This makes viruses, especially 
those infecting prokaryotes (i.e. Archaea and Bacteria), the most predominant 
biological entities on Earth (Pietilä et al., 2014). Soon after the discovery of the 
Archaea domain, many viruses and virus-like particles have been isolated from 
extremely hot, low pH or hypersaline niches (Prangishvili 2013; Wang et al., 2015). 
Intriguingly, these viruses exhibit unique morphologies comparing to those infecting 
Bacteria (another domain of prokaryotes) and fall into 10 new virus families in the 
current virus classification (Pina et al., 2011; Peng et al., 2012; Prangishvili 2013). 
For instance, spindle-shaped viruses are exceptional on their own since this 
morphotype is a hallmark of viruses infecting Archaea (Krupovic et al., 2013) and it 
has never been described for bacteriophages or eukaryal viruses.  
Spindle-shaped viruses infecting organisms of the genus Sulfolobus belong to 
the family Fuselloviridae, which comprises so far ten members (SSV1, SSV2, SSV3, 
SSV4, SSV5, SSV6, SSV7, SSV8, SSV9 and ASV1) (Contursi et al., 2014a; Wang et 
al., 2015). Sulfolobus spindle-shaped virus 1 (SSV1) is a model virus for investigating 
virus-host relationship in Archaea, since it is the only UV-inducible archaeal virus 
isolated so far (Fröls et al., 2007; Contursi 2014a; Fuso et al., 2014). Investigation of 
SSV1 transcription has laid the basis for understanding how gene expression is 
regulated in Archaea (Reiter et al., 1988a; 1988b). Moreover, its genome has served 
as a backbone for the construction of vectors for genetic manipulation and gene 
expression in Sulfolobus (Contursi et al., 2013). SSV1 is a temperate virus that, upon 
infection, establishes a stable coexistence with the host by keeping its copy number 
low and constant throughout the growth of infected cells. It is worth noting that, unlike 
lambda-lysogens where only provirus exists, SSV1-lysogens carry both a provirus 
(an integrated viral genome in the host chromosome) and a few episomal copies of 
the viral DNA (Nadal et al., 1986; Schleper et al., 1992). Consequently, viral progeny 
is constitutively produced at a low level even in the absence of the inducing stimulus 
(i.e. UV-light exposure). Therefore, the lysogenic state of SSV1 is better defined as a 
carrier stage (Fusco et al., 2013 and 2015 submitted). The transcriptional map of 
SSV1 highlighted the chronological expression of the viral genes as consequence of 
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the UV exposure and helped speculating about the function of their products. 
However, so far, the general lack of sequence similarity with other proteins in public 
database has hindered functional studies of these viral genes. Indeed, only a limited 
number of proteins encoded by SSV1 or other fuselloviruses have been functionally 
and/or structurally characterized (Kraft et al., 2004a; 2004b; Menon et al., 2008; 
Guillière et al., 2009; Contursi et al., 2011; Schlenker et al., 2012; Contursi et al., 
2013; Contursi et al., 2014b; Fusco et al., 2013). 
On the other hand, although SSV2 resemble SSV1 in the shape of the viral 
particle as well as in genome organization and gene synteny, its replication induction 
is regulated by the physiological state of the host cell rather than by an external 
stimulus as demonstrated for SSV1. After infecting the native host S. isandicus 
REY15/4, the copy number of the virus is kept low (around 1-3 copies per cell) until 
the host enters into the stationary growth phase in which a steep increase of the copy 
number occurs (25-50 copies per cell) (Contursi et al., 2006). Noteworthy, this effect 
has not been observed for the permissive host S. solfataricus, in which SSV2 shows 
a copy number comparable to that of the induced state of the natural host throughout 
the growth of S. solfataricus. This led to hypothesis that a transcription factor 
encoded by the natural host S. islandicus was likely involved in the regulation of the 
viral replication induction and this factor is presumably absent from the foreign host 
S. solfataricus (Contursi et al., 2006). 
Recently, a transcriptome analysis has been carried out to define the gene 
expression pattern of SSV2 upon infection of S. solfataricus cells (Ren et al., 2013). 
This allowed detecting seven non-overlapping transcripts that were termed after the 
SSV1 counterparts. Moreover, genome transcription occurred, as for SSV1, in a 
temporal fashion during the very early phase of the infection. Nevertheless, early 
genes were not adjacently located and displayed a distributive pattern of expression 
(Ren et al., 2013). The analysis of the SSV2 gene expression pattern in the carrier 
stage (i.e. once the virus has settle down into the host cell) would allow identifying a 
minimal set of genes required for the maintenance of a basal virus-host interaction. 
Nevertheless, this aspect has received little attention so far. 
Only a few global gene expression analyses of hosts infected with archaeal 
viruses have been reported (Fröls et al., 2007; Ortmann et al., 2008; Okutan et al., 
2013; Ren et al., 2013; Quax et al., 2013). Worth-mentioning are those performed on 
the lytic Sulfolobus islandicus rod-shaped virus 2 (SIRV2), which exhibits a 
chronologically coordinated gene expression (Okutan et al., 2013; Quax et al., 2013) 
as well as on the Sulfolobus turreted icosahedral virus (STIV), which does not show 
any temporal regulation of genes expression (Ortmann et al., 2008). Viral-host 
interactions in Crenarchaea have been successful investigated at gene expression 
level both for lytic and temperate viruses, using as host S. solfataricus P2 isolated 
from a hot spring in Naples (Italy). S. solfataricus is a suitable crenarchaeal model to 
study fusellovirus-host relationships, indeed, it has been shown that several strains 
isolated in Italy are susceptible to infection by all fuselloviruses isolated to date 
(Ceballos et al., 2012). Moreover, the strain P2 of S. solfataricus harbours the 
CRISPR-Cas antiviral defense system, which is one of the main players of the virus-
host arms race. A CRISPR locus is an array of repeats, which are identical in 
sequence and length within the same locus and are interspaced by spacer 
sequences. In brief, to achieve viral immunity, DNA sequences of invading genetic 
elements (i.e. protospacers) are integrated in the array of a CRISPR locus in a 
process known as “adaptation”, thus becoming new spacers of the CRISPR loci. 
Transcription of these loci produces long-crRNAs (pre-CRISPR RNAs), which are 
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processed to produce mature crRNAs. Subsequently, mature crRNAs form 
ribonucleoprotein complexes with Cas proteins to detect and degrade the foreign 
nucleic acid in the stage known as “interference”. 
The genome of S. solfataricus P2 harbors six CRISPR loci (from A to F) and 
cas gene cassettes encoding for up to seven different interference complexes, i.e. of 
subtypes I-A (Cascade complex), III-B (CMR complex) and III-A (Zhang and White 
2013). Whereas ribonucleoprotein complexes of subtypes IA and III-A excerpt DNA 
recognition and degradation, those belonging to the subtype III-B cleave RNA in a 
sequence-specific manner. These features make S. solfataricus P2 an exceptional 
model to investigate the modulation of the CRISPR-Cas system activity in response 
to the infection by different viruses. In this regard, we report herein a global gene 
expression analysis that highlights gene expression remodulation in S. solfataricus 
upon the stable establishment of SSV1 and SSV2 into the host cells. Previous 
studies have been carried out to investigate on variation of gene expression in the 
immediate aftermath of SSV2 infection (up to 10 hours later) or upon UV-stimulus in 
SSV1 lysogens. We show that once SSV1 and SSV2 settle down into the cells, the 
host response elicited by the two viruses is very different. Noteworthy, the up-
regulation of CRISPR system occurs only in cells infected with SSV2. 
 
Materials and methods 
Strains, media and growth conditions 
SSV1-, SSV2- and SSV1/SSV2-infected strains of Sulfolobus solfataricus P2 
were generated, as described elsewhere (Contursi et al. 2006, Fusco et al. 2013), 
using as host the uracil auxotrophic mutant InF1 (Gudbergsdottir et al. 2011). 
Cultures were grown aerobically in TYSU, i.e. a glycine-buffered Brock’s basal salt 
solution supplemented with 0.1% tryptone, 0.05% yeast extract, 0.2% sucrose and 
0.002 % uracil (w/v), being the final pH 3.2 upon addition of concentrated H2SO4. 
Incubation was conducted in 250-ml Erlenmeyer flasks at 75 °C, with a shaking rate 
of 150 rpm in an Innova 3100 Water bath shaker (New Brunswick Scientific Corp).  
Aliquots from frozen cultures of the uninfected InF1 and the infected strains 
(SSV1-InF1, SSV2-InF1 and SSV1/SSV2-InF1) were revitalized by inoculating in 
TYSU medium. Cell growth was spectrophotometrically monitored at 600 nm (OD600) 
throughout the cultivation by means of a Variant Cary® 50 Bio UV/Visible 
Spectrophotometer (McKinley Scientific). Once reached 0.4 OD600, cultures were 
diluted to 0.05 OD600, incubated back to 75°C and samples collected at 0.4 OD600 
(early exponential phase) and 1.2 OD600 (late exponential phase). Cellular pellets 
were obtained through centrifugation at 3,000 × g for 10 min using the Centrifuge 
5810R (Eppendorf) and treated for total DNA and RNA preparations. 
To isolate single clones from the SSV2-InF1 strain, serial dilutions of this 
culture were plated on TYSU-Gelrite and incubated at 75°C. Isolated colonies 
appeared on the plate surface after 7-10 days (about 100 colonies per plate). Several 
colonies were inoculated in liquid medium (about 10 per plate), let to grow until 0.4 
OD600 and culture supernatant tested by plaque assay for viral titre determination, 
using the uninfected InF1 strain as lawn and the supernatant of the SSV2-InF1 
culture as control. Single clones showing a lower viral titre were further screened 
through three subsequent steps in order to select SSV2-cured cells. 
 
RNA extraction, cDNA synthesis and labeling  
Total RNA samples were prepared by means of the TRIzol reagent (Sigma 
Aldrich®) and carried-over DNA was digested using TurboTM DNase (Ambion®), 
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according to the manufacturer’s instructions and the enzyme was thermal inactivated 
at 70°C for 10 min after the addition of 5 mM EDTA. DNA-free RNA samples were 
purified by phenolic extraction and ethanol precipitation. RNA pellets were dissolved 
in nuclease-free water and both concentration and integrity were checked through: i) 
electrophoresis on denaturing, formaldehyde-containing 2.0% (wt/vol) agarose gel 
and ii) determination of the 260nm/280nm adsorption ratio using a Nanodrop 1000 
Spectrophotometer (Thermo Scientific). Only samples showing ratios between 2.1 
and 1.9 were used for cDNA synthesis. 
cDNA labeled with 5-(3-aminoallyl)-dUTP (aa-dUTP) was generated by means 
of the Amersham CyScribe Post Labeling Kit (GE Healthcare) according to the 
manufacturer's directions, with few modifications as follows: 4 µl of random hexamers 
primers, 1 µl random nonamers primers, 10-15 µg total RNA and nuclease-free water  
were mixed in a final volume of 11 µl. The mixture was denatured at 70°C for 5 
minutes and chilled at room temperature for 10 minutes. 4 µl of 5× CyScribe buffer, 1 
µl dNTP mix, 1 µl aa-dUTP, 2 µl DTT 0.1 M and 1 µl CyScribe reverse transcriptase, 
were added to the reaction mixture and incubated at 42°C for 90 min. Afterwards, the 
RNA template was degraded by adding 2 µl of 2.5 M NaOH and incubating at 37 °C 
for 15 minutes. The allyl-dUTP cDNA sample was purified using the Illustra Cyscribe 
GFX Purification kit (GE Healthcare) after neutralizing the reaction mixture with the 
addition of 10 µl of 2 M HEPES free acid. The concentration of the purified cDNA was 
spectrophotometrically determined.  
The CyDye labeling of the amino allyl-modified cDNA was achieved using the 
Amersham CyScribe Post Labeling Kit (GE Healthcare) and purification of the 
labelled cDNA was carried out by means of the MinElute® PCR purification kit 
(Qiagen), following the manufacturer's instructions. The “reference” and the 
“experiment” cDNA samples were labeled with cyanine-3 (Cy-3) and cyanine-5 (Cy-
5), respectively. The ratio between the CyDye-labeled and the total cDNAs was used 
to monitor the labelling efficiency. Only “reference” and the “experiment” cDNA 
samples showing similar labelling efficiency were co-hybridized on the same slide. 
 
Microarray hybridization and data analysis 
  Customized microarray slides harbor about of 7,000 spots and were designed 
by the Sulfolobus genome chips consortium and manufactured by Ocimum 
Biosolutions (Hyderabad). A single array includes probes, spotted in duplicate, for 
3,042 S. solfataricus P2 genes, for several crenarchaeal viruses, three plasmids as 
well as for human and Arabidopsis thaliana sequences as negative controls 
(Ortmann et al., 2008, Okutan et al., 2013, Ren et al., 2013). The microarray slide 
was first dipped into a coupling jar containing 25 ml of prewarmed prehybridization 
solution (1% BSA; 5× SSC; 0.1% SDS) and then incubated at 42°C for 40 minutes 
under shaking (Thermo-Electron Corporation). The prehybridized slide was washed 
three times with distilled water and once with 100% isopropanol. Finally, the slide 
was dried by centrifugation and a LifterSlip coverslip was applied onto the array-area. 
The hybridization solution (60% deionized formamide, 7× SSC, 2% SDS, 0.2 
µg/µl herring sperm DNA, 0.2 µg/µl tRNA) was incubated at 95°C for 2 minutes and 
chilled on ice for 1 minute, before adding equal amounts of reference and the 
experiment cDNA (50 picomoles CyDye for each). Subsequently, the hybridization 
mixture was carefully injected between the array surface and the coverslip. The slide 
was sealed in a hybridization chamber and incubated at 42°C for 18 hours. Washing 
of the hybridized slide was performed with: i) a prewarmed solution A (2× SSC; 0.1% 
SDS) at 42°C for 5 minutes under gently shaking; ii) a prewarmed solution B (0.1× 
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SSC; 0.1% SDS) for 20 minutes at 42°C and iii) a solution C (0.1× SSC) for five times 
at room temperature. Finally, the slide was dried by centrifugation and immediately 
scanned using the Array WorXe (Applied Precision). Data analysis was conducted by 
ImaGene® v. 9.0 (BioDiscovery), using default settings and included the following 
steps: data import, background adjustment, normalization, summarization and quality 
assessment. 
Up to four independent experiments were carried out for each 
reference/experiment cDNA couple. Moreover, since each probe is present in 
duplicate on a slide, the fold-change variation for each gene is the average among 
the collected data points. In particular, the software Imagene® gives a log2 ratio value 
for each analysed spot: 
 
[log2 (FCy-5 exp)] – [log2 (Fcy-3 ref)] = log2 (Fcy5 exp/ Fcy3 ref) 
 
where “F” indicates the normalized fluorescence intensities of the Cy-3 and Cy-5 
detected in a given spot. The variation of the gene expression fold (VGEF) is 
calculated through the following equation: 
 
VGEF = 2log2(Fcy-5exp/ Fcy-3ref) 
 
Only genes with a VGEF of ≥ 2 as well as a p value of < 0.05 were regarded as 
differentially expressed. 
 
PCR analysis of CRISPR loci leader-proximal regions and of the SSV2 
integration site 
A fundamental step in the CRISPR-Cas system is the adaptation, which 
consist in the Cas proteins-mediate incorporation of new spacers that occurs 
immediately downstream the leader sequence of a given CRISPR locus. With the 
purpose of detecting new spacers integration at the leader-proximal regions of all the 
CRISPR loci (A-F) in the S. solfataricus genome, six primer couple were used (Tab. 
1). In particular, these oligonucleotides were designed to amplify the first 5-8 repeat-
spacer units located immediately downstream the leader sequence (Erdman and 
Garrett 2012). Thus, integration of new spacers will produce longer PCR products 
than the control sample (uninfected InF1). 
Total DNA samples were prepared using the DNeasy tissue kit (Qiagen), 
following the manufacturer’s instructions and their concentration was 
spectrophotometrically measured using a Nanodrop 2000 Spectrophotometer 
(Thermo-Scientific). PCR master mixes were prepared as follows: 1× Taq Buffer, 2.5 
mM MgCl2, 0.2 mM dNTP mix, 0.6 µM primer-fw, 0.6 µM primer-rv and 0.05U/µl of 
Taq DNA Polymerase (Thermo Scientific). The thermal cycling protocol was as 
follows: an initial denaturation step of 5 min at 95°C, followed by 35 cycles of 1 min at 
95°C, 1 min at 50°C, and 1 min at 72°C. A final step at 72°C has been carried out for 
10 min at the end of the 35th cycle. A negative (no template) was also included in the 
analysis. PCR products were analysed in a 1% agarose gel. 
In parallel, to check the occupancy of the SSV2-integration site in the S. 
solfataricus genome, a PCR analysis was carried out by means of the primers 
SSV2attAp01, SSV2attAp02 and SSV2attAp03 (described in Contursi et al. 2006), 
whose sequences are listed in Table 1. The reactions were set up (as described 
above) except for the annealing temperature that was of 55°C. 
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Table 1 
Primers used for PCR analyses 
 
Name Sequence (5’-3’) Length (nt) 
Lpr-LcsA-fw AGCTTCTGACCCGCTCCTGA  20 
Lpr-LcsA-rv GCACATCATCAAACAATGGTAAGCC 25 
Lpr-LcsB-fw AGGGGTTTGTGGGATGGGTTGTG  23 
Lpr-LcsB-rv ACAACTACCACCACTACCACGG  22 
Lpr-LcsC-fw TCGCTTATCTCTCTCATGCGCCATT  25 
Lpr-LcsC-rv TGTCCCGTTTTTGTAAGTGGGGG  21 
Lpr-LcsD-fw AGTTCCACCCCCGAAGCTCCT  21 
Lpr-LcsD-rv AGCCGGGACAAGTTTCACAAATTGA  25 
Lpr-LcsE-fw ATAGGGAAAGAGTTCCCCCG  20 
Lpr-LcsE-rv TGACTCTAGTGCAATCTTCGA  21 
Lpr-LcsF-fw CGGCGTTATAATGGGTATCGGAATCGG  27 
Lpr-LcsF-rv GCTCACTATCTCACCCCTATCAATACCC 28 
SSV2attAp01 GTGTTCTACCTTTTCCACAGTC 22 
SSV2attAp02 TGGGTACGTCATTTATTGATCTT 23 
SSV2attAp03 GCTTTTATGCAGTTATTGCTTT 22 
orc1-fw TATAAATTGTTATAGACATAGAACGCTGTA 30 
orc1-rv TTAAATACTTCTTGTGCCGATAGTCC  26 
vp3-fw GTTATTGGTGTAGTTCTGTT 20 
vp3-rv GGGTACAACAATTAAGACTA 20 
 
 
Semi-quantitative PCR analysis of the SSV2 DNA content 
Cell pellets of the initial population InF1-SSV2 and of the screened clones 
showing a lower SSV2 titre (clone 1, 1Q and 1Q1) were treated for total DNA 
extraction using the DNeasy tissue kit (Qiagen), following the manufacturer’s 
instructions. To follow the variation of the SSV2 DNA content among the different 
clones, a semi-quantitative PCR analysis was performed. Two primer couples were 
designed using Primer3 software (available at the website: http://bioinfo.ut.ee/primer 
3-0.4.0/), in order to amplify: (i) a 108-bp region of the host single-copy gene orc1 
and (ii) a 238-bp region of the SSV2 single-copy gene vp3 (Table 1). A master mix 
was prepared and PCR reactions were carried out as describe elsewhere (Fusco et 
al., 2014), using the following cycling protocol: an initial denaturation step of 5 min at 
95°C, followed by 30 cycles of 40 sec at 95°C, 40 sec at 62°C, and 1 min at 72°C. 
For each reaction, tubes were taken from the thermocycler at the 20th, 25th and 30th 
cycle of amplification. PCR products were run a 2% agarose gel in 1× TAE buffer (40 
mM Tris, 20 mM acetic acid and 1 mM EDTA). 
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Results and discussion 
Two fuselloviruses, SSV1 and SSV2, were chosen as model study since they 
are not lytic and are therefore suitable for analysing variation of gene expression in 
stable infected populations, i.e. once the host/virus relationship has been settled 
down (carrier stage). Indeed, previous studies were carried out in the immediate 
aftermath of the viral infection (Ren et al., 2012), on lytic viruses (Ortmann et al., 
2008, Okutan et al., 2013, Quax et al., 2013) or upon induction of the viral replication 
(Fröls et al., 2007). Furthermore, the double-infected SSV1/SSV2-InF1 strain is a 
ternary system, which is suitable for analysing the mutual effect of the two viruses on 
each other as well as on the host gene expression. 
 
Viral gene expression in the infected strains 
To evaluate the effect of the viral infection on the host gene expression, S. 
solfataricus P2 (InF1) was infected to generate virus harbouring stains with a single 
virus, including SSV1-InF1, SSV2-InF1 and SSV1/SSV2-InF1; this latter carries both 
fuselloviruses. SSV1 and SSV2 genes show sequence identity and genome synteny 
and, accordingly, SSV2 promoters were named after their SSV1 counterparts (Ren et 
al., 2013; Contursi et al 2014). The only significant difference is the absence, in the 
SSV2 genome, of a region similar to that of SSV1 that is involved in regulating the 
switch from the lysogenic to the UV-induced state. Microarray experiments were 
performed for all the strains, at two different phases, i.e. at 0.4 OD600nm (early-
exponential) and 1.2 OD600nm (late-exponential), in order to define which viral genes 
were expressed. With this aim, microarray slides were co-hybridized with the total 
cDNA samples from: 
 
1) uninfected InF1 vs infected SSV1-InF1, collected at 0.4 OD600nm 
2) uninfected InF1 vs infected SSV1-InF1, collected at 1.2 OD600nm 
3) uninfected InF1 vs infected SSV2-InF1, collected at 0.4 OD600nm 
4) uninfected InF1 vs infected SSV2-InF1, collected at 1.2 OD600nm 
5) uninfected InF1 vs infected SSV1/SSV2-InF1, collected at 1.2 OD600nm 
6) uninfected InF1 vs infected SSV1/SSV2-InF1, collected at 1.2 OD600nm 
 
cDNA were prepared from the uninfected and infected strains and used as reference 
and experimental samples, respectively. These comparisons allowed us to identify 
viral genes expressed in the infected strains. SSV1 genes found to be expressed at 
both the growth phases analysed were those encoding: i) the structural proteins VP1, 
VP3 and VP2, ii) the integrase D335, iii) the transcription repressors F55 and iv) 
A291 and C124 (Fig. 1) for which virion docking/release and structural functions have 
been proposed, respectively (Fröls et al., 2007, Ren et al., 2013). Interestingly, most 
of the viral gene expressed by the SSV2-InF1 strain were homologous to those 
expressed from SSV1, i.e.: VP1, VP3, A305 (SSV1-A291) and C121 (SSV1-C124) 
(Fig. 1). In addition, the DnaA-like protein B233 and the D79 were found expressed. 
A probe matching the 3’ non-coding region of b233 gene detected transcriptional 
activity, thus indicating that the mRNA of b233 extends over about a hundred 
nucleotides downstream its own stop codon (Fig. 1). In the double-infected strain 
(SSV1/SSV2-InF1), viral genes expressed were those encoding: i) the SSV1 and 
SSV2 structural proteins VP1 and VP3, ii) the homologous proteins A291/A305 and 
iii) C124/C121, iii) the transcription repressor F55 of SSV1 and iv) B233 and D79 of 
SSV2 (Fig. 1). It is noteworthy that the transcription patterns of SSV1 and SSV2 were 
nearly identical, despite the fact that replication induction for these two viruses is 
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triggered by different stimuli, i.e. the UV-light exposure and the host 
physiological/metabolic state, respectively. Therefore, this analysis defined a minimal 
set of genes required, in the carrier stage, for the replication and packaging of both 
fuselloviruses (Fig. 1). 
 
 
 
  
Figure 1. Schematic representation of the SSV1 and SSV2 genomes. (A) Red-filled arrows are 
viral genes expressed in the carrier stage for both the SSV1 (outer) and the SSV2 (inner) genomes. 
Clockwise- and anticlockwise-oriented arrows represents ORFs encoded by the plus and minus 
strand, respectively. (B) List of viral gene expressed in all the stains analyzed. 
 
 In order to evaluate variation of the expression levels of the viral genes during 
the host growth, the following co-hybridization were carried out: 
 
1) SSV1-InF1 collected at 0.4 OD600nm vs SSV1-InF1 collected at 1.2 OD600nm 
2) SSV2-InF1 collected at 0.4 OD600nm vs SSV2-InF1 collected at 1.2 OD600nm 
3) SSV1/SSV2-InF1 collected at 0.4 OD600nm vs SSV1/SSV2 collected at 1.2 
OD600nm 
 
cDNA from the infected strain collected at 0.4 OD600nm and 1.2 OD600nm were used as 
reference and experimental samples, respectively. This analysis revealed a 
constitutive expression of all the above-listed SSV1 and SSV2 genes, except for the 
SSV2 ORF a305, which was down-regulated of 2.9-fold (Table S3 and S4). 
 
Expression variation in the uninfected InF1 strain throughout the growth  
To evaluate the effect of viral infection on the host gene expression, we first 
identified the up- and down-regulated genes during the growth of the uninfected InF1 
strain. With this aim, microarray slides were co-hybridized with total cDNA samples 
from: 
 
 
1) InF1 collected at 0.4 OD600nm(ref) vs InF1 collected at 1.2 OD600nm(exp) 
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A total of 60 up-regulated and 27 down-regulated genes were detected (Tab. 2). 
Among the up-regulated ones, the expression of 38 genes increased of 2.0-4.9 folds, 
13 showed a 5.0-9.9 fold-change and only for 5 genes the expression was up-
regulated among 10.0 and 33.0 folds. On the other hand, all down-regulated genes 
showed a fold of repression comprised in the range 2.0-4.9, except for one (sso2574) 
whose transcription was down-regulated by 5.9 folds. 
A remarkable number of the up-regulated S. solfataricus genes encode 
proteins belonging to three functional categories: hypothetical protein, transport and 
energy metabolism (Tab. 2). The transcriptional activation of genes involved in the 
transport of small metabolites is not surprising and it is likely due to the shortage of 
nutrients, which occurs in a later stage of the growth. Moreover, it is interesting that a 
homologous of the gene encoding the bacitracin resistance protein (sso1860) is up-
regulated, hinting to defence mechanisms acting against xenobiotic peptides 
produced by other member cells to face overpopulation. On the other hand, down-
regulated genes mostly cluster into the categories of transcription and regulation as 
well as translation (Tab. 2). Noteworthy, the down-regulation of many genes 
encoding for ribosomal proteins is probably consistent with the reduction of the 
proteins synthesis and, in turn, with the decrease of cell growth rate. A complete list 
of the differentially regulated genes, grouped by functional categories, is reported in 
the Table S1. 
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Table 2 
Functional distribution of up- and down-regulated genes. 
 
 
Functional 
Groupa 
Gene expression 
Up-regulated genes Down-regulated genes 
 InF1 SSV1 InF1 
SSV2 
InF1 
SSV1/SSV2 
InF1   InF1 
SSV1 
InF1 
SSV2 
InF1 
SSV1/SSV2 
InF1 
Aminoacid 
Biosynthesis 2 1 2 1    2 0 2 0 
Cellular  
Envelope and 
Membrane 
1 0 1 0    0 0 1 0 
Cellular  
Process 2 1 4 2    2 1 8 2 
Central 
Intermediary 
Metabolism 
0 2 0 2    0 0 2 0 
Cofactor 
Biosynthesis 0 0 0 0    0 0 2 1 
Energy 
Metabolism 10 1 19 0    1 0 12 3 
Hypothetical 
Proteinb 16 3 10 1    6 4 16 3 
IS Elements 1 2 6 0    1 0 0 0 
Lipid 
Metabolism 2 0 3 1    0 0 0 0 
Nucleotides 1 0 0 0    0 0 7 1 
Protease and 
Protein 
Modification 
0 0 0 0    1 0 2 0 
Replication 
and 
Repair 
1 0 1 0    0 0 3 2 
RNA 2 1 1 1    0 1 0 0 
Transcription 
and 
Regulation 
3 1 11 2    5 2 7 2 
Translation 0 0 0 0    7 4 14 0 
Transport 17 4 7 1    1 1 5 2 
Uncategorized 
Helicases 1 1 3 0    1 0 2 2 
Cas genes 0 0 8 0    0 0 0 0 
Viral Genes 0 0 0 0    0 0 1 1 
STIV infection 
differentially 
regulated 
1 0 1 0    0 0 1 0 
Total 60 17 77 11    27 13 85 19 
aPutative functions are derived from the website of the Sulfolobus solfataricus P2 
complete sequencing project. bHypothetical proteins with no putative function. 
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Host gene expression variations as consequence of SSV1 infection 
In order to detect remodulation of the host gene expression in the SSV1-InF1 
lysogenic strain, a microarray analyses was carried out by co-hybridizing cDNA 
samples as follows:  
 
1) SSV1-InF1 collected at 0.4 OD600nm(ref) vs SSV1-InF1 collected at 1.2 OD600nm(exp) 
 
To determine the host genes whose expression is altered as a consequence of the 
SSV1 infection, we excluded from the analysis those that were up- and down-
regulated in the uninfected InF1 strain as a consequence of the physiological 
changes occurring in the passage from the early to the late exponential growth 
phase. Among the thirty differentially expressed host genes, 17 were up- and 13 
down-regulated throughout the growth of the SSV1-InF1 strain (Tab. 2). Changes in 
the expression level tended to be higher for the up-regulated genes. The majority of 
the down-regulated ones decreased by 2 to 2.5-folds, whereas 5 genes were up-
regulated with a increasing from 2.8 to 4.3-fold (Tab. S2). Although these genes are 
scattered over several functional categories, a similar trend to that of the uninfected 
strain was observed. Indeed, genes encoding proteins involved in the transport and 
translation are up- and down-regulated, respectively. 
These data show that the infection by SSV1 has only a limited effect on the 
host gene expression, suggesting a harmonic coexistence with the host in the carrier 
stage. Accordingly, SSV1 is a temperate virus that self-regulates its gene expression 
in the carrier stage through the pleiotropic effect of the transcription regulator F55 
(Fusco et al., 2015 submitted), which represses the expression of the UV-inducible 
as well as of the early genes. 
 
Re-modulation of the host gene expression by SSV2 infection: the case of the 
CRISPR-Cas system activation 
To investigate on variation of host gene expression during the growth of the 
stably infected SSV2-InF1 strain, a microarray analysis was carried out by co-
hybridizing cDNA samples as follows: 
 
SSV2-InF1 collected at 0.4 OD600nm(ref) vs SSV2-InF1 collected at 1.2 OD600nm(exp) 
 
As already described for the SSV1-InF1 strain, all the variations of gene expression 
reported herein for the SSV2-InF1 strain, have to be considered merely due to the 
SSV2 infection. Noteworthy, a total of 162 host genes were differentially expressed 
throughout the growth of the SSV2-InF1 strain, with 77 and 85 genes that were found 
to be up- and down-regulated, respectively (Tab. 2). By comparing the total number 
of differentially regulated host genes between the SSV1-InF1 (30 genes) and the 
SSV2-InF1 (162 genes) strains, it is evident that the remodulation occurring as 
consequence of the SSV2 infection is outstanding (Tab. 2). Expression variation is in 
general higher for up-regulated genes (between 2.0 and 7.9 folds) than for those 
down-regulated (between 2.0 and 6.0 folds). Moreover, the expression of the majority 
of down-regulated genes decreased by 3.0-folds or less, whereas 34 up-regulated 
genes were differentially regulated of 4-folds or greater (Tab. S3). Intriguingly, 
although SSV2 is a not-lytic virus, its effect on the host gene expression is 
comparable to the lytic virus STIV (Ortman et al., 2008), indeed, 5% of the S. 
solfataticus genes were directly affected by the SSV2 infection. 
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 Among these, genes encoding for proteins belonging to the functional 
categories of energy metabolism as well as transcription and regulation tended to be 
up-regulated (Tab. 2). Furthermore, induction of IS elements transcription (Tab. S3) 
has already been reported after viral infection for the lytic virus SIRV2 (Quax et al 
2013) as well as consequently to UV-light (Fröls et al., 2007) and heat shock 
exposure (Cooper et al., 2009), thus highlighting their involvement in the general 
stress response in S. solfataricus. On the other hand, down-regulated genes are 
mostly associated with categories of translation (Tab. 2 and S3). Moreover, 
repression of stress response genes encoding for the proteasome subunit (sso0278) 
and Bcp3 (sso0225) resemble the response of S. solfataricus to the infection by 
SIRV2, which is able in this way to circumvent host defences (Okutan et al., 2013). 
Expression remodulation of genes involved in informational processing (i.e. 
transcription and translation) has been also observed for the lytic viruses STIV 
(Ortman et al., 2008) and SIRV2 (Okutan et al., 2013). This indicates that all these 
viruses indicate the dependency of SSV2 on the host apparatus and its attempt to 
take the control over the host informational machinery, despite the difference in their 
life cycle.  
 One of the most interesting outcomes from this analysis was the expression 
variation observed for a group of genes involved in CRISPR-Cas antiviral system, 
i.e.: i) the type IA interference cassette located downstream the locus C, which 
includes the genes sso1439 (cas3’’), sso1441 (cas5), sso1442 (cas7) and sso1443 
(csa5); ii) sso1424 (small subunit CASCADE complex) and sso1425 (csm3) 
belonging to the type IIIA interference cassette localized downstream the former one; 
iii) the sso1389 (csx1 putative transcription factor) localized upstream the locus A 
and iv) sso1997 (cas7 type IA) lying in the proximity of the locus F (Fig. 2, Tab. 3). 
 
 
 
 
Figure 2. CRISPR/cas loci of S. solfataricus P2. The six CRISPR/cas loci of the S. solfataricus P2 
genome are schematized, where red-filled arrows are cas genes up-regulated in the SSV2-InF1 stain. 
Gene cassettes are black-framed and labeled. 
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Table 3 
SSV2-infection affected CRISPR loci and cas genes 
 
Gene ID Function 
 CAS GENE PRODUCT 
SSO1389  csx1 (CRISPR-Cas system-associated protein) 
SSO1424  csa5 (CRISPR-Cas system-associated protein) 
SSO1425 csm3 (CRISPR-associated RAMP) 
SSO1439 cas’’ (Nuclease subunits of Cas3) 
SSO1441 cas5 (CASCADE complex core) 
SSO1442 cas7 (CRISPR-Associated Protein, Csa2) 
SSO1443 csa5 (CRISPR-Associated Protein) 
SSO1997 CRISPR-associated auto-regulator, DevR family homolog 
   
CRISPR 
locus Probe position 
SSOLCTR-A 1708..1767 
SSOLCTR-A 3373..3432 
SSOLCTR-B STIV 
SSOLCTR-B 278..343 
SSOLCTR-B 1493..1557 
SSOLCTR-C pNOB8 
SSOLCTR-C 10-71 
SSOLCTR-C 1916-1980 
SSOLCTR-D ATV 
SSOLCTR-D 105..174 
SSOLCTR-D 483..551 
SSOLCTR-D 5568..5630 
SSOLCTR-F 3689..3753 
SSOLCTR-F 4350..4419 
 
  
 In parallel, with the exception of the locus E, all the CRISPR loci were found to 
be up-regulated during the growth of the SSV2-InF1 strain, with the highest 
expression induction observed for loci A, C and D (Tab. 3). Noteworthy, proteins 
encoded by the aforementioned up-regulated type IA interference cassette constitute 
the CASCADE effector complex of S. solfataricus (CRISPR-associated Complex for 
Antiviral Defence), which is involved in the interference step of the defence system 
(Zhang and White 2013); thus, hinting to interference processes acting against 
SSV2. Interestingly, loci A, B, D and F of the S. solfataricus P2 strain contain spacers 
matching fuselloviral genomes with the highest density observed at the leader-
proximal region of the locus F (Lillestøl et al., 2009). Although this latter is a non-
extending locus, due to the lack a leader sequence, it can still be useful in 
challenging viral infection since it generates crRNAs. Accordingly, the aCASCADE 
(archaeal CASCADE) co-purified with crRNAs from all CRISPR loci (Lintner et al., 
2011) and probably exert its activity with all the crRNAs of S. solfataricus, including 
the locus F (Manica and Schleper 2013). Moreover, the expression of this locus has 
been further confirmed in the strain SSV2-InF1 by RT-PCR (data not shown). 
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The presence of SSV1 quenches the effect of SSV2 infection on host gene 
expression  
In order to evaluate the global variation of the host genes transcription caused 
by the co-presence of SSV1 and SSV2, slides hybridizations were carried out using 
cDNA samples as follows: 
 
 
SSV1/SSV2-InF1 collected at 0.4 OD600nm (ref) 
vs 
SSV1/SSV2-InF1 collected at 1.2 OD600nm (exp) 
 
 
As done before, data from the uninfected strain were used to filter those of the 
double-infected one, so that gene expression variation reported is merely due to the 
presence of the viruses. Among viral genes, no significant variation was observed 
with the exception of the SSV2 gene a305 that showed a down-regulation trend, 
similarly to that observed for the single-infected strain SSV2-InF1 (Tab. S4). On the 
other hand, among 29 regulated host genes, 11 were up- and 19 down-regulated 
during the growth of the double-infected strain (Tab. 2). Therefore, the presence of 
SSV1 in the same host cells of SSV2 quenched the gene expression variation from 
162 (being differentially regulated in the single-infected SSV2-InF1 strain) to only 30 
genes. It is worth of note that genes and clusters of the CRISR/Cas system did not 
undergo to transcription induction in double-infected cells. Instead, the expression 
pattern of the viral genes is overall identical to that displayed by the single-infected 
SSV1- and SSV2-InF1 strains. The two fuselloviruses show syntenic genomes, with 
the only significant difference in the UV-inducible of SSV1, which is lacking in the 
SSV2 genome. Therefore, it is tempting to speculate that the SSV1 F55 transcription 
factor, encoded by this region, interferes with the remarkable remodulation of the 
host gene expression induced by SSV2. 
 
Screening for single clones from the CRISPR/Cas responsive SSV2-InF1 strain   
 To investigate on whether the activation of the CRISPR/Cas system (see 
above) enabled the cells to get rid of SSV2, we performed a screening of the strain 
SSV2-InF1 for the isolation of cured cells. Therefore, clones showing a decreased 
viral titre, compared to the SSV2-InF1 initial population, were further characterized at 
DNA level to evaluate SSV2 content through semi-quantitative PCR. Among these, 
results are shown for clones 1, 1Q and 1Q1 that are representative of the first, 
second and third round of screening, respectively. As shown in figure 3, the PCR 
products were analysed for each sample on agarose gel at the 20th, 25th and 30th 
cycle of amplification; the initial population SSV2-InF1 was used as reference. 
Although the intensity of the orc1 signal is nearly identical when the same 
amplification cycle is considered, the amplification band relative to the viral product 
vp3 decreases at each round of screening until it becomes hardly visible for the clone 
1Q1 (Fig. 3). These data confirm that the progressive decrease of the viral titre 
observed for 1, 1Q and 1Q1 clones (data not shown), is mirrored by a drop of the 
intracellular SSV2 DNA content (Fig. 3). 
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Figure 3. SSV2 DNA detection by semi-quantitative PCR. Black-straight arrows point out to 
molecular weight markers as well as to the host (orc1) and the viral (vp3) PCR products. Total DNA 
samples were prepared from the initial population (SSV2-InF1) as well as from the screened clones (1, 
1Q and 1Q). The decreased intensity of the vp3 amplification band indicates that the SSV2 copy 
number droped throughout the screenin. 
 
 
 
 
Figure 4. PCR analysis of the integration site occupancy in the screened clones. Black-straight 
arrows point out to molecular weight markers. PCR products p01/p02 (968 bp, free integration site) 
and p01/p03 (722 bp, integrated provirus) have been amplified from the SSV2-InF1 as well as from 
the screened clones (1, 1Q and 1Q), to check the occupancy of the integration site in the host 
genome. As shown from the right panel, with the exception of the virus-free sample (InF1), all clones 
carries the provirus. However, provirus-free cells still persist in the cultures (left panel) although their 
amount decreased throughout the screening, until no empty integration sites are detected after at the 
third step of screening (1Q1). 
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In parallel, a PCR analysis of the SSV2 integration site was carried out for the 
same clones. To do this, the primers SSV2attAp01, SSV2attAp02 and SSV2attAp03 
(Contursi et al., 2006) were chosen. The primer couple Ap01-Ap02 amplify a product 
of about 968bp only if the integration site is empty (no provirus). On the other hand, 
the couple Ap01-Ap03 lead to the amplification of a 722bp product only if the 
integration site is occupied by SSV2 (Fig. 4). The presence of the product Ap01-Ap02 
for the infected strain SSV2-InF1 as well as for the clone 1 and 1Q indicates that a 
portion of the cell population do not carry the provirus. Whereas, the absence of such 
amplicon in the 1Q1 clone, suggests that virtually all the cells have the integrated 
SSV2 in the attachment site. The amplification of the product Ap01-Ap03 further 
confirms the presence of the provirus (Fig. 4). Since the excision of the provirus 
strictly depends on the presence of an active integrase/excision enzymes, encoded 
by the episomal copies (She et al., 2001), the degradation of the latters by the host 
CRISPR/Cas system led to the entrapment of the integrated viral genome (Fig. 4) as 
already hypothesized elsewhere (Garret et al., 2011). 
 
SSV2 infection causes deletions at the leader-proximal region of the locus F 
A fundamental step of the CRISPR-cas system is the adaptation, which 
consist in the Cas proteins-mediate incorporation of new spacers from foreign DNAs 
that occurs immediately downstream the leader sequence of a given CRISPR locus 
upon viral infection. In order to detect the integration of new spacers, leader-proximal 
regions of all the six loci in the S. solfataricus genome were amplified (Fig. 5). In 
particular, primer couples were chosen as described elsewhere (Erdman and Garrett 
2012), so that integration of new spacers would have produced longer PCR products 
when compared with a control sample (uninfected InF1). 
Our PCR analysis detected no differences in the length of the amplified 
products (loci A-E) among the initial population SSV2-InF1 infected and the screened 
clones (Fig. 5), thus confirming that no adaptation occurred upon infection with SSV2 
at these loci. Nevertheless, smaller PCR products (between 230 and 450 bp) were 
found when the leader-proximal region of the locus F was amplified from the 1Q1 
DNA (Fig. 5). In order to shed light on the identity of these amplicons, PCR products 
were run on an agarose gel and single bands were cut off, purified and sequenced. 
Surprisingly, this analysis showed that progressive deletions occurred at the leader-
proximal region of the locus F and up to six repeat-spacer units were found to be 
lacking (Fig. 6). 
In this regard, it is noteworthy that Stern and co-workers have point out that 
the incorporation of self-targeting spacers leads to autoimmunity and selects for the 
loss of CRISPR functions (Stern et al., 2010). Moreover, it has been demonstrated 
that when S. solfataricus is transformed with a plasmid that carries an essential gene 
and is also a target of the CRISPR system, surviving transformants show mutations 
that eliminate the plasmid-targeting spacer (Gudbergsdottir et al., 2011). What would 
happen if the invading DNA, such as a virus, could not be destroyed because 
managed to integrate into the host genome, thus becoming ‘self’? In the hypothesis 
that the host is challenging the SSV2 infection (as shown by microarray data), it is 
likely that the CRISPR-Cas system targets also the integrated viral genome (i.e., the 
provirus). This event casts a huge fitness cost on cells harbouring the self-targeting 
spacer (Dyall-Smith 2011), therefore the selective pressure could drive the 
inactivation of the CRISPR.Cas system to ensure the survival of SSV2-lysogens. Our 
results indicate that this is achieved through deletion of spacer units responsible for 
the recognition of the SSV2 genome (Fig. 5 and 6). 
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Figure 5. Leader-proximal region amplification of the S. solfataricus P2 CRISPR array. PCR 
amplifications have been performed to amply leader-proximal regions of all six CRISPR loci (A to F) 
from the virus-free strain (InF1), SSV2-infected initial population (SSV2-InF1) and from the screened 
clone 1Q1. The wild-type PCR product (W) has been amplified for all the loci, thus indication no 
acquisition of spacers (no adaptation). Intriguingly, shorted PCR products were amplified from the 
locus F of the clone 1Q1. Sequencing of these fragments confirmed loss of repeat/spacer units from 
this locus (see Fig. 6). 
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Figure 6. Schematic illustration of repeat/spacer units loss from the locus F. The array F is 
reported as grey rectangles (repeats) interspersed by colourful rectangles (spacers). A short intergenic 
region separates the array from the opposite-oriented cas genes cassette (IA3, see also Fig. 2). 
Deletions are schematised to show that from 2 to 6 repeat/spacer units were lost in the clone 1Q1. 
 
Conclusions 
 Analysis of both viral and host transcriptome upon SSV1 and SSV2 infection in 
S. solfataricus has revealed new insights into archaeal host-virus interactions. 
Previous studies were carried out to detect variation of gene expression during the 
infection process or upon UV-irradiation. Herein, by exploiting stable infected cells 
and in the absence of any inductive viral stimulus, we demonstrate not only that the 
host response towards the two viruses is extremely different during lysogenic growth, 
but that it is also influenced by the co-presence of both fuselloviruses (Tab. 2). In 
particular, whereas S. solfataricus establishes a harmonious coexistence with SSV1, 
the reaction against the infection by SSV2 is outstanding and includes the 
transcriptional activation of CRISPR loci and cas genes (Tab. 3). This result is 
consistent with the isolation of single clones showing low SSV2 viral titre and 
intracellular copy number (Fig. 3). Our study highlighted an interesting aspect of the 
host-viral interaction in the frame of the CRISPR-response, i.e. host cells containing 
an integrated provirus (Fig. 4) are forced to develop a surviving strategy in order to 
avoid self-attack of the CRISPR-system. In fact, since the provirus is identical in 
sequence to the episomal copies, it can be targeted by the CRISPR system as well, 
thus casting a fitness cost on cells that are actively challenging the SSV2 infection. 
Our data show, for the first time, that S. solfataricus cells developed a specific 
strategy to safeguard host genome integrity, i.e. throughout deletion of self-targeting 
spacers (Fig. 5 and 6). How deletion of specific spacers at CRISPR loci to avoid self-
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attack can occur is matter of further investigation and it is expected to reveal 
completely novel molecular components and/or mechanism of the complex CRISPR 
response.  
 Another relevant aspect revealed by this study is the absence of the CRISPR 
response in the double-infected SSV1/SSV2 S. solfataricus strain (Tab 2 and S4). 
The two viral genomes are overall identical with the only significant difference being 
the absence in the SSV2 genome of a region responsible for the UV-induction in 
SSV1 (Fig. 1). It is tempting to speculate that transcription factors and/or other 
molecular components encoded by this SSV1 region are responsible for silencing the 
CRISPR response in the double infected strain. A combination of biochemical and 
genetic approaches is needed to move toward a better understanding of the mutual 
influence of the two fuselloviruses in this virus-host system. 
 
 
Acknowledgements  
We thank the Sulfolobus Gene Chip Consortium for constructing the microarrays 
used for our experiments . This study was supported by grants from Danish 
Independent Research Council (DFF-0602-02196B, DFF-1323-00330 and 11-
106683), from the Ministero dell’Istruzione, dell’Università e della Ricerca Scientifica 
(Progetti di Ricerca di Interesse Nazionale E61J10000020001) and a grant from the 
Carlsberg Foundation. 
 
 
References 
Ceballos RM, Marceau CD, Marceau JO, Morris S, Clore AJ, Stedman KM. 2012. 
Differential virus host-ranges of the Fuselloviridae of hyperthermophilic Archaea: implications 
for evolution in extreme environments. Front Microbiol. 3:295. 
 
Comeau AM, Hatfull GF, Krisch HM, Lindell D, Mann NH, Prangishvili D. 2008. Exploring 
the prokaryotic virosphere. Res Microbiol 159:306-13. 
 
Contursi P, D’Ambrosio K, Pirone L, Pedone E, Aucelli T, She Q, De Simone G, 
Bartolucci S. 2011. C68 from the Sulfolobus islandicus plasmid-virus pSSVx is a novel 
member of the AbrB-like transcription factor family. Biochem J 435:157-166. 
 
Contursi P, Farina B, Pirone L, Fusco S, Russo L, Bartolucci S, Fattorusso R, Pedone 
E5. 2014b. Structural and functional studies of Stf76 from the Sulfolobus islandicus plasmid-
virus pSSVx: a novel peculiar member of the winged helix-turn-helix transcription factor 
family. Nucleic Acids Res. 42:5993-6011. 
 
Contursi P, Fusco S, Cannio R, She Q. 2014a. Molecular biology of fuselloviruses and their 
satellites. Extremophiles 3:473-489. 
 
Contursi P, Fusco S, Limauro D, Fiorentino G. 2013. Host and viral transcriptional 
regulators in Sulfolobus: an overview. Extremophiles 17:881-895. 
 
Contursi P, Jensen S, Aucelli T, Rossi M, Bartolucci S, She Q. 2006. Characterization of 
the Sulfolobus host-SSV2 virus interaction. Extremophiles 10:615-627. 
 
Cooper CR, Daugherty AJ, Tachdjian S, Blum PH, Kelly RM. 2009. Role of vapBC toxin-
antitoxin loci in the thermal stress response of Sulfolobus solfataricus. Biochem Soc Trans 
37:123-126. 
__________________________________________________________Chapter III –SSV2– 
 –104– 
 
Dyall-Smith M. 2011. Dangerous weapons: a cautionary tale of CRISPR defence. Mol 
Microbiol 79:3-6. 
 
Erdmann S, Garrett RA. 2012. Selective and hyperactive uptake of foreign DNA by adaptive 
immune systems of an archaeon via two distinct mechanisms. Mol Microbiol 85:1044-1056. 
 
Fröls S, Gordon PM, Panlilioc MA, Schleper C, Sensen CW. 2007 Elucidating the 
transcription cycle of the UV-inducible hyperthermophilic archaeal virus SSV1 by DNA 
microarrays. Virology 365:48-59. 
 
Fusco S, Aulitto M, Bartolucci S, Contursi P. 2014. A standardized protocol for the UV 
induction of Sulfolobus spindle-shaped virus 1. Extremophiles. In press. 
 
Fusco S, She Q, Bartolucci S, Contursi P. 2013. Tlys, a newly identified Sulfolobus spindle-
shaped virus 1 transcript expressed in the lysogenic state, encodes a DNA-binding protein 
interacting at the promoters of the early genes. J Virol 87:5926-5936. 
 
Garrett RA, Shah SA, Vestergaard G, Deng L, Gudbergsdottir S, Kenchappa CS, 
Erdmann S, She Q. 2011. CRISPR-based immune systems of the Sulfolobales: complexity 
and diversity. Biochem Soc Trans. 39:51-57. 
 
Gudbergsdottir S, Deng L, Chen Z, Jensen JVK, Jensen LR, She Q, Garrett RA. 2011. 
Dynamic properties of the Sulfolobus CRISPR/Cas and CRISPR/Cmr systems when 
challenged with vector-borne viral and plasmid genes and protospacers. Mol Microbiol 79:35-
49 
 
Guillière F, Peixeiro N, Kessler A, Raynal B, Desnoues N, Keller J, Delepierre M, 
Prangishvili D, Sezonov G, Guijarro JI. 2009. Structure, function, and targets of the 
transcriptional regulator SvtR from the hyperthermophilic archaeal virus SIRV1. J Biol Chem 
284:22222-22237. 
 
Kraft P, Kümmel D, Oeckinghaus A, Gauss GH, Wiedenheft B, Young M, Lawrence CM. 
2004a. Structure of D-63 from Sulfolobus spindle-shaped virus 1: surface properties of the 
dimeric four-helix bundle suggest an adaptor protein function. J Virol 78:7438-7442. 
 
Kraft P, Oeckinghaus A, Kümmel D, Gauss GH, Gilmore J, Wiedenheft B, Young M, 
Lawrence CM. 2004b. Crystal structure of F-93 from Sulfolobus spindle-shaped virus 1, a 
winged-helix DNA binding protein. J Virol 78:11544-11550. 
 
Krupovic M, Quemin ER, Bamford DH, Forterre P, Prangishvili D. 2013. Unification of the 
globally distributed spindle-shaped viruses of the Archaea. J Virol 88:2354-2358. 
 
Lillestøl RK, Shah SA, Brügger K, Redder P, Phan H, Christiansen J, Garrett RA. 2009. 
CRISPR families of the crenarchaeal genus Sulfolobus: bidirectional transcription and 
dynamic properties. Mol Microbiol 72:259-272.  
 
Lintner NG, Kerou M, Brumfield SK, Graham S, Liu H, Naismith JH, Sdano M, Peng N, 
She Q, Copié V, Young MJ, White MF, Lawrence CM. 2011. Structural and functional 
characterization of an archaeal clustered regularly interspaced short palindromic repeat 
(CRISPR)-associated complex for antiviral defense (CASCADE). J Biol Chem 286:21643-
21656. 
 
Manica A, Schleper C. 2013. CRISPR-mediated defense mechanisms in the 
hyperthermophilic archaeal genus Sulfolobus. RNA Biol 10:671-678. 
__________________________________________________________Chapter III –SSV2– 
 –105– 
 
Menon SK, Maaty WS, Corn GJ, Kwok SC, Eilers BJ, Kraft P, Gillitzer E, Young MJ, 
Bothner B, Lawrencem CM. 2008. Cysteine usage in Sulfolobus spindle-shaped virus 1 and 
extension to hyperthermophilic viruses in general. Virology 376:270-278. 
 
Nadal M, Mirambeau G, Forterre P, Reiter WD, Duguet M. 1986. Positively supercoiled 
DNA in a virus-like particle of an archaebacterium. Nature 321:256-258. 
 
Okutan E, Deng L, Mirlashari S, Uldahl K, Halim M, Liu C, Garrett RA, She Q, Peng X. 
2013. Novel insights into gene regulation of the rudivirus SIRV2 infecting Sulfolobus cells. 
RNA Biology 10:875-885. 
 
Ortmann AC, Brumfield SK, Walther J, McInnerney K, Brouns SJ, van de Werken HJ, 
Bothner B, Douglas T, van de Oost J, Young MJ. 2008. Transcriptome analysis of 
infection of the archaeon Sulfolobus solfataricus with Sulfolobus turreted icosahedral virus. J 
Virol 82:4874-4883. 
Peng X, Garrett RA, She Q. 2012. Archaeal viruses-novel, diverse and enigmatic. Sci China 
Life Sci 55:422-433. 
 
Pietilä MK, Demina TA, Atanasova NS, Oksanen HM, Bamford DH. 2007. Archaeal 
viruses and bacteriophages: comparisons and contrasts. Trends Microbiol 22:334-344. 
 
Pina M, Bize A, Forterre P, Prangishvili D. 2011. The archeoviruses. FEMS Microbiol Rev 
35:1035-1054. 
 
Prangishvili D. 2013. The wonderful world of archaeal viruses. Annu Rev Microbiol 8:565–
585. 
 
Quax TE, Voet M, Sismeiro O, Dillies MA, Jagla B, Coppée JY, Sezonov G, Forterre P, 
van der Oost J, Lavigne R, Prangishvili D. Massive activation of archaeal defense genes 
during viral infection. J Virol 87:8419-8428.  
 
Reiter WD, Palm P, Zillig W. 1988a. Analysis of transcription in the archaebacterium 
Sulfolobus indicates that archaebacterial promoters are homologous to eukaryotic pol II 
promoters. Nucleic Acids Res 16:1-19. 
 
Reiter WD, Palm P, Zillig W. 1988b. Transcription termination in the archaebacterium 
Sulfolobus: signal structures and linkage to transcription initiation. Nucleic Acids Res 
16:2445-2459. 
 
Ren Y, She Q, Huang L. 2013. Transcriptomic analysis of the SSV2 infection of Sulfolobus 
solfataricus with and without the integrative plasmid pSSVi. Virology. 441:126-134. 
 
Schlenker C, Goel A, Tripet BP, Menon S, Willi T, Dlakić M, Young MJ, Lawrence CM, 
Copié V. 2012. Structural studies of E73 from a hyperthermophilic archaeal virus identify the 
‘‘RH3’’ domain, an elaborated ribbon-helix-helix motif involved in DNA recognition. 
Biochemistry 51:2899-2910. 
 
Schleper C, Kubo K, Zillig W. 1992. The particle SSV1 from the extremely thermophilic 
archaeon Sulfolobus is a virus: demonstration of infectivity and of transfection with viral DNA. 
Proc Natl Acad Sc USA 89:7645-7649. 
 
She Q, Peng X, Zillig W, Garrett RA, 2001. Gene capture events in archaeal chromosomes. 
Nature 409, 478. 
__________________________________________________________Chapter III –SSV2– 
 –106– 
 
Stern A, Keren L, Wurtzel O, Amitai G, Sorek R. 2010. Self-targeting by CRISPR: gene 
regulation or autoimmunity? Trends Genet. 26:335-340. 
Suttle CA. 2007. Marine viruses–major players in the global ecosystem. Nat Rev Microbiol 
5:801-12. 
 
Wang H, Peng N, Shah SA, Huang L, She Q. 2015. Archaeal extrachromosomal genetic 
elements. Mol Micro Biol Revs In press. 
 
Zhang J, White MF. 2013. Hot and crispy: CRISPR-Cas systems in the hyperthermophile 
Sulfolobus solfataricus. Biochem Soc Trans. 41:1422-1426. 
 
 
 
 
 
 
Supplementary material 
 
Table S1. Uninfected S. solfataricus InF1 strain: a complete list of the up-regulated 
and down-regulated genes throughout the growth 
 
Gene ID 
Average 
log2 Ratio 
S.D. 
log2 Ratio VGEF Function 
NT02SS2357 2.89 0.71 7.43 Intergenic region 
SSO0127 1.07 0.17 2.09 2-isopropylmalate synthase 
SSO0389 2.24 0.28 4.73 Glycosylated S-layer protein 
SSO0488 2.06 1.23 4.18 Phosphate ABC transporter 
SSO0489 5.06 0.40 33.46 Phosphate binding periplasmic protein  
SSO0490 3.87 0.40 14.64 Phosphate transport system permease 
SSO0491 2.51 1.13 5.71 Phosphate transport system permease 
SSO0545 2.47 1.20 5.54 Hypothetical protein 
SSO0786 2.54 0.83 5.80 Amino acid specific permease 
SSO0929 1.56 0.32 2.94 Ribonucleotide reductase (nrd) 
SSO1005 1.41 0.59 2.65 Hypothetical protein 
SSO10788 2.03 0.12 4.09 Bacterial response and virulence 
SSO1092 2.18 1.10 4.54 Hypothetical protein 
SSO11071 1.08 0.12 2.12 Pyruvate synthase delta chain 
SSO1129 1.74 0.41 3.35 Heterodisulfite reductase, subunit B 
SSO11385 1.59 0.47 3.00 non-coding RNA homolog 
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Table S1.1 Uninfected S. solfataricus InF1 strain: a complete list of the up-regulated 
and down-regulated genes throughout the growth 
 
Gene ID 
Average 
log2 Ratio 
S.D. 
log2 Ratio VGEF Function 
SSO1171 1.10 0.14 2.14 Maltose ABC transporter 
SSO1183 2.76 1.39 6.76 Inorganic phosphate transporter 
SSO11855 1.21 0.34 2.32 STIV-infection differentially regulated 
SSO1227 2.03 0.90 4.07 Toluene-4-monooxygenase system protein A 
SSO1237 1.14 0.11 2.21 First ORF in transposon ISC1491 
SSO1287 1.70 0.64 3.25 Hypothetical protein 
SSO1288 2.82 0.79 7.08 Hypothetical protein 
SSO1320 1.18 0.18 2.27 Hypothetical protein 
SSO1526 1.58 0.86 3.00 Pyruvate dehydrogenase, alfa subunit 
SSO1665 1.34 0.54 2.54 Cytosine permease 
SSO1835 2.40 1.29 5.26 DNA polymerase beta domain  
SSO1858 1.74 0.65 3.34 Hypothetical protein 
SSO1860 1.47 0.50 2.77 Bacitracin resistance protein 
SSO1865 1.32 0.48 2.49 Universal stress protein family 
SSO1894 2.73 0.69 6.64 Hypothetical protein 
SSO1910 1.87 0.30 3.66 Hypothetical protein 
SSO1931 2.07 1.11 4.20 Hypothetical protein 
SSO2029 3.00 0.92 7.99 Hypothetical protein 
SSO2044 1.71 0.41 3.27 NAD specific glutamate dehydrogenase  
SSO2126 1.69 0.60 3.23 L-lactate permease 
SSO2476 1.26 0.01 2.40 Metabolite permease, putative 
SSO2505 3.49 0.92 11.24 Sugar transport protein 
SSO2523 2.35 0.74 5.09 Long-chain-fatty-acid--CoA ligase  
SSO2629 2.03 0.44 4.08 Oxidoreductase (flavoprotein) 
SSO2630 1.17 0.38 2.25 SirA family protein 
SSO2632 1.44 0.38 2.71 Hypothetical protein 
SSO2636 2.27 0.67 4.83 Carbon monoxide dehydrogenase 
SSO2756 1.38 0.17 2.60 Pyruvate synthase beta chain 
SSO2797 1.18 0.34 2.27 Conserved hypothetical protein 
SSO2815 1.26 0.27 2.39 2-oxoacid--ferredoxin oxidoreductase 
SSO2863 1.82 1.01 3.53 Acetyl-CoA synthetase  
SSO2864 1.29 0.09 2.45 Conserved hypothetical protein 
SSO2966 1.36 0.59 2.57 Conserved hypothetical protein 
SSO2967 3.04 0.32 8.20 Hypothetical protein 
SSO2969 1.53 0.37 2.89 Quinol oxidase-2, subunit I 
SSO2970 2.23 0.76 4.69 Quinol oxidase-2, cytochrome b 
SSO2971 1.90 0.57 3.72 Quinol oxidase-2, rieske iron-sulfur protein-2 
SSO2973 2.61 0.25 6.11 Quinol oxidase-2, subunit I/III, cytochrome aa3  
SSO3043 3.35 0.43 10.19 ABC transporter, binding protein 
SSO3053 4.67 2.27 25.53 Maltose ABC transporter 
SSO3058 2.08 1.66 4.24 Maltose ABC transporter, 
SSO3066 2.13 0.57 4.39 Arabinose ABC transporter 
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Table S1.2 Uninfected S. solfataricus InF1 strain: a complete list of the up-regulated 
and down-regulated genes throughout the growth 
 
Gene ID 
Average 
log2 Ratio 
S.D. 
log2 Ratio VGEF Function 
SSO3120 3.28 0.46 9.71 Metabolite transport protein, putative 
SSO3180 2.42 0.03 5.33 Phosphate transporter related protein 
SSO7127 1.79 0.71 3.46 non-coding RNA homolog 
SSO0091 -2.22 0.69 -4.67 LSU ribosomal protein L7AE (rpl7AE) 
SSO0164 -1.58 0.29 -2.99 LSU ribosomal protein S8E (rps8E) 
SSO0200 -1.29 0.46 -2.44 ArsR family transcriptional regulators homolog 
SSO0219 -1.55 0.63 -2.93 SSU ribosomal protein S12AB (rpS12AB) 
SSO0278 -1.25 0.38 -2.38 Proteasome subunit 
SSO0366 -1.49 0.49 -2.81 Glutamine synthetase  
SSO0536 -1.86 0.46 -3.64 S-adenosylmethionine decarboxylase 
SSO0742 -1.18 0.26 -2.26 LSU ribosomal protein L15E 
SSO0746 -1.17 0.14 -2.26 SSU ribosomal protein S3AE (rps3AE) 
SSO0752 -1.24 0.28 -2.37 LSU ribosomal protein L21E (rpl21E) 
SSO0962 -1.71 0.39 -3.27 DNA binding protein SSO10b (Alba 1) 
SSO1067 -1.34 0.44 -2.54  Second ORF in transposon ISC1359 
SSO1100 -1.20 0.33 -2.30 Hypothetical protein 
SSO1101 -1.39 0.54 -2.62 Transcriptional regulator 
SSO1107 -1.28 0.39 -2.43 Hypothetical protein 
SSO1586 -1.65 0.36 -3.13 Conserved hypothetical protein 
SSO1593 -2.13 1.10 -4.38 Benzoate transporter 
SSO2574 -2.56 0.84 -5.91 Ferredoxin (zfx-1) 
SSO2595 -1.07 0.22 -2.10 Conserved hypothetical protein 
SSO2613 -1.68 0.04 -3.21 Peroxiredoxin, bacterioferritin comigratory 
SSO3155 -1.99 1.04 -3.98 Tryptophan repressor binding protein (wrbA) 
SSO5343 -1.02 0.09 -2.02 Conserved hypothetical protein 
SSO5410 -1.06 0.05 -2.08 Small nuclear riboprotein protein (snRNP-1) 
SSO6454 -1.05 0.12 -2.08 snRNP-2 small nucleare riboprotein 
SSO7114 -1.06 0.11 -2.08 SSU ribosomal protein S27E 
SSO9724 -1.00 0.11 -2.00 Hypothetical protein 
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Table S2. S. solfataricus SSV1-InF1 infected strain: a complete list of the up-regulated 
and down-regulated genes throughout the growth 
 
 
 
 
 
 
 
 
Gene ID 
Average 
log2 Ratio 
S.D. 
log2 Ratio  VGEF Function 
 
 
small-RNA 
sR116 1.22 0.31 2.33 small cytoplasmic RNA 
 
SSO0269 1.39 0.54 2.61 GTP-binding protein (hflX)  
SSO0276 1.40 0.42 2.64 
Small nuclear ribonucleoprotein 
(snRNP)  
 
SSO0794 1.33 0.10 2.51 Transposase ISC1476  
SSO0999 1.45 0.63 2.73 ABC Transporter  
SSO10452 2.07 0.67 4.20 Hypothetical protein  
SSO1052 1.38 0.39 2.60 Oligosaccharyl transferase STT3  
SSO1069 1.85 0.77 3.62 Amino acid transporter  
SSO1126 1.34 0.20 2.54 ChainA, Putative Oxidoreductase  
SSO1284 1.56 0.36 2.94 
Oligo/dipeptide transport, permease 
protein 
 
SSO1717 1.47 0.66 2.76 Second ORF in transposon ISC1048  
SSO1752 1.02 0.02 2.02 Hypothetical protein  
SSO2660 1.39 0.55 2.61 Rieske iron-sulfur protein-1 (soxL-1)  
SSO2661 1.50 0.29 2.83 P-aminobenzoate N-oxygenase   
SSO3085 1.15 0.36 2.22 Hypothetical sulphur transporter  
SSO3123 0.93 0.05 1.91 Hypothetical protein  
SSO3211 1.02 0.03 2.03 4-aminobutyrate aminotransferase  
small-RNA 
sR102 -1.27 0.53 -2.42 small cytoplasmic RNA 
 
SSO0221 -1.30 0.15 -2.47 LSU ribosomal protein L30E (rpl30E)  
SSO0637 -1.74 0.65 -3.34 Hypothetical protein  
SSO0961 -1.16 0.23 -2.24 Hypothetical protein  
SSO12181 -0.96 0.08 -1.94 Hypothetical protein  
SSO2138 -1.53 0.33 -2.89 PadR family transcripitonal regulator   
SSO2180 -1.35 0.49 -2.55 Hypothetical protein  
SSO2253 -1.12 0.03 -2.18 
Rubrerythrin (oxidative stress 
tolerance) 
 
SSO2381 -0.92 0.05 -1.90 
Translation initiation factor 2, beta 
subunit 
 
SSO2827 -1.09 0.21 -2.13 Predicted transcriptional regulator  
SSO5478 -1.05 0.21 -2.07 LSU ribosomal protein L24E (rpl24E)  
SSO5663 -1.18 0.25 -2.26 Protein transport protein sec61  
SSO5668 -0.98 0.13 -1.97 LSU ribosomal protein LX  
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Table S3. S. solfataricus SSV2-InF1 infected strain: a complete list of the up-regulated 
and down-regulated genes throughout the growth 
 
Gene ID 
Average 
log2 Ratio 
S.D. 
log2 Ratio VGEF Function 
small-RNA_sR103 1.03 0.10 2.05 RNA 
SSO0044 1.29 0.12 2.45 
Heme bearing subunit I of the 
terminal oxidase (doxB) 
SSO0045 1.32 0.07 2.50 Terminal oxidase, subunit (doxC) 
SSO0227 1.40 0.17 2.63 
DNA-directed RNA polymerase, 
subunit B’’ (rpoB1) 
SSO0269 1.29 0.20 2.45 GTP-binding protein (hflX) 
SSO0276 1.46 0.24 2.75 
Small nuclear ribonucleoprotein 
(snRNP) homolog 
SSO0931 1.42 0.12 2.67 Predicted transcriptional regulator 
SSO0944 1.04 0.07 2.05 Hypothetical protein 
SSO0980 1.30 0.05 2.47 Transposase ISC1217 
SSO0999 1.58 0.22 2.99 ABC transporter 
SSO1000 1.09 0.21 2.13 
Maltose transport inner membrane 
protein 
SSO1004 1.42 0.21 2.67 FAD linked oxidase homologue 
SSO10449 1.03 0.07 2.04 Predicted transcriptional regulator 
SSO10452 1.24 0.09 2.36 Hypothetical protein 
SSO11076 1.44 0.12 2.71 Glycosyltransferase, putative 
SSO1125 1.05 0.21 2.08 DsrE/DsrF-like family homologue 
SSO1141 1.43 0.36 2.69 Copper binding protein 
SSO1152 1.05 0.09 2.07 
Peptidase U62 modulator of DNA 
gyrase homolog 
SSO11550 1.27 0.19 2.42 
STIV infection differentially regulated 
gene 
SSO11575 1.41 0.19 2.65 Hypothetical protein 
SSO1162 1.52 0.13 2.86 Multidrug resistance protein 
SSO1268 1.05 0.21 2.07 
Glutamine-fructose-6-phosphate 
transaminase (isomerizing glmS-2) 
SSO1281 1.15 0.27 2.21 Last part of transposase in ISC1250 
SSO1282 1.93 0.31 3.81 
Oligo/dipeptide transport, ATP 
binding protein . (dppD-2) 
SSO1284 2.36 0.28 5.14 
Oligo/dipeptide transport, permease 
protein (dppB-2) 
SSO1312 1.75 0.23 3.36 
Ring oxydation complex/ 
phenylacetic acid degradation related 
protein 
SSO1334 1.63 0.29 3.10 
Malate synthase, putative 
(aceB/mas) 
SSO1389 1.61 0.34 3.05 
 csx1(CRISPR/cas system-
associated protein) 
SSO1439 0.80 0.06 1.74 cas’’ (Nuclease subunits of Cas3) 
SSO1424 1.45 0.24 2.74 
csa5(CRISPR/cas system-associated 
protein  so-called) ‘small’ subunit 
SSO1425 1.21 0.22 2.32 csm3 (CRISPR-associated RAMP) 
SSO1441 1.42 0.26 2.67 cas5 (CASCADE complex core) 
SSO1442 2.99 0.01 7.93 
cas7 (Crispr-Associated Protein, 
csa2) 
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Table S3.1 S. solfataricus SSV2-InF1 infected strain: a complete list of the up-
regulated and down-regulated genes throughout the growth 
 
Gene ID 
Average 
log2 Ratio 
S.D. 
log2 Ratio VGEF Function 
SSO1443 2.56 0.15 5.91 
csa5 (CRISPR/cas system-
associated protein)  
SSO1691 1.16 0.12 2.23 Hypothetical protein 
SSO1717 1.42 0.08 2.68 Second ORF in transposon ISC1048 
SSO1812 1.85 0.27 3.60 SirA family protein homologue 
SSO1814 1.16 0.07 2.23 Transposase ISC1234 
SSO1842 1.35 0.49 2.55 
Glyceraldehyde-3-phosphate 
dehydrogenase, NADP dependent 
(gapN-2) 
SSO1870 1.85 0.11 3.60 Rusticyanin homologue 
SSO1911 0.99 0.06 1.98  Hemerythrin 
SSO1997 2.13 0.47 4.37 
CRISPR-associated autoregulator, 
DevR family homolog 
SSO2048 1.97 0.19 3.93 Hypothetical protein 
SSO2059 1.25 0.38 2.38 
Acetyl-CoA synthetase (acetate-CoA 
ligase acsA-6) 
SSO2067 1.25 0.48 2.38 
Indolepyruvate ferredoxin 
oxidoreductase alpha subunit (iorA) 
SSO2131 1.30 0.34 2.46 
Transcriptional regulator homolog 
(Lrp/AsnC family) 
SSO2291 3.00 0.00 7.98 Protein kinase, putative 
SSO2617 1.04 0.11 2.06 
Dipeptide ABC transporter permease 
protein dppC-3 
SSO2656 0.99 0.04 1.99 
Quinol oxidase (SoxABC), 
cytochrome B subunit (soxC) 
SSO2657 1.41 0.10 2.66 
Quinol oxidase (SoxABC), 
cytochrome aa3 subunit (soxB) 
SSO2660 1.23 0.09 2.34 Rieske iron-sulfur protein-1 (soxL-1) 
SSO2661 1.22 0.08 2.33 Hypothetical protein 
SSO2681 1.00 0.07 2.01 Hypothetical protein 
SSO2690 2.11 0.15 4.30 
Sulfolobus mercury resistance 
protein, MerI (Sulfolobus islandicus) 
SSO2757 2.60 0.31 6.06 
Pyruvic-ferredoxin oxidoreductase 
alpha chain  (porA-2) 
SSO2758 1.22 0.16 2.33 
Pyruvic-ferredoxin oxidoreductase 
gamma chain  (porG-2) 
SSO2761 1.07 0.15 2.09 Acyl-CoA dehydrogenase (acd-5) 
SSO2827 1.11 0.07 2.15 Predicted transcriptional regulator 
SSO2831 1.06 0.03 2.08 AAA family ATPase 
SSO2846 1.21 0.09 2.32 
Extracellular ligand-binding receptor  
homolog 
SSO2881 1.09 0.23 2.14 Fe-S oxidoreductase homologue 
SSO2882 1.41 0.26 2.65 Transposase ISC1234 
SSO2986 1.12 0.02 2.18 Predicted transcriptional regulator 
SSO2991 2.00 0.18 4.01 Hypothetical protein 
SSO3045 1.23 0.20 2.34 ABC transporter, ATP binding protein 
SSO3054 1.76 0.40 3.38 
Terminal oxidase, small hydrophobic 
subunit (doxE) 
SSO3107 1.21 0.13 2.31 Dihydroxy-acid dhydratase ilvD 
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Table S3.2 S. solfataricus SSV2-InF1 infected strain: a complete list of the up-
regulated and down-regulated genes throughout the growth 
 
Gene ID 
Average 
log2 Ratio 
S.D. 
log2 Ratio VGEF Function 
SSO3123 1.38 0.17 2.60 Hypothetical protein 
SSO3130 1.15 0.12 2.21 
Iron-sulfur protein, conserved 
putative 
SSO3131 1.19 0.12 2.28 
Heterodisulfide reductase related 
protein 
SSO3174 1.15 0.13 2.23 
Histidine kinase (Sulfolobus 
solfataricus) 
SSO3178 1.32 0.04 2.50 Hypothetical protein 
SSO3188 1.64 0.11 3.12 Hypothetical protein 
SSO5027 1.08 0.12 2.11 Hypothetical protein 
SSO5098 1.42 0.15 2.67 
Terminal oxidase, small hydrophobic 
subunit (doxE) 
SSO7239 1.13 0.14 2.18 Conserved hypothetical protein 
SSO9088 1.64 0.19 3.11 Intergenic region 
SSO9180 1.01 0.02 2.02 7 KD DNA-binding protein 
SSO9500 1.37 0.14 2.58 Conserved hypothetical protein 
SSOLCTR1a_647
0_1708-1767 1.07 0.00 2.11 CRISPR Locus A 
SSOLCTR1a_647
0_3373-3432 0.03 0.03 1.02 CRISPR Locus A 
SSOLCTR1a_647
0_6329-6394 0.68 0.02 1.60 CRISPR Locus A 
SSOLCTR1b_596
4_278-343 0.77 0.05 1.70 CRISPR Locus B 
SSOLCTR1b_596
4_1493-1557 0.63 0.01 1.55 CRISPR Locus B 
SSOLCTR1b_596
4 0.52 0.04 1.44 CRISPR Locus B 
SSOLCTR1c_199
3_10-71 1.41 0.08 2.66 CRISPR Locus C 
SSOLCTR1c_199
3 1.15 0.18 2.22 CRISPR Locus C 
SSOLCTR1c_199
3_1916-1980 0.94 0.01 1.91 CRISPR Locus C 
SSOLCTR1d_600
5_483-551 1.40 0.08 2.65 CRISPR Locus D 
SSOLCTR1d_600
5 0.93 0.17 1.91 CRISPR Locus D 
SSOLCTR1d_600
5_105-174 0.85 0.16 1.80 CRISPR Locus D 
SSOLCTR1d_600
5_5568-5630 1.27 0.02 2.42 CRISPR Locus D 
SSOLCTR1e_402 0.03 0.05 1.02 CRISPR Locus E 
SSOLCTR1f_577
6_3689-3753 0.68 0.09 1.60 CRISPR Locus F 
SSOLCTR1f_577
6_4021-4090 0.00 0.04 1.00 CRISPR Locus F 
SSOLCTR1f_577
6_4350-4419 0.62 0.19 1.54 CRISPR Locus F 
SSO0067 -1.65 0.15 -3.13 
SSU ribosomal protein S2AB 
(rps2AB) 
SSO0074 -1.09 0.13 -2.13 SSU ribosomal protein S31AB 
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Table S3.3 S. solfataricus SSV2-InF1 infected strain: a complete list of the up-
regulated and down-regulated genes throughout the growth 
 
Gene ID 
Average 
log2 Ratio 
S.D. 
log2 Ratio VGEF Function 
SSO0098 -1.19 0.16 -2.28 Methionine aminopeptidase 2 
SSO0099 -1.70 0.06 -3.24 Conserved hypothetical protein 
SSO0173 -1.24 0.01 -2.36 Aspartyl-tRNA synthetase (aspS) 
SSO0192 -1.64 0.04 -3.12 Glutaredoxin related protein 
SSO0199 -2.21 0.07 -4.64 
S-adenosylmethionine synthetase 
(maT) 
SSO0202 -1.31 0.23 -2.48 
D-arabino 3-hexulose 6-phosphate 
formaldehyde lyase (hpS-2) 
SSO0217 -1.19 0.26 -2.28 
SSU ribosomal protein S7AB 
(rpS7AB) 
SSO0230 -1.49 0.18 -2.81 
Nucleoside diphosphate kinase (NDP 
kinase) (ndk) 
SSO0235 -1.05 0.02 -2.08 Radical SAM protein homolog  
SSO0240 -1.26 0.22 -2.39 
Adenylosuccinate lyase 
(adenylosuccinase)(ASL) (purB) 
SSO0256 -1.11 0.02 -2.16 Conserved hypothetical protein 
SSO0292 -1.32 0.10 -2.50 
exosome complex RNA-binding 
protein Csl4 homolog 
SSO0320 -1.13 0.20 -2.19 Hypothetical protein 
SSO0352 -1.14 0.05 -2.20 
Apoptosis-related Tfar19 related 
protein   
SSO0353 -1.39 0.14 -2.63 
SSU ribosomal protein S19E 
(rps19E) 
SSO0356 -1.67 0.00 -3.17 
Phosphate regulatory protein, 
putative 
SSO0358 -1.11 0.27 -2.16 Conserved hypothetical protein 
SSO0363 -1.06 0.16 -2.09 Prolidase 
SSO0397 -1.60 0.15 -3.04 
Proliferating cell nuclear antigen 
putative homolog 
SSO0408 -1.48 0.09 -2.79 SSU ribosomal protein S13E 
SSO0415 -1.54 0.18 -2.91 
DNA-directed RNA polymerase, 
subunit E (rpoE1) 
SSO0420 -1.16 0.04 -2.24 Reverse gyrase (topR-1) 
SSO0435 -1.71 0.03 -3.28 
SSU ribosomal protein S24E 
(rps24E) 
SSO0436 -1.30 0.28 -2.46 Thiazole biosynthetic enzyme 
SSO0439 -1.08 0.20 -2.11 tRNA intron endonuclease, putative 
SSO0460 -1.62 0.03 -3.08 
MRP protein homolog, conserved 
ATPase (mrp) 
SSO0481 -1.16 0.26 -2.23 HAD-superfamily hydrolase homolog 
SSO0501 -1.10 0.06 -2.15 Conserved hypothetical protein 
SSO0503 -1.23 0.04 -2.35 Conserved hypothetical protein 
SSO0553 -1.14 0.17 -2.20 Conserved hypothetical protein 
SSO0554 -1.30 0.37 -2.46 
Ribosomal protein L11 
methyltransferase, putative 
SSO0555 -1.31 0.10 -2.48 Conserved hypothetical protein 
SSO0608 -1.42 0.37 -2.67 Conserved hypothetical protein 
SSO0615 -1.50 0.23 -2.82 
Orotate phosphoribosyltransferase 
(OPRT) (pyrE) 
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Table S3.4 S. solfataricus SSV2-InF1 infected strain: a complete list of the up-
regulated and down-regulated genes throughout the growth 
 
Gene ID 
Average 
log2 Ratio 
S.D. 
log2 Ratio VGEF Function 
SSO0626 -1.96 0.30 -3.88 
Phosphoribosylaminoimidazole-
succinocarboxamide synthase 
(SAICAR synthetase) (purC) 
SSO0708 -1.07 0.15 -2.09 
LSU ribosomal protein L14AB 
(rpl14AB) 
SSO0757 -1.16 0.06 -2.23 Spermidine synthase 
SSO0771 -1.22 0.21 -2.34 
Cell division control 6/orc1 protein 
homolog (cdc6-2) 
SSO0881 -1.47 0.01 -2.78 
VPS24 Conserved protein implicated 
in secretion homolog 
SSO0886 -1.20 0.12 -2.30 myo-inositol-1-phosphate synthase 
SSO0911 -1.19 0.01 -2.28 Cell division protein 
SSO0946 -1.89 0.09 -3.70 
Transcription initiation factor IIB 
(TFIIB) homolog (TFB-2) 
SSO0951 -1.37 0.19 -2.58 
TATA box binding protein, 
hypothetical (tfIID) 
SSO0981 -1.21 0.07 -2.31 Pyruvate kinase (pyK) 
SSO10285 -1.35 0.15 -2.55 Coenzyme PQQ synthesis protein 
SSO12199 -1.08 0.06 -2.11 
Nucleotide pyrophosphohydrolase 
[Sulfoloblfataripyrophosphohydrolase 
[Sulfolobus solfataricus] 
SSO1889 -1.66 0.24 -3.16 ATP-dependent RNA helicase 
SSO1890 -1.15 0.10 -2.23 
major facilitator superfamily MFS_1 
homolog 
SSO2089 -1.07 0.14 -2.09 
TenA family transcriptional regulator 
homolog 
SSO2146 -1.28 0.03 -2.42 
major facilitator superfamily MFS_1 
homolog 
SSO2182 -1.13 0.14 -2.19 
Isocitrate dehydrogenase, probable 
(idh) 
SSO2190 -1.19 0.10 -2.29 Hypothetical protein 
SSO2222 -1.08 0.23 -2.11 Thioredoxin reductase (trxB-1) 
SSO2231 -1.59 0.33 -3.00 Hypothetical protein 
SSO2255 -1.15 0.05 -2.22 
Peroxiredoxin, bacterioferritin 
comigratory protein homolog  (bcp-3) 
SSO2279 -1.69 0.06 -3.23 Hypothetical protein 
SSO2292 -2.11 0.31 -4.31 
Amino acid transporter related 
protein 
SSO2390 -1.57 0.12 -2.98 
Inorganic pyrophosphatase, putative 
(ppa) 
SSO2407 -1.36 0.02 -2.56 
2-isopropylmalate synthase, putative 
(leuA-3) 
SSO2423 -1.01 0.05 -2.02 
Type I phosphodiesterase/nucleotide 
pyrophosphatase homolog 
SSO2431 -1.23 0.20 -2.35 
Carbon monoxide dehydrogenase 
subunit G homolog 
SSO2433 -1.09 0.16 -2.12 
Carbon monoxide dehydrogenase, 
small chain (cutC-1) 
SSO2583 -1.22 0.04 -2.33 Sulfolipid biosynthesis protein (sqdB) 
SSO2585 -1.18 0.26 -2.27 L-lactate dehydrogenase    
SSO2598 -1.22 0.15 -2.33 Transcriptional activator (tenA-2) 
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Table S3.5 S. solfataricus SSV2-InF1 infected strain: a complete list of the up-
regulated and down-regulated genes throughout the growth 
 
Gene ID 
Average 
log2 Ratio 
S.D. 
log2 Ratio VGEF Function 
SSO2635 -1.12 0.03 -2.17 Hypothetical protein 
SSO2653 -1.48 0.08 -2.79 Conserved hypothetical protein 
SSO2706 -1.03 0.11 -2.04 
5-methylthioadenosine 
phosphorylase (mtaP) 
SSO2778 -1.08 0.06 -2.11 UspA domain protein homolog 
SSO3003 -1.14 0.06 -2.21 Glucose 1-dehydrogenase (dhg-1) 
SSO3189 -2.58 0.02 -6.00 
Amino acid transporter related 
protein 
SSO3200 -1.11 0.07 -2.15 Conserved hypothetical protein 
SSO3219 -1.04 0.18 -2.06 
Sugar phosphate nucleotydyl 
transferase 
SSO3224 -1.32 0.07 -2.50 
Amino acid transporter related 
protein 
SSO3226 -1.06 0.17 -2.09 
Fructose-bisphosphate aldolase 
homolog 
SSO5345 -0.97 0.06 -1.96 
Traslation elongation factor EF-1 
beta subunit 
SSO5478 -1.54 0.18 -2.91 LSU ribosomal protein L24E (rpl24E) 
SSO5544 -1.20 0.01 -2.30 Carboxylate-amine ligase  
SSO5668 -0.96 0.07 -1.94 LSU ribosomal protein LX 
SSO5798 -1.16 0.09 -2.24 
DNA-directed RNA polymerase, 
subunit E (rpoE2) 
SSO6264 -1.57 0.26 -2.98 Conserved hypothetical protein 
SSO6453 -1.20 0.04 -2.29 LSU ribosomal protein L37E (rpl37E) 
SSO6830 -1.23 0.18 -2.35 
STIV infection differentially regulated 
gene 
SSV2_A305 -1.54 0.04 -2.91 SSV2 ORF 
 
 
Table S4 S S. solfataricus SSV1/SSV2-InF1 infected strain: a complete list of the up-
regulated and down-regulated genes throughout the growth 
 
Similarly regulated in the SSV1-InF1 infected strain 
Similarly regulated in the SSV2-InF1 infected strain 
Similarly regulated in both single-infected strains 
 
Gene ID 
Average 
log2 Ratio 
S.D. 
log2 Ratio VGEF Function 
non-coding-
RNA_Sso-181 1.07 0.06 2.11 non-coding RNA 
SSO0276 1.67 0.06 3.18 
Like-Sm ribonucleoprotein core 
homologue 
SSO0445 1.14 0.15 2.20 
Agmatinase (agmatine 
ureohydrolase) (speB-1) 
SSO0535 1.04 0.06 2.06 Acyl carrier protein synthase 
SSO0544 1.02 0.05 2.03 ExsB family protein homologue 
SSO1052 1.16 0.08 2.23 
Oligosaccharyl transferase STT3 
subunit (B5) 
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Table S4.1 S S. solfataricus SSV1/SSV2-InF1 infected strain: a complete list of the up-
regulated and down-regulated genes throughout the growth 
 
Similarly regulated in the SSV1-InF1 infected strain 
Similarly regulated in the SSV2-InF1 infected strain 
Similarly regulated in both single-infected strains 
 
Gene ID 
Average 
log2 Ratio 
S.D. 
log2 Ratio VGEF Function 
SSO1284 1.07 0.07 2.10 
Oligo/dipeptide transport, permease 
protein (dppB-2) 
SSO1312 1.46 0.27 2.74 
Ring oxidation complex/ phenylacetic 
acid degradation related protein 
SSO1859 1.11 0.04 2.16 Heat shock protein (htpX-1) 
SSO2048 1.28 0.12 2.44 Hypothetical protein 
SSO3051 1.41 0.10 2.66 Alpha-glucosidase (malA) 
SSO0099 -1.22 0.15 -2.34 
Glutaredoxin related protein, metal-
dependent hydrolase 
SSO0192 -1.15 0.11 -2.22 Glutaredoxin related protein 
SSO0356 -1.37 0.33 -2.58 
Phosphate regulatory protein, 
putative 
SSO0397 -1.09 0.10 -2.13 
Proliferating cell nuclear antigen 
putative homologue 
SSO0420 -1.07 0.04 -2.10 Reverse gyrase (topR-1) 
SSO0437 -1.16 0.17 -2.23 
3-octaprenyl-4-hydroxybenzoate 
decarboxylase 
SSO0460 -1.14 0.16 -2.20 
MRP protein homologue, conserved 
ATPase (mrp) 
SSO0503 -1.11 0.15 -2.16 Hypothetical protein 
SSO0626 -1.34 0.25 -2.53 
Phosphoribosylaminoimidazole-
succinocarboxamide synthase 
SSO0881 -1.19 0.08 -2.28 Hypothetical protein 
SSO0951 -1.26 0.11 -2.40 
TATA box binding protein, 
hypothetical (tfIID) 
SSO1877 -1.25 0.06 -2.37 Small metal-binding protein 
SSO1889 -1.03 0.35 -2.05 ATP-dependent RNA helicase 
SSO2292 -1.89 0.30 -3.71 Amino acid transporter, putative 
SSO2390 -1.01 0.03 -2.02 
Inorganic pyrophosphatase, putative 
(ppa) 
SSO3189 -1.97 0.21 -3.93 Amino acid transporter, putative 
SSO5544 -1.23 0.21 -2.35 Carboxylate-ammine ligase 
SSO5847 -1.01 0.26 -2.01 Hypothetical protein 
SSV2_A305 -1.20 0.26 -2.29 SSV2 ORF 
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4.1 Concluding remarks 
 
 Nowadays, many industries take advantage from microbial metabolism to 
transform raw substrates into value-added products. These established industrial 
workflows can be ideally divided into: 1) those producing bacterial biomasses as end 
products (such as starter fermentative cultures, live mucosal vaccines as well as 
probiotics) and 2) those that use whole-bacteria or microbial-derived biocatalysts for 
fermented food (wine, beer and cheese) and/or bioactive molecules production (such 
as enzymes or metabolites). Although microorganisms are valuable bio-factories 
exploitable for a countless number of applications, they are, at the same time, 
susceptible to viral infections as the majority of living organisms. It has been 
demonstrated that viruses can interfere with any industrial workflow by causing loss 
of microbial biomass and, in turn, leading to a drop of the production yield. As a 
consequence, companies that rely on bioprocesses invest in research to boost 
microbial defences. As mentioned before, thanks to their ability of rapidly respond to 
environmental stimuli, prokaryotes (Bacteria and Archaea) have evolved a wide 
‘arsenal’ of strategies to defend against viral infections. Potentially, all these 
mechanisms of resistance could be exploited in order to generate robust microbial 
strains for biotechnological applications. In this regard, the discovery of the CRISPR-
Cas antiviral defence system was considered as a promising solution, because this 
system is not only able to challenge viral infections but, unlike other defence 
strategies, it is sequence-specific, adaptive and heritable. This led to foresee the 
opportunity of ‘programming’ microbial strains to be selectively immune against viral 
infections, thus setting up safeguarded bioprocesses through naturally or artificially 
adding new spacers into CRISPR loci. 
 Recent comparative genomic analyses have shown a high abundance of 
genes encoding for defence systems in the genomes of thermophiles. Moreover, it 
has been observed that these genes cluster into genomic regions referred as 
defence islands. In parallel, direct analyses of environmental samples have revealed 
that viruses infecting thermophilic Archaea, especially those belonging to the phylum 
Crenarchaea, are extremely different from the bacterial and eukaryal counterparts. 
These evidences have fostered numerous studies aimed at dissecting host-virus 
interactions, especially in the frame of the CRISPR-Cas system response. The model 
archaeon used in this study, i.e. S. solfataricus P2, is suitable for this purpose 
because it shows a complex organization of CRISPR loci and cas genes. 
Additionally, it is a permissive host for SSV1 and SSV2, which belongs to a viral 
family that groups viruses with morphology, genome organization and genes 
sequence that have never been observed before. 
 The first aim of this project was to study the interaction between S. solfataricus 
P2 and the UV-inducible fusillovirus SSV1. This because preliminary whole-
transcription analyses revealed that this virus did not induce the activation of the 
CRISPR-Cas system once infected the host. Therefore, the scope of this analysis 
was to understand how SSV1 could establish this harmonious relationship with        
S. solfataricus. Interestingly, this led to reveal a new aspect of the SSV1 life cycle 
regulation. Indeed, a novel viral gene (f55) was found to be expressed at high level in 
SSV1-lysogens, thus indicating an important role of the encode protein (F55) in the 
maintenance of the virus-host relationship during lysogeny. Given the similarity 
between the SSV1 genome region harbouring f55 and that from which the lambda 
repressor CI is expressed, our interest was to functional characterize the putative 
transcription repressor F55 in order to unravel the lysogeny/induction switch of SSV1. 
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The reported experiments confirmed that the RHH DNA-binding protein F55 site-
specifically binds in vitro to target sequences in the promoters of the UV-inducible 
Tind, the early-induced T5, T6 transcripts as well as to its own promoter. Furthermore, 
the setting up a suitable protocol for the UV irradiation of the SSV1-lysogens, 
enabled investigations on the regulative role of F55 in vivo. This analysis showed that 
F55 is indeed the key regulator of the lysogeny/induction transition of SSV1. In 
particular, it acts by repressing the transcription of SSV1 early-genes in lysogenic 
cells and by allowing their expression once the infected cell is exposed to UV-light. 
This makes F55 the first fuselloviral regulator for which a defined role has been 
proved in vivo. Moreover, the analysis of the viral titre and copy number led to 
highlight substantial differences between the lysogenic state of the phage lambda 
and that of SSV1. For instance, lambda expresses only the CI repressor during 
lysogeny and is carried exclusively as a provirus. On the other hand, SSV1 
expresses other genes besides F55 that altogether allow the co-presence of both 
episomal and integrated DNA as well as the production of SSV1 virions throughout 
the growth of the infected host. As a result, the lysogeny of SSV1 was defined as a 
carrier stage, in which the virus keeps low titre and copy number. In this latter case, 
the UV irradiation leads to step into a stage at high copy number that does not cause 
apparent cell lysis (induced state). These differences are also mirrored by the 
regulation of the F55 expression, which has been shown not to be as stringent 
(on/off) as for CI of lambda. In fact, in the case of SSV1, the transition from lysogeny 
to induction is regulated by oscillation in the F55 intracellular concentration rather 
than by its presence/absence as reported for CI. Arguably, this leaky regulation 
evolved as consequence of the non-lytic nature of SSV1, which can produce a viral 
progeny also in the lysogenic host, without causing cell death. Have the ability of 
SSV1 to be self-consistent in regulating its copy number been responsible for the 
defeated activation of the CRISPR-Cas system in S. solfataricus? Data collected for 
the SSV1/SSV2 double-infected strain led to speculate that transcription factors 
(probably F55) and/or other molecular components encoded by SSV1 might be 
responsible for direct or indirect silencing the CRISPR-Cas response in the SSV1-
infected host. Anyhow, further investigations are underway to define this aspect. For 
instance, analysis of the leader-proximal region of the S. solfataricus CRISPR loci 
are planned to be carried out in the SSV1-InF1 strain after cycles of UV-irradiations. 
This would allow understanding if new spacers acquisition is stimulated when SSV1 
is present at high copy number for a wider time windows. 
 On the other hand, as concerns the interaction between S. solfataricus and 
SSV2, reported data clearly shown that this virus triggers a CRISPR-Cas antiviral 
response once it establishes a stably infection into the host cells. Despite the 
similarities with SSV1, SSV2 shows a major difference in the regulation of the 
replication induction. Indeed, in this latter case, it is not an exogenous stimulus that 
induces viral replication but it is a host-depended signal, which is probably produced 
when the cells enter into the stationary phase of the growth, at least as concerns the 
natural host S. islandicus. Since in the permissive host S. solfataricus it has been 
shown that this regulation is lost, the stain SSV2-InF1 has provided an exceptional 
opportunity to study host response toward the infection of a virus that does not self-
regulate its replication induction. Almost all six CRISPR loci of S. solfataricus were 
found to be up-regulated in this strain, together with cas genes coding for proteins 
that assemble into a type I interference complex. This suggests that the final target is 
the SSV2 DNA rather than RNA. However, PCR analysis of the leader-proximal 
region of all the loci proved that no adaptation occurred as consequence of the SSV2 
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infection; hence, immunity against SSV2 is probably conferred by previously acquired 
spacers (Fig. 1, phase I). Even though it was expected that this response would have 
allowed the host to completely challenge the viral infection, it was found that the virus 
managed to skip the CRISPR-Cas system. This is supported by the following 
observations: i) it was impossible to isolate SSV2-cured clones from the SSV2-InF1 
strains, although this latter was challenging the infection (Fig. 1, pahse I), ii) clones 
with a low titre and copy number showed a bias in the attachment-site occupancy; 
indeed, the integration site always harboured the provirus, indicating that provirus-
capture events occurred (Fig. 1, phase II) and iii) these clones underwent to spacer 
loss at the leader-proximal region of the locus F, which harbours spacers directed 
against SSV2 (Fig. 1, phase III). These evidences raised interesting questions, such 
as: i) what would happen if the invading virus cannot be readily destroyed because 
managed to become ‘self’, as in the case of SSV2? and ii) which are the 
consequences of these events on the production of virus-resistant strains for 
biotechnological applications? It is clear enough that these findings cast doubts on 
the applicability of such defence system to create safeguarded bioprocesses, at least 
as concerns integrative viruses. Although strains carrying spacers directed against 
such viruses could be selected, they would be not stable because of self-attach 
events that could easily occur against the integrated provirus and, in turn, against the 
host chromosome (Fig. 1, phase III). A suitable alternative would be the use of 
CRISPR-Cas systems of type III, which target RNA rather than DNA. However, this 
would limit their use only for hosts with such subtype of CRISPR-Cas systems. 
Another possibility would require a deep knowledge of the virus-host interaction that, 
in turn, would allow the selection of starter strains with mutated attachment sites. 
Even though the drawback of autoimmunity has been highlighted, these data are 
interesting from an evolutionary point of view. In fact, as aforementioned, adaptation 
on one side (host) always stimulates counter-adaptation to the other side (virus). 
Hence, once again, it is confirmed that: ‘the evolutionary arms race is a never-ending 
story!’ 
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Figure 1. Autoimmunity model. Upon SSV2 infection, targeting-spacers are used to challenge the 
viral DNA. Since the number of the episomal copies exceeds, it is likely that they are the first to be 
recognized and targeted (phase I). Once the viral copy number decreases, because of the CRISPR-
Cas response, the provirus is trapped into the host chromosome since none or very few functional 
copies of the integrase genes are present. Moreover, since no differences occur between episomes 
and provirus, CASCADE complexes can target this latter and cleave it (phase II). This could lead, in 
turn, to host genome degradation by the action of exonuclease enzymes (Phase III). 
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